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Stellingen 
1. Daling van het carotenoi'den gehalte in het bloed, binnen een normaal 
fysiologisch bereik en een periode van een jaar, heeft geen nadelige effecten 
op de gezondheid van het oog, de huid en hart en bloedvaten. 
Dit proefschrift. 
2. Een omgekeerde relatie tussen de dichtheid van het macula pigment en de 
lens, suggereert dat lutei'ne en zeaxanthine in het oog de veroudering van de 
lens kunnen vertragen. 
O.a. dit proefschrift. 
3. Het feit dat biomerkers vaak niet afdoende zijn gevalideerd, laat onverlet dat 
toepassing ervan waardevolle inzichten kan opleveren over mogelijke 
werkingsmechanismen van voeding in relatie tot gezondheid. 
4. Het aanpassen van de smaak van groente en fruit kan bijdragen aan een 
gezonder en langer leven. 
Mombaerts. Nature Genetics 2000;25:130-2. 
5. Een staaroperatie is een voorteken voor de ontwikkeling van coronaire 
hartziekten. 
Hu et al. American Journal of Epidemiology 2001;153:875-81. 
6. 'Net zomin als er een veilige auto bestaat, bestaat veilige voeding. Veiligheid 
hangt immers nauw samen met hoe een product wordt gebruikt of 
geconsumeerd.' 
C. Dutilh, De Volkskrant, 8 december 2001. 
7. Door de ICT ontwikkelingen ter bevordering van het leggen en onderhouden 
van relaties raken veel mensen relationeel gezien in een isolement. 
Stellingen behorend bij het proefschrift 
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Abstract 
Observational epidemiological studies have consistently shown that a diet rich in 
carotenoid-containing fruit and vegetables is associated with a reduced risk of 
chronic diseases. Because intervention studies with hard endpoints are time-
consuming and costly, the use of biomarkers could be a promising approach. We 
studied the relation between serum carotenoid concentrations in a normal 
physiological range and biomarkers of eye, skin and cardiovascular health. 
In a cross-sectional study among 376 subjects the associations between serum and 
adipose tissue lutein and macula pigment (MP) density in the eye were stronger in 
men than in women. MP density was inversely associated with lens density. Lens 
density was not related to serum and adipose tissue concentrations of lutein after 
adjustment for age. A modifying effect was observed on the association between 
serum carotenoids and minimal erythema dose, a marker of skin sensitivity to UV 
light. Several carotenoids were inversely associated with markers of inflammation 
markers and endothelial function. 
In a 1-year randomized double blind placebo-controlled trial among 341 subjects, 
the effects of 0 ,7 , 10 and 17 g/d consumption of sucrose polyesters (SPE) on 
serum carotenoids and functional biomakers were studied. Lipid standardized 
carotenoid concentrations decreased by 13-33% in the group consuming 17 g/d 
SPE in comparison with the control group. Decreases of serum carotenoids in the 
10 g/d and 7 g/d SPE groups were less. No negative effects were observed on 
markers of oxidation, eye health, cardiovascular health, and immune status. In a 4-
week randomized single blind placebo-controlled trial among 47 subjects, the 
effect of 500 g/d fruit and vegetables + 200 mL fruit juice was studied in 
comparison with 100 g/d fruit and vegetables consumption on serum carotenoids 
and biomarkers of cardiovascular health. Serum carotenoids increased by 
22-128%. Homocysteine concentrations decreased by 11%. No effect was 
observed on serum lipids, blood pressure and fibrinolysis/coagulation variables. 
Overall, our studies used biomarkers that are indicative of biological processes 
currently thought to be important in disease etiology. But the predictive value has 
not been established. Therefore, our studies cannot be conclusive for disease risk. 
However, they seem to add proof to the hypothesis that serum carotenoid decreases 
or increases within normal physiological ranges in periods up to one year, have no 
or limited impact on biomarkers related to eye, skin and cardiovascular health. 
Contents 
1. Introduction 9 
2. Macular pigment density in relation to serum and adipose tissue 
concentrations of lutein and serum concentrations of zeaxanthin 29 
3. Lutein and zeaxanthin in the eye may retard aging of the lens 55 
4. Determinants of skin sensitivity to solar irradiation 73 
5. Serum carotenoids and vitamins in relation to biomarkers of endothelial 
function and inflammation 93 
6. Substantial decreased carotenoid concentrations, as caused by sucrose 
polyesters, have no impact on chronic disease markers 111 
7. Fruits and vegetables increase plasma carotenoids and vitamins and 
decrease homocysteine in humans 135 
8. Fruit and vegetables and cardiovascular risk profile: a diet controlled 
intervention study ^ 
9. General discussion 171 
Summary 186 
Samenvatting 191 
Dankwoord 196 
About the author 198 
List of publications 199 
Chapter 1 
Introduction 
Chapter 1 
The common denominator of the studies in this thesis is their focus on potential 
health effects of carotenoids in relation to eye, skin and cardiovascular health. 
Observational epidemiological studies have consistently shown that a diet rich in 
carotenoid-containing fruit and vegetables is associated with a reduced risk of 
chronic diseases, such as cardiovascular disease, some types of cancer, cataract and 
macular degeneration. Although the preventive mechanisms are not fully 
understood, many authorities now recommend an intake of more than 400 g/d of 
fruit and vegetables, and carotenoids are widely held to explain in part the 
beneficial effect of fruit and vegetables. Therefore, the introduction of products in 
which fat was replaced by non-digestible sucrose polyesters (SPE) met with 
scientific concern because SPE intake lowers plasma concentrations of carotenoids, 
probably associated with negative effects. This introduction should provide the 
reader with background information to comprehend the studies presented in this 
thesis. First, some information on carotenoids in man is given. Second, the state-of-
the-art is summarized with regard to health effects of carotenoids on the eye, the 
skin and the cardiovascular system. Third, the concept of biomarkers is introduced 
and biomarkers of eye health, skin health and cardiovascular health are discussed 
with information on their relation to carotenoids, if available. Finally, the outline of 
the thesis and the research questions asked in this thesis are given. 
Research on carotenoids 
Up to now, P-carotene has been the most studied carotenoid, but the knowledge of 
other carotenoids is rapidly expanding (Van den Berg et ah, 2000). Earlier 
observational studies have shown quite consistently a reduced risk of cancer in 
individuals with a high intake of carotenoids or high blood carotenoid 
concentrations (van Poppel and Goldbohm, 1995). Based on these promising 
associations, intervention trials were executed to evaluate the cancer-protective 
effect of P-carotene supplementation. These large-scale studies of high doses of P-
carotene (15-30 mg/day) have shown no effect (Hennekens et ah, 1996) or even an 
increased risk of lung cancer in smokers (ATBC Study Group, 1994; Omenn et ah, 
1996). Only one study showed a protective effect of combined p-carotene, 
selenium and vitamin E supplementation (Blot et ah, 1993). Also, intervention 
trials did not confirm the protective effect of P-carotene on cardiovascular disease 
(Hennekens et ah, 1996). Recently, a high intake of lycopene was found to be 
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associated with a lower risk for prostate cancer (Giovannucci, 1999) and high 
lutein and zeaxanthin consumption with a lower age-related macular degeneration 
risk (Seddon et al, 1994). Previous findings suggest that carotenoids other than P-
carotene, probably at nutritionally relevant concentrations, may be important in 
preventing disease. Otherwise, carotenoid concentrations could reflect other 
components or processes in the body related to disease risk. 
Recently, laboratory analyses allowed of measuring individual carotenoids in 
serum and other tissues, such as adipose tissue, prostate, skin and the eye (Stahl et 
al, 2000a; Seddon et al, 1994; Kardinaal et al, 1995; Handelman et al, 1988; 
Bone et al, 1985). The main carotenoids found in blood are lutein, zeaxanthin, (3-
cryptoxanthin, a-carotene, p-carotene and lycopene in concentrations ranging from 
0.05 to 0.40 fa.mol/L, while most other carotenoids are present in blood and tissues. 
Adipose tissue is readily accessible for biopsy and adipose tissue concentrations of 
carotenoids could also be used next to serum concentrations as a marker of 
carotenoid status (Kardinaal et al, 1995). 
Intervention studies have shown that blood carotenoid concentrations can be 
influenced by dietary intake. For example, fruit and vegetable consumption can 
increase serum carotenoid concentrations (Zino et al, 1997; Yeum et al, 1996). 
Absorption of dietary carotenoids is inhibited by non-absorbed lipophilic and lipid-
like compounds. A few years ago, products in which fat was replaced by sucrose 
polyesters (SPE) were introduced in the US market. Consumption of these products 
with fat substitutes reduces the bioavailability of carotenoids and can lower serum 
carotenoid concentrations (Weststrate and van het Hof, 1995). More recently, 
products enriched with phytosterol and plant stanol esters capable of lowering LDL 
cholesterol were launched on the market. These products also diminish carotenoid 
absorption, albeit to a lesser extent (Weststrate and Meijer, 1998; Plat and 
Mensink, 2001). These changes in serum carotenoid concentrations may influence 
carotenoids concentrations in several tissues and, eventually, disease risk. 
Health effects of carotenoids on the eye 
The eyes contain many parts, all working together to process sensory information 
for vision. Light enters the eye at the corneal surface and passes through the lens to 
the posterior of the eye where the light is focused as an image on the retina (Taylor, 
1999). The retina is a thin, transparent, light-sensitive neural tissue that originates 
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from the central nervous system during embryonic development. The retina is the 
actual organ of vision and contains the photoreceptors (cones and rods). These 
photoreceptors are responsible for the conversion of light into electric signals, 
which are transported by nerve cells to the brain. The macula is a structure near the 
centre of the retina that contains the fovea and a small pit, the fovea centralis. This 
specialized part of the retina contains a high concentration of photoreceptors and is 
responsible for vision thus allowing of such activities as reading (Taylor, 1999). 
This macula region in the retina is damaged by age-related macular degeneration 
(AMD), the leading cause of blindness in the Western world. One hypothesis is 
that oxidative stress could play a role in the pathogenesis of AMD. The retina is 
susceptible to oxidative stress due to high oxygen consumption, a high proportion 
of polyunsaturated fatty acids in the photoreceptors and exposure to visible light 
(Beattyetal, 1999). 
The carotenoids lutein, zeaxanthin and meso-zeaxanthin may play a critical role in 
the maintenance of normal vision because these polar compounds are the main 
carotenoids in the macula for shaping macular pigment (MP), while other, non-
polar carotenoids are absent. The high concentration of these carotenoids is 
responsible for the yellow color, called macula lutea or 'yellow spot'. It has been 
hypothesized that these carotenoids reduce the risk of AMD by preventing damage 
to the retina by absorbing high-energy blue light or by virtue of their antioxidant 
activity (Landrum et al, 1997a). Some observational epidemiological studies have 
shown a reduced risk of AMD in subjects with a higher intake of lutein and 
zeaxanthin or higher plasma concentrations of lutein and zeaxanthin (Seddon et al, 
1994; Eye Disease Case Control Study Group, 1993; Goldberg et al, 1988). Other 
epidemiological studies have not shown significant reductions in risk of AMD with 
high serum concentrations or dietary intakes of lutein and zeaxanthin (Mares-
Perlman et al, 1995a; Sanders et al, 1993; Mares-Perlman et al, 2001). A recent 
large randomized placebo controlled trial showed that the intake of a supplement 
with both antioxidants (vitamin C, E and P-carotene) and zinc in comparison with 
placebo the development of advanced AMD statistically reduced. (AREDS, 
2001a). 
The primary function of the lens is to collect and focus light on the retina. The lens 
is a simple tissue made of epithelial cells and fiber cells. Epithelial cells on the 
anterior surface of the lens divide, transmigrate to the core of the lens and 
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differentiate into fiber cells. These fiber cells synthesize proteins, called 
crystallines, which fill the fiber cells, thus resulting in a clear lens (Taylor, 1999). 
As the lens ages, or with stress due to light exposure (McCarty and Taylor, 1999) 
or smoking (West, 1999), the proteins are photooxidatively damaged and 
aggregate, causing precipitations and an opaque lens, which interferes with vision 
and is involved in cataract (Taylor, 1999). Cataract is a major cause of visual 
disability leading eventually to blindness. Fortunately, surgical removal of the lens 
is successful in restoring adequate vision in most cases. 
Because of the involvement of oxidative processes in the development of cataract, 
interest has focused on antioxidant compounds. Lens proteins are protected 
indirectly by antioxidant enzymes: superoxide dismutase, catalase and glutathione 
reductase/peroxidase. Direct protection is offered by antioxidants: glutathione 
(GSH), ascorbate (vitamin C), tocopherol (vitamin E) and carotenoids. The major 
lens carotenoids are lutein and zeaxanthin (Taylor, 1999). 
In observational studies, consumption of foods rich in lutein and zeaxanthin or high 
serum concentrations of these carotenoids was associated with a lower relative risk 
of cataract (Chasan-Taber et al, 1999; Brown et al, 1999; Lyle et al, 1999; 
Hankinson et al, 1992; Jacques and Chylack, 1991). However, Mares-Perlman et 
al. (1995b) did not detect an altered risk for cataract among consumers of these 
specific carotenoids. Two prospective intervention studies on the effect of a high 
amount of antioxidants on cataract and vision-loss showed conflicting results. The 
AREDS study did not find an effect of vitamin C, E, P-carotene and zinc on the 
development or progression of cataract (AREDS, 2001b). The REACT (Chylack et 
al, 2002) showed a small deceleration in the progression of cataract after 
supplementation with high amounts of vitamin C, E and P-carotene. 
Health effects of carotenoids on the skin 
The human skin is the largest organ of the body and acts as a protective covering of 
the body. Skin condition and functioning is affected by environmental factors, such 
as UV radiation, free radicals, toxic and allergenic compounds and mechanical 
damage, as well as by endogenous factors such as genetic predisposition, immune 
and hormone status and stress (Boelsma et al, 2001). 
The effects of UV light may be either beneficial or damaging. Sunlight is essential 
for the formation of vitamin D, and UV light exposure may be used successfully in 
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the treatment of some disease conditions like acne and eczema. Damaging effects 
induced by UV irradiation via light-dependent formation of reactive oxygen 
species (ROS) are the development of sunburn, aging of the skin and skin cancer. 
Protective effects of carotenoids in the skin have been shown in the treatment of a 
genetic disorder, erythropoietic protoporphyria. In this disease an enzyme defect 
causes the uptake of the photosensitizer protoporphytin in the skin, where it 
absorbs light and forms ROS. Treatment with large amounts of P-carotene leads to 
the accumulation of p-carotene in the skin which alleviates the symptoms 
(Mathews-Roth, 1993). Not only P-carotene can accumulate in the skin but also 
other carotenoids (Stahl et al, 2000a; Peng et al, 1995). 
Observational data on the relation between carotenoids and risk of non-melanoma 
skin cancer are sparse and inconsistent. Some studies report an inverse relation 
between carotenoid concentrations and non-melanoma skin cancer (Wei et al, 
1994; Kune et al, 1992) while others could not support the hypothesis that diets 
high in specific vitamins lower the risk of this disease (van Dam et al, 2000). No 
effect was found in a large randomized trial of 12 years of supplementation with p-
carotene on non-melanoma skin cancer (Frieling et al, 2000). 
Health effects of carotenoids on cardiovascular disease 
Cardiovascular disease is the main cause of death in the Netherlands and other 
Western countries. The mechanisms leading to this disease are multifactorial and 
have not yet been fully unravelled. Several risk factors, including smoking, high 
homocysteine concentrations, high blood pressure and high serum cholesterol 
concentrations, adversely affect endothelial function. 
Atherosclerosis is seen as an inflammatory disease (Ross, 1999). The vascular 
endothelium can be activated by a variety of inflammatory stimuli, including 
oxidized LDL, free radical species or high mechanical stress. The activated 
endothelium releases cytokines and up-regulates the expression of adhesion 
molecules. In normal conditions, this process is transient but when the 
inflammation continues, circulating monocytes are attracted to the endothelium by 
chemokines, bind adhesion molecules and transmigrate to the subendothelial space. 
Within the sub-endothelial space, they become macrophages, scavenge oxidized 
LDL and become foam cells. This contributes to the development of fatty streak in 
the early stage of atherosclerosis (Brown and Hu, 2001; Ross, 1999). Platelets can 
14 
Introduction 
adhere to the dysfunctional endothelium and then become activated, which results 
in loose thrombus formation, which is stabilized by the activation of the 
coagulation cascade. If the process of injury continues, intermediate and advanced, 
complicated lesions will be formed (Ross, 1999). 
In general, epidemiological studies have found inverse associations between serum 
or adipose p-carotene concentrations and cardiovascular disease risk (Kardinaal et 
al, 1993; Gey et al, 1993; Street et al, 1994). In contrast to the consistent results 
of the observational studies, intervention studies could not confirm the protective 
effects of carotenoids (Greenberg et al, 1996; Omenn et al, 1996; ATBC Study 
Group, 1994; Hennekens et al, 1996). The discrepancy in results between 
observational studies and intervention studies could be explained by the fact that 
serum concentrations were confounded by one or more factors related to (3-
carotene concentrations and also predictive of cardiovascular disease, for example 
other constituents of fruit and vegetables (Kritchevsky, 1999). 
Evidence that fruit and vegetables protect against cardiovascular disease is 
accumulating (Ness and Powles, 1997; Law and Morris, 1998; Liu et al, 2000). 
Vegetables and fruit are rich sources of a variety of components, including 
vitamins, trace minerals, dietary fiber, folate and many other classes of bioactive 
compounds including carotenoids and flavonoids. These compounds could have 
different mechanisms of actions, for example modulation of cholesterol synthesis, 
modulation of detoxification enzymes, stimulation of the immune system, 
reduction of blood pressure and antioxidant effects (Lampe, 1999). 
Biomarkers, or how to assess health effects of diet in human intervention 
studies 
Formal proof for the positive or negative effects of nutritional compounds requires 
clinical trials with hard end-points, such as morbidity or death. Such studies are 
indispensable but time-consuming and costly. A promising approach to strengthen 
epidemiological studies seems to be the use of biomarkers that can be used as 
predictors of the actual effect of diet on disease. 
The European Commission Concerted Action on Functional Food Science 
(FUFOSE), which was co-ordinated by the International Life Science Institute 
(ILSI), developed a consensus document on the identification and validation of 
relevant markers that can predict potential benefits or risks related to a target 
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function in the body. In the causal pathway between intake and effect, one might 
distinguish biomarkers by their relation with different processes, namely 
biomarkers of exposure or internal dose, biomarkers of target function/biological 
response and intermediate end-points, the latter two designated as biomarkers of 
enhanced function and biomarkers of reduced risk (Diplock et al, 1999). Serum 
concentrations of carotenoids or vitamins (marker of exposure/internal dose) can be 
studied in relation to oxidation of LDL (biomarker of biological response) or 
narrowing of the carotid artery wall (intermediate end-point as evidence for 
cardiovascular disease) in subjects with different genotypes (susceptibility marker). 
Figure 1 Classification of markers (modified from Diplock et al, 1999) 
Intake of 
food ^ 
component 
Improved state 
of health and 
well-being 
effect 
Morbidity/ 
mortality 
In the evaluation of suitability of biomarkers, such properties as relevance, validity, 
reproducibility and feasibility must be studied (Diplock et al, 1999). Firstly, the 
measured biomarker must have biological relevance for objective of the study; 
markers must be clearly linked to the phenomena involved in the biological 
processes being studied. Biomarkers must be validated analytically in standard 
quality control procedures. Biomarkers must also be reproducible, i.e. consistent 
outcomes within observers, among observers and among different centres. Validity 
of biomarkers of exposure is established when a change in intake predicts a change 
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in the biomarkers of exposure, while the validity of biomarkers of enhanced 
function or reduced disease risk is established when a change in these biomarkers 
predicts a change in disease risk. The feasibility of biomarkers in human 
intervention studies is dependent on analytical considerations (e.g. sample 
collection, storage and transport conditions, time required for laboratory analyses) 
and ethical considerations (e.g. easily accessible material, minimally invasive), and 
the biomarker must be potentially modifiable within the time frame of the study. 
Biomarkers of eye health 
Macular pigment (MP) in the eye could be measured by spectral reflectance 
analysis (van de Kraats et al, 1996). Spectral reflectance analysis is a reliable 
method that could be used in a naive target population, with a within subject 
variation of 17% (Berendschot et al, 2000). MP density can also be measured by 
heterochromatic flicker photometry (Hammond et al, 1997a), MP maps from 
scanning laser ophthalmoscopy (Berendschot et al, 2000), the resonance Raman 
scattering method (Bernstein et al, 1998, 2001) and auto fluorescence spectrometry 
(Delori et al, 2001). The estimates of MP density values by these methods are 
highly correlated mutually (Delori et al, 2001, Berendschot etal, 2000). 
Results of previous studies show that MP can be influenced by consumption of 
green leafy vegetables and corn (Hammond et al, 1997a; Johnson et al., 2000) and 
the use of lutein supplements within several weeks (Berendschot et al, 2000; 
Landrum et al, 1997b). The relation between MP density and AMD is not clear 
yet. Bone et al. (2001) showed that donor eyes from subjects with AMD had 30% 
lower MP density values than donor eyes of subjects without AMD. This supports 
the hypothesis that MP density could protect against AMD. In contrast, 
Berendschot et al. (in press) have found that there was no difference in MP density 
between healthy subjects and patients with different stages of AMD. In addition, it 
is not known if a change in MP density can accurately predict a change in risk of 
AMD. 
Spectral reflectance analyses has been shown to yield reliable estimates of lens 
density (van de Kraats et al, 1996). There is a strong relation between lens aging 
and cataract, the latter being the end stage of deterioration of the aging lens 
(Sample et al, 1988; Bron et al, 2000). Although these studies show a strong 
positive association between lens density and age, there are substantial individual 
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differences irrespective of age. Other risk factors of cataract or nutrition could play 
a role in these individual differences. MP density could be used as a marker of 
lutein and zeaxanthin in the eye. It has been shown that MP density correlates 
inversely with lens density (Hammond et al, 1997b). 
Biomarker of skin health 
Sunburn is a well-known acute effect of excessive UV exposure. Low-dose or brief 
exposure to UV irradiation is tolerated by the skin without noticeable or clinically 
relevant changes. Only after reaching a certain threshold, tissue damage results in a 
delayed and prolonged vasodilation allowing passage of lymphocytes and 
macrophages into the tissue and inducing an inflammatory response, which is 
clinically visible as erythema (Boelsma et al, 2001). 
A frequently used measure for the skin's sensitivity to UV light is the minimal 
erythema dose (MED). One MED is the minimal amount of energy required to 
induce visible erythema, which can be defined as a uniform, clearly demarcated or 
just perceptible redness at 16-24 h after UV exposure (Boelsma et al, 2001). Thus, 
a low MED indicates a high sensitivity to UV irradiation. The coefficient of 
variation is <12.5% (A. Vink, personal communication). 
Carotenoid supplements have been shown to provide moderate protection against 
sunburn as measured by erythema (Stahl et al, 2000b, Lee et al, 2000). Just one 
study with tomato paste (Stahl et al, 2001) showed a positive relation between 
dietary intake of lycopene and erythema, which suggests that lycopene decreases 
the sensitivity of the skin to UV light. Sun exposure is the main established risk 
factor for non-melanoma skin cancer (Armstrong and Kricker, 2001), but the 
relation between skin sensitivity to UV light as measured by MED and the 
resulting risk of skin cancer is not established. 
Biomarkers of cardiovascular health 
Biomarkers of cardiovascular disease (CVD) can be classified as risk factors, such 
as blood pressure, cholesterol and homocysteine, and as manifestations of altered 
function, such as impaired endothelial function or intima-media thickness of the 
carotid artery wall. Impaired endothelial function can be measured by enhanced 
endothelial activation and impaired endothelium-dependent vasodilation as 
markers of altered function. Endothelial activation is reflected in increased plasma 
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concentrations of soluble adhesion molecules, including vascular cell adhesion 
molecules (VCAM-1), intercellular adhesion molecules (sICAM-1), E-selectins 
and P-selectins. These molecules are involved in leukocyte recruitment and platelet 
adhesion during thrombosis and inflammation (Brown and Hu, 2001). 
Concentrations of these adhesion molecules are elevated in patients with ischemic 
heart disease (Morisaki et ah, 1997) and coronary heart disease (Hwang et ah, 
1997) and could predict future risk of myocardial infarction (Ridker et ah, 1998) 
and coronary artery disease (Blankenberg et ah, 2001). Endothelium-dependent 
vasodilation can be measured by a non-invasive ultrasound technique, which 
measures the increase in arterial diameter induced by a local increase in arterial 
blood flow (de Roos et ah, 2001). Numerous studies have confirmed impaired 
vasodilation in patients with CVD (Celermajer et ah, 1992; Cox et ah, 1989; 
Zeiher et ah, 1991). Several studies have consistently shown that inflammation 
markers, such as C-reactive protein (CRP), fibrinogen and amyloid A, can predict 
cardiovascular disease (Danesh et ah, 1998; Ridker et ah, 2000). Arterial 
thrombosis can be measured by coagulation and fibrinolysis markers, but their 
causal role in relation to disease has to be established. 
Carotenoids might play a role in the protection against the initiation of CVD by 
virtue of their antioxidant function which may protect against LDL-oxidation or 
through other mechanisms, such as anti-inflammatory processes. Some intervention 
studies show a preventive effect of several carotenoids on LDL oxidation 
(Agarwall and Rao, 1998; Uprichard et ah, 2000; Bub et ah, 2000). Inflammation 
processes have to be taken into account when studying the relation between 
carotenoids and CVD, as suggested by several groups (Kritchevsky, 1999; 
Kritchevsky et ah, 2000; Erlinger et ah, 2001). Previous observational studies have 
shown negative associations between serum carotenoids and inflammation 
markers, such as CRP and leucocytes (Kritchevsky et ah, 2000; Erlinger et ah, 
2001). In an intervention study in patients with diabetes type II no effect was seen 
on markers of inflammation after tomato juice consumption (Uprichard et ah, 
2000). 
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Other components in fruit and vegetables 
Many components of fruit and vegetables could have an influence on the 
mechanisms underlying CVD. Results of most published studies support a role for 
vitamin C and vitamin E in preserving endothelium-dependent vasodilation 
mediated, at least in part, by their antioxidant activity (Brown and Hu, 2001). Folic 
acid can have a beneficial effect on the vascular endothelium by reducing plasma 
homocysteine concentrations or through other mechanisms by reducing oxidative 
stress (Wilmink et al, 2000). In a four-week controlled, parallel-design dietary 
intervention trial it was shown that dietary folate (560 |ug) from vegetables and 
citrus fruit could decrease homocysteine concentrations by 2.0 umol/L (95% CI 
1.0-3.0) (Brouwer et al, 1999). In a large randomized controlled trial it was shown 
that a diet rich in fruit and vegetables (ca. 8.5 servings per day) could reduce 
systolic blood pressure by 2.8 mmHg (P < 0.0001) and diastolic blood pressure by 
1.1 mmHg (P = 0.07) after 8 weeks (Appel et al, 1997). A diet consisting of both 
fruit and vegetables and low-fat dairy products and with reduced saturated and total 
fat concentrations ('combination diet') reduced blood pressure even more. As a 
secondary outcome of this trial, serum lipids were not significantly reduced by the 
fruit and vegetable diet, although the 'combination diet' reduced total cholesterol, 
LDL cholesterol and HDL cholesterol by 7.3%, 9.0% and 7.5%, respectively (all P 
< 0.0001) (Obarzanek et al, 2001). In another intervention trial a recommendation 
to increase fruit and vegetable consumption alone produced no change in serum 
lipids despite significant increases in serum carotenoid and vitamin C 
concentrations (Zino et al, 1997). Human studies that relied on other biomarkers 
possibly related to chronic disease risk have been reviewed by Lampe (1999). 
Outline of this thesis 
As mentioned above, carotenoids are potential beneficial components in fruit and 
vegetables in relation to chronic diseases given the results of observational 
epidemiological studies. Intervention trials have shown that high-dose P-carotene 
supplementation has no protective effect or even increases disease risk. Therefore, 
it seems advisable to study the effects of those carotenoids which are most 
abundant in the diet at nutritionally relevant concentrations with regard to disease 
risk, in particular diseases in which carotenoids are found in the target tissue of the 
disease, for example the eye as target tissue in age-related macular degeneration. 
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Carotenoids are not the only potential preventive compounds in fruit and 
vegetables against chronic diseases, such as cardiovascular disease. Therefore, it 
seems also advisable to study the effect of fruit and vegetables as a whole at 
nutritionally relevant consumption concentrations on disease risk. Because 
intervention studies with hard end-points are time-consuming and costly, the use of 
biomarkers as predictors of the actual effect of diet on disease could be a promising 
approach. 
The objective of the studies reported in this thesis was to evaluate the effects of 
carotenoid status in normal physiological ranges in man on biomarkers of eye, skin 
and cardiovascular health. This thesis describes the results of an observational 
study and two human intervention studies. The results presented for the 
observational study were obtained from the baseline measurements of an 
intervention study. In this first intervention study, the effects of SPE consumption 
was studied on biomarkers of eye, skin and cardiovascular health. In a second 
intervention study, the effects of a high but realistic intake of fruit and vegetables 
were assessed on biomarkers of cardiovascular health. 
In the observational study the following research questions were addressed: 
1. What is the quantitative relation of serum and adipose tissue carotenoid 
concentrations in a normal physiological range with biomarkers of eye health in 
human volunteers? Macular pigment (MP) density (Chapter 2) and lens density 
(Chapter 3) were measured as biomarkers of eye health. Chapter 3 also evaluates 
the relation between MP density and lens density. 
2. What is the quantitative relation of serum carotenoid concentrations in a normal 
physiological range with sensitivity of the skin to UV light in human volunteers? 
Minimal erythema dose (MED) was used as a biomarker of skin health. In addition, 
we evaluated the associations between phenotypic correlates, such as hair, skin and 
eye color, and MED (Chapter 4). 
3. What is the quantitative relation of serum carotenoid concentrations in a normal 
physiological range with biomarkers of endothelial function and inflammation in 
human volunteers? Results on intercellular adhesion molecule (sICAM-1), flow-
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mediated vasodilation (FMD), C-reactive protein (CRP), fibrinogen (Fbg) and 
leucocytes are reported in Chapter 5. 
In the intervention studies the following research questions were addressed: 
4. What is the effect of a long-term intake of sucrose polyesters (SPE) as part of a 
normal dietary pattern on serum carotenoids and fat-soluble vitamins, markers of 
oxidative damage and functional markers of eye and cardiovascular health and 
immune status? 
Studies on the long-term health effects of decreased carotenoid concentrations or 
effects of SPE are lacking. Therefore, we conducted a 1-year randomized, double 
blind, placebo-controlled parallel human intervention trial to investigate the 
possible effects of a long-term decrease in carotenoid concentrations, caused by 
SPE, on biomarkers of oxidation, eye, cardiovascular health and immune status 
(Chapter 6). 
5. What is the effect of an increased fruit and vegetable consumption on serum 
carotenoids, vitamins and markers of cardiovascular risk profile? 
Besides carotenoids, fruit and vegetables contain other potential beneficial 
compounds protecting against the risk of chronic diseases. It is thought that this 
combination of compounds, provided by consumption of a variety of fruit and 
vegetables, is responsible for the beneficial effects of fruit and vegetables. We 
performed a 4-week randomized placebo-controlled parallel human intervention 
trial to investigate the effect of an increased fruit and vegetable consumption on 
serum carotenoids, vitamins and markers of cardiovascular health (Chapters 7 and 
8). 
In the general discussion (Chapter 9), main findings are summarized and discussed, 
that are related to carotenoid status in a normal physiological range on biomarkers 
of enhanced function or reduced risk. Secondly, the predictive value of the 
biomarkers used in our studies is discussed. 
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Abstract 
Background: Macular pigment (MP), concentrated in the central area of the retina, 
contains the carotenoids lutein and zeaxanthin. A low MP density could be a risk 
factor for age-related macular degeneration (AMD). Little information is available 
regarding MP density in relation to serum lutein and zeaxanthin and adipose lutein 
in a general population. 
Objective: To investigate the associations between serum lutein and zeaxanthin, 
adipose lutein and MP density, taking into account potential confounders in a 
population. 
Design: 376 volunteers aged 18-75 years were recruited. In a cross-sectional 
design, serum {n = 376) and adipose tissue (n = 187) were analyzed for carotenoids 
and MP density was measured by spectral fundus reflectance. 
Results: Mean MP density in the total study group was 0.33 ± 0.15. MP density 
was 13% higher in men than in women (P < 0.05). Serum and blood concentrations 
were significantly higher in women for a-tocopherol, vitamin C and all carotenoids 
except for lycopene. Adipose lutein concentrations were also significantly higher in 
women than in men. Regression models showed a positive significant association 
between serum lutein, serum zeaxanthin, adipose lutein concentrations and MP 
density in men after adjustment for age, but no relation in women. In men, serum 
lutein was still significantly associated with MP density after adjustment for age, 
total cholesterol, BMI and smoking. 
Conclusion: The associations between MP density and serum lutein, serum 
zeaxanthin and adipose lutein concentrations are stronger in men than in women. 
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Introduction 
Age-related macular degeneration (AMD) is the main cause of visual impairment 
in Western countries and affects the central region of the retina with the highest 
degree of visual acuity, the macula lutea. Macular pigment (MP) possibly acts as a 
blue light filter to protect the macular region against photo-oxidation by light 
(Landrum et al, 1997a). In addition, MP is capable of scavenging free radicals 
(Khachik et al, 1997). The carotenoids lutein and zeaxanthin are the predominant 
pigments in this area (Snodderly, 1995). Some observational epidemiological 
studies have shown a reduced risk of AMD in subjects with a higher intake of 
lutein and zeaxanthin or higher plasma concentrations of lutein and zeaxanthin 
(Seddon et al, 1994; Eye Disease Case-Control Study Group, 1993; Goldberg et 
al, 1988). Other epidemiological studies have not shown significant reductions in 
risk of AMD with high serum concentrations or dietary intakes of lutein and 
zeaxanthin (Mares-Perlman et al, 1995; Sanders et al, 1993; VandenLangenberg 
et al, 1998; Mares-Perlman et al, 2001). MP density was associated with 
preservation of visual sensitivity in another study (Hammond et al, 1998). The 
possibility that MP is protective against AMD is likely but further research is 
necessary (Beatty et al, 1999). 
If it is demonstrated that MP density has a protective effect on AMD, it is 
important to understand the influence of several factors on MP density and on the 
relationship between MP density and serum concentrations of lutein and 
zeaxanthin, a possible biochemical indicator of intake of carotenoids (Hunter, 
1990). 
In previous studies, MP density was positively related to dietary intake and serum 
concentrations of lutein and zeaxanthin (Hammond et al, 1996a; Bone et al, 
2000). A dietary intervention study showed that an increase in intake of lutein and 
zeaxanthin from foods could increase MP density (Johnson et al, 2000). Two other 
studies reported a change in MP density through lutein supplements (Landrum et 
al, 1997b; Berendschot et al, 2000). In one study some subjects failed to show a 
change in MP density after increasing dietary intake of lutein and zeaxanthin 
(Hammond et al, 1997). 
Previous studies have shown an influence of several factors on the relationship 
between MP density and serum concentrations of lutein and zeaxanthin, for 
example sex and smoking (Hammond et al, 1996a; Hammond et al, 1996b). In 
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addition, in men, a significant positive correlation was found between MP density 
and adipose lutein concentration (Johnson et al, 2000), another possible 
biochemical indicator of carotenoid intake (Hunter, 1990). In contrast, they 
reported a negative correlation between adipose lutein and MP density in women. 
So far, these associations were only evaluated in small study samples. We 
determined the relation between serum lutein, serum zeaxanthin and MP density in 
376 volunteers, adjusting for possible confounding factors. The relation between 
adipose tissue lutein concentrations and MP density was determined in 187 
volunteers, adjusted for possible confounding factors. 
Subjects and methods 
Subjects 
The 380 subjects in our study were recruited from the pool of volunteers of TNO 
Nutrition and Food Research and through advertizing in local and regional 
newspapers and on television. The cross-sectional data analyzed here were 
gathered during the baseline measurements of an intervention study designed to 
test an unrelated hypothesis. Advertizing aimed at recruiting people with a general 
interest in participating in nutrition studies. Respondents who expressed potential 
interest (n = ± 6900) received a form with the in- and exclusion criteria of the study 
and a questionnaire requesting data on daily fruit and vegetable consumption and 
lifestyle factors. This questionnaire was designed for ranking and selection of 
subjects according to their intake and not for quantitative measurements. It was a 
simple questionnaire consisting of questions about the usual fruit and vegetable 
intake, including fruit juices over the last month. This questionnaire contained 8 
items about fruit and vegetable intake, including fruit juices in days/week. In 
addition, 8 questions were included about the portion size, 4 questions about food 
item specification and 1 question about vitamin and/or mineral supplements. 
The major inclusion criterion was an age of 18-75 years. The main exclusion 
criteria were pregnancy and/or lactation or wishing to become pregnant, serum 
cholesterol > 7.5 and/or triacylglycerol > 2.3 mmol/L if not under stabilized 
hypercholesterolemia/ hyperlipidemia treatment, and anticoagulant therapy, and 
vegetarians and vegans. 
A total of 2734 questionnaires were returned. Respondents in the highest quintile 
of fruit and vegetable consumption and those in the lowest tertile (calculated in the 
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total group) were selected. In the lowest stratum vitamin supplement users were 
excluded (n = 127). Finally, we invited 547 respondents of the highest quintile and 
775 respondent of the lowest tertile for an oral briefing. At the oral briefing 
volunteers were informed about the measurements, blood sampling and macular 
pigment density measurement, and about an extra measurement in a subgroup, a fat 
biopsy. The volunteers were told that a fat biopsy could be painful for people with 
less adipose tissue on the buttocks. They had the opportunity to refuse sampling. 
After the oral briefing 589 volunteers were interested in participation and were 
screened. Informed consent was obtained from all subjects. 
During the screening, 54 volunteers were excluded because of the exclusion criteria 
for serum cholesterol and/or triacylglycerol. A number of 122 volunteers withdrew 
during the screening. A total of 413 volunteers were allocated to an entry number. 
Before the start of the study, 33 subjects withdrew from the study. 
At day one, 380 volunteers (179 men, 201 women) entered the study. This group 
consisted of 216 subjects from the low fruit and vegetable intake group and 164 
subjects from the high fruit and vegetable intake group. We randomly selected 
volunteers from whom we would obtain an adipose tissue sample taking sex and 
age into account. If initially selected volunteers refused this measurement, other 
volunteers were randomly selected. 
The study was performed according to ICH (International Conference on 
Harmonization of Technical Requirements of Registration of Pharmaceuticals for 
Human Use) guidelines for good clinical practice, and was approved by an external 
Medical Ethical Committee. The study was conducted at the Department of 
Nutritional Physiology of TNO Nutrition and Food Research, Zeist, and the 
measurements were performed from June 29 to September 16, 1998. 
The final study group (95% whites) comprised 177 men aged 4 2 + 1 5 years and 
199 women (pre- and postmenopausal) aged 41 + 13 years. Of these, 120 (68%) 
and 144 (72%) were non-smokers, respectively (see Table 1 and 2). Of this study 
group we obtained an adipose tissue sample from 89 men aged 43 ±15 years and 
98 women aged 42 ± 14 years. Of these volunteers, 63 (71%) and 68 (69%) were 
non-smokers, respectively. 
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Blood and adipose tissue sampling 
Blood samples from subjects were obtained between 800 and 930h after an 
overnight fast. For the analysis of carotenoids and a-tocopherol blood was 
collected in tubes containing clot activator and gel (Becton Dickinson, Vacutainer 
systems). These tubes were immediately stored in a closed box, to avoid 
breakdown of carotenoids by UV light. Tubes were centrifuged within 15-30 min 
after collection at ca. 2000 x g for 10 min at ca. 4°C to obtain serum. After 
centrifugation serum was removed and stored at ca. -80°C. All serum handling 
before storage was done in subdued light. 
For the analysis of vitamin C, blood was collected in tubes containing lithium 
heparin (Becton Dickinson, Vacutainer systems). A 0.5 mL aliquot of blood was 
added to 2 mL metaphosphoric acid (50 g/L; Mallinckrodt Baker, Deventer, 
Netherlands) before freezing to preserve the vitamin C concentration during 
storage. This mixture was stored at ca. -80°C. 
For the analysis of total cholesterol, LDL cholesterol, HDL cholesterol and 
triacylglycerol blood was collected in tubes containing clot activator and gel 
(Becton Dickinson, Vacutainer systems). Tubes were centrifuged within 15-30 min 
after collection at ca. 2000 x g for 10 min at ca. 4°C to obtain serum. After 
centrifugation serum was removed and stored at ca. -20°C. 
Subcutaneous adipose tissue (approximately 50 mg) was obtained by needle biopsy 
from the lateral buttock (Beynen and Katan, 1985), using a 16-gauge needle 
attached to a plastic container in which the tissue was collected by connecting a 
vacuum tube. Samples were kept in the plastic container, immediately placed on 
dry ice and stored at ca. -80°C. 
Chemical analyses 
Serum samples 
At the day of analysis serum samples were thawed and mixed well. Samples were 
deproteinized by adding 500 \xL sample to 500 uL ethanol (Nedalco, Bergen op 
Zoom, Netherlands) containing tocol (3,4-Dihydro-2-methyl-2-(4,8,12-
trimethyltridecyl)-2H-l-benzopyran-6-ol, Matreya, Pleasant Gap, USA) as internal 
standard. After vortex mixing the samples were allowed to stand for 15 min at 
room temperature to complete precipitation of proteins. Subsequently, 1.0 mL n-
hexane (Merck, Darmstadt, Germany) was added and vortexed for 4 min. After 
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centrifugation (2000 x g, 10 min, 4°C), 0.5 mL of the upper hexane layer was 
evaporated to dryness. The residue was dissolved in 0.5 mL of a mixture of 
methanol (Rathburn Chemicals, Walkerburn, UK), acetonitrile (Biosolve, 
Valkenswaard, Netherlands) and dichloromethane (Mallinckrodt Baker). A 50 uL 
portion was injected on the HPLC system. Quality of the measurements was 
assessed by analyzing plasma quality control samples in each batch. The 
coefficient of variation for the analysis of lutein, zeaxanthin, P-cryptoxanthin, all-
trans lycopene, a-carotene, P-carotene and a-tocopherol were 3.7, 11.5, 8.3, 6.2, 
14.9, 5.8 and 2.8%, respectively (at mean concentrations of 0.16, 0.03, 0.11, 0.31, 
0.05, 0.25 and 20.9 u.mol/L in the quality control samples, respectively). The 
HPLC system consisted of the following equipment: a Waters 2690 solvent 
delivery/injection system (Waters, Etten-Leur, Netherlands), a Waters 996 diode 
array and a Jasco 920 fluorescence detector (Jasco Benelux, Maarssen, 
Netherlands). System control and data acquisition/processing was performed by 
Millennium chromatography manager version 3.05 (Waters). 
Separation was obtained by two CI8 reversed-phase columns (250 mm x 4.6 mm, 
5 p.m) in series, thermostatically controlled at 30°C. The samples were eluted using 
a gradient consisting of methanol, acetonitrile, 2-propanol (Mallinckrodt Baker) 
and milliQ® (Millipore, Etten-Leur, Netherlands) at a flow rate of 1.5 mL/min. 
This HPLC system allows simultaneous detection of retinoids, tocopherols and 
carotenoids as well as their isomers (Figure 1). Additionally, the diode array data 
provide spectral information for confirmation of the identity of the analytes. 
Fat biopsies 
Fat biopsies of about 50 mg were transferred to glass tubes and weighed accurately. 
After addition of 0.4 mL 10% sodium ascorbate solution (Sigma-Aldrich Chemie, 
Steinheim, Germany) and 2.0 mL 1.5 mM ethanolic KOH solution (Merck) the 
samples were saponified for 30 min at 80°C. Subsequently, the samples were 
cooled down to room temperature, 2.0 mL di-isopropyl ether (Merck) was added 
and the samples were mixed vigorously. Of this extract 2.5 mL was vortexed with 
2.5 mL water for 4 min. The upper di-isopropyl ether layer was isolated and 
evaporated to dryness. The residue was dissolved in 0.1-0.2 mL of a mixture of 
methanol, acetonitrile and dichloromethane. A 50 u.L portion was injected on the 
HPLC system, the same system as for the serum samples. In each series quality 
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control samples consisting of a mixture of butter and olive oil were analyzed to 
check for reproducibility. The concentration of the quality control sample was 0.39 
umol/kg lutein with a coefficient of variation of 6.8%. 
Blood samples 
At the day of analysis blood samples were thawed and mixed well. Vitamin C was 
extracted from whole blood using metaphosphoric acid (Mallinckrodt Baker). 
Samples were allowed to stand for 20 min at 4°C to precipitate the protein and 
oxidize ascorbic acid to dehydroascorbid acid. After centrifugation samples were 
subsequently derivatized with 1,2-diaminobenzene (Merck) to quinoxline and 
injected on the HPLC system. In each series blood quality control samples were 
analyzed to check for reproducibility. The reproducibility of the assay was 10%. 
HPLC analysis was performed on an isocratic reversed-phase system consisting of 
a Gilson 234 injector (Meyvis, Bergen op Zoom, Netherlands), a Gynkotek model 
300 pump (Separations, Hendrik-Ido-Ambacht, Netherlands), a C18 column (125 
mm x 4.6 mm, 5 um) and a Jasco 920 fluorescence detector. Mobile flow rate was 
1.1 mL/min and consisted of methanol and buffer pH 7.8. Data acquisition and 
processing were performed by Turbochrom version 6.1.2.0.1 :D19 (PerkinElmer 
Instruments, Nieuwerkerk a/d IJssel, Netherlands). 
Macular pigment density measurement 
MP density was measured in the right eye, if possible. The subjects' pupils were 
dilated with tropicamide 0.5% (Chauvin, Brussels, Belgium). Spectral fundus 
reflectance was measured with the Utrecht Retinal Densitometer (Van de Kraats et 
ah, 1996). Briefly, a rotating wheel (14 revolutions per second) offered a sequence 
of 14 interference filters in the range 430 to 740 nm to enable quasi-simultaneous 
measurement of the reflectance across the visual spectrum. Light reflected from the 
fundus was measured in a detection field of 1.5°, concentric within the illumination 
field of 1.8°. To obtain an estimate of the mean MP density in this area, spectral 
fundus reflectance was measured in two conditions: (1) with the instrument's entry 
and exit pupils aligned to the peak of the Stiles-Crawford (SC) function, and (2) 2 
mm temporal to the SC peak. A detailed optical model of foveal reflection was 
used to arrive at individual estimates of parameters as equivalent thickness of blood 
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Figure 1 Chromatogram of carotenoid, tocopherol and retinol analyses1 
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layer and densities of MP, lens and melanin (Van de Kraats et al, 1996). In short, 
the incoming light was assumed to reflect at the inner limiting membrane, the disks 
in the outer segments of photoreceptors and the sclera. Using known spectral 
characteristics of the different absorbers within the eye (lens, MP, melanin, blood), 
the densities of the pigments and percent reflectance at the interfaces were 
optimized, to fit the measured data at all wavelengths. A previous study using the 
same method showed a within subject variation coefficient of 17% (Berendschot et 
al, 2000). 
Measurement of potential confounders and baseline characteristics 
Iris color and smoking status were determined because of their previously 
documented associations with MP density (Hammond et al, 1996b; Hammond et 
al, 1996c). Iris color was graded by a set of four standard photographs, providing a 
five-grade classification system (Seddon et al, 1990). Blue and gray irises were 
classified as grade 1 or 2. These grades were distinguished by assessing the 
proportion of total iris area with brown or yellow pigment. A green iris was 
assigned grade 2 or 3. Similarly, these grades depended on the extent of brown or 
yellow pigment in the iris. A predominantly brown iris was assigned grade 3, 4 or 
5, depending on the intensity of the yellow or brown pigment (Seddon et al, 1990). 
Smoking status was obtained by a questionnaire; subjects were classified into 6 
categories ranging from non-smoking (category 0) to more than 15 cigarettes/day 
(category 5). 
Serum triacylglycerols were analyzed by enzymatic hydrolysis with subsequent 
enzymatic determination of the liberated glycerol by colorimetry (commercial 
available kit; Boehringer, Mannheim, Germany). Total cholesterol was analyzed by 
enzymatic conversion to a stable chromogen, which can easily be detected by 
colorimetry (Boehringer, Mannheim, Germany). HDL cholesterol was analyzed by 
precipitation with polyethylene glycol, centrifugation and enzymatic detection by 
colorimetry (Boehringer, Mannheim, Germany) and LDL cholesterol was 
calculated using the Friedewald formula (Friedewald et al, 1972). 
Further, age was determined, body weight and height measured and body mass 
index (BMI) calculated. Body weight was assessed by weighing the subject 
wearing indoor clothing, without shoes, wallet and keys. Height was measured 
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without shoes. Body mass index (BMI) was calculated with the formula body 
weight (kg)/ body height squared (m2). 
Statistical analyses 
The SAS statistical software package SAS/STAT (Version 6, SAS Institute, Cary, 
NC, USA) was used for data analysis. T-tests were used to evaluate the differences 
in serum carotenoids, vitamins, MP density and continuous baseline characteristics 
between men and women, smokers and non-smokers and high and low fruit and 
vegetable intake. ANOVA was used to evaluate differences in MP density between 
different iris color categories. If we found significant differences between 
categories, the Scheffe test was used for multiple comparisons. Pearson correlation 
coefficients were calculated between baseline characteristics and both serum lutein 
concentrations and MP density. Correlation coefficients, adjusted for total 
cholesterol were calculated between serum lutein, MP density and other 
carotenoids and vitamins. If variables were not normally distributed, variables were 
log-transformed. Linear regression (GLM procedure) was used to evaluate the 
association between MP density and serum lutein and zeaxanthin concentrations 
and adipose lutein concentrations. 
Firstly, two linear models with the independent variables serum lutein or 
zeaxanthin, adjusted for age were fitted (Model la-lb). Then, a model with both 
serum lutein and zeaxanthin, adjusted for age, was performed (Model lc). This was 
our basic model. After inclusion of the sex variable and the interaction term lutein 
x sex or zeaxanthin x sex in the models, these interaction terms were significant (P 
< 0.05). This resulted in final general linear models for men and women separately. 
Variables that could influence the association between serum lutein and macular 
pigment density were investigated as potential confounders: smoking status and 
BMI. The models were adjusted for each potential confounder separately. The 
regression coefficient of serum lutein after adjustment for each potential 
confounder separately was compared with the regression coefficient of serum 
lutein in the basic models for men and women. If the change in the magnitude of 
the regression coefficient was more than 10%, the confounder was added to the 
model. Total cholesterol was also included in the model, because serum 
carotenoids were related to serum lipid concentrations. We also corrected for other 
carotenoids and vitamins to evaluate whether they were confounders. 
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Mean serum lutein concentrations were calculated across quartiles of lutein divided 
by total cholesterol in men and women. Because of the heterogeneity of the female 
group (pre- and postmenopausal), a regression analysis to evaluate the association 
between serum lutein and MP density was performed among women older and 
younger than 50 years. Previous procedures were also used to analyze the 
association between adipose tissue lutein concentration and MP density. If the P-
value was less than 0.05, the regression coefficients of the variables were 
considered as significant (P < 0.05). Regression diagnostics were used to examine 
the residuals and influential points and test the model assumptions. 
Two volunteers squinted too much during the MP density measurement. Further, 
one measurement was not approved by the analyst of the MP density measurement 
and one subject was withdrawn from the study before MP density measurement. 
Data from these 4 subjects were not included in the statistical analyses. Eight 
subjects were measured in the left eye instead of the right eye. Their measurements 
were included in the analysis, because there is a good correlation between both 
eyes (Hammond and Fuld, 1992). From the 187 adipose tissue obtained, the lutein 
concentrations of 21 samples were below the lower limit of quantification. Half of 
the limit of detection value was assigned to these samples and these data were 
included in the analyses. Data of 177 men and 199 women were used in the 
regression analyses after adjustment for age. Because of missing data in 
covariables, data of 175 men and 197 women were used in the multiple variable 
regression analyses, adjusted for age, total cholesterol, BMI and smoking status. In 
the two regression models for adipose lutein concentrations adjusted for age or age, 
BMI and smoking status 187 (89 men, 98 women) values were used. 
Results 
Study group characteristics 
Study group characteristics and associations with serum lutein and MP density are 
presented in Tables 1 and 2. The 10th, 50th and 90th percentiles of serum lutein 
concentrations were 0.10 u.mol/L, 0.17 u.mol/L and 0.27 u.mol/L. The 10lh, 50th and 
90th percentiles of serum zeaxanthin concentrations were 0.03 u,mol/L, 0.05 u.mol/L 
and 0.08 u,mol/L. Iris color was not classified for all participants, but the group 
consisted mainly of people with blue or gray irises (category 1) (Table 1). 
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In men, we found significantly higher serum lutein concentrations in non-smokers 
in comparison with smokers. 
Table 1 Baseline characteristics of volunteers and mean serum lutein concentrations and 
macular pigment (MP) density per category 
Characteristics Serum lutein 
Men Women Men Women 
MP density 
Men Women 
Total 
Smoking 
No 
Yes 
177 
120 
57 
199 
144 
55 
Fruit and vegetable consumption 
Low 
High 
Iris color 
Blue or gray 
Blue, gray or 
green 
Green or light 
brown 
Brown 
Dark brown 
116 
61 
101 
28 
10 
13 
7 
98 
101 
115 
24 
15 
13 
5 
0.16 + 0.07 0.19 ±0.08 0.35 ± 0.152 0.31+0.14 
0.17±0.073 0.1910.09 0.35 ±0.14 0.30 ±0.14 
0.15 ±0.06 0.17 ±0.08 0.34 ±0.17 0.33 ±0.14 
0.16±0.064 0.16±0.064 0.34 ±0.14 0.30 ±0.13 
0.18 ±0.07 0.21 ±0.09 0.36 ±0.17 0.32 ±0.15 
0.16 ±0.07 0.19 ±0.09 0.35 ±0.14 0.31 ±0.14 
0.15 ±0.06 0.19 ±0.06 0.33 + 0.15 0.33 ±0.15 
0.17 ±0.07 0.17 + 0.07 0.32 ±0.17 0.28 ±0.18 
0.17 ±0.07 0.19 ±0.06 0.28 ±0.14 0.33 ±0.15 
0.19 ±0.06 0.22 ±0.12 0.50±0.196 0.22 ± 0.06 Mean ± SD. Significantly different from women (P < 0.05). Significantly different from 
smokers (P < 0.05).4 Significantly different from high fruit and vegetable consumption (P 
< 0.01). 5 Data missing for 18 men and 27 women. 6 Significantly different from iris color 
category brown, Scheffe test. 
Women had significantly higher total cholesterol and HDL concentrations than 
men (Table 2). Serum lutein concentrations correlated significantly with height 
(men), BMI (women), total cholesterol, HDL cholesterol and LDL cholesterol 
(both sexes) (Table 2). 
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Serum and blood concentrations were significantly lower in men than in women for 
a-tocopherol, vitamin C and all carotenoids but lycopene (Table 3). After 
adjustment for total cholesterol, serum P-carotene (P = 0.07) and a-tocopherol (P = 
0.42) were not significantly different between men and women. 
Table 2 Baseline characteristics in men (n = 177) and women (n 
with serum lutein (R lut) or macular pigment density (R mac) 
199) and correlation 
Variable 
Age (y) 
BMI (kg/m2)1 
Height (m) 
Body weight (kg)1 
Total cholesterol 
(mmol/L)2 
LDL cholesterol 
(mmol/L)2 
HDL cholesterol 
(mmol/L)2 
Triacylglycerols 
(mmol/L)2 
mean 
Men 
42 ±15 
24.513.5 
1.82 ±0.08 
81.4+13.2 
5.39 ±0.96 
3.82 ±0.96 
1.39 ±0.31 
1.20 ±0.63 
±SD 
Women 
41 ±13 
25.0 ±4.9 
1.69±0.078 
71.5 ± 14.9s 
5.67±0.927 
3.76 ±0.92 
1.76±0.448 
1.09 ±0.49 
Rlut3 
Men 
0.265 
-0.05 
-0.305 
-0.215 
0.20s 
0.15s 
0.21s 
-0.01 
Women 
0.30s 
-0.24s 
-0.136 
-0.28s 
0.35s 
0.26s 
0.25s 
0.01 
R 
Men 
0.03 
-0.21 s 
-0.10 
-0.23s 
-0.10 
-0.08 
0.07 
-0.18s 
mac4 
Women 
0.04 
0.07 
-0.06 
0.04 
0.11 
0.14s 
-0.12 
0.17s 
1
 176 men. 2 198 women. 3 Correlation between serum lutein and characteristics. 4 
Correlation between MP density and characteristics. 5 P < 0.05. 6 P < 0.06. 7 Significantly 
different from men; P < 0.010.8 Significantly different from men; P < 0.001. 
Lutein concentrations in adipose tissue were higher in women than in men (P < 
0.001) (Table 3). The correlation between serum lutein and adipose lutein 
concentrations was 0.46 in men and 0.53 in women after adjustment for total 
cholesterol (P < 0.001). Serum lutein concentrations were significantly correlated 
to blood vitamin C, a-tocopherol and other serum carotenoids, except for lycopene 
in both men and women after adjustment for total cholesterol (Table 3). 
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Macular pigment density 
Mean MP density in the total study group was 0.33 ±0.15 (range 0.02 to 0.80). 
Mean MP density was 13% higher in men than in women (P = 0.02) (Table 1). In 
both men and women, MP density did not differ significantly between smokers and 
non-smokers or between the groups with high and low fruit and vegetable 
consumption. In men, MP density of iris category 5 was significantly higher than in 
iris category 4 (Table 1). MP density correlated significantly with BMI (men), 
body weight (men), LDL-cholesterol (women) and triacylglycerol (both sexes) 
(Table 2). 
Table 3 Serum and adipose carotenoid, serum a-tocopherol and blood vitamin C 
concentrations in men (n = 177) and women (n = 199) and correlation with serum lutein (R 
lut) or macular pigment density (R mac)1 
Variable 
Serum lutein 
Serum zeaxanthin 
Serum P-cryptoxanthin 
Serum lycopene 
Serum a-carotene 
Serum P-carotene 
Serum a-tocopherol 
Blood vitamin C 
Adipose tissue lutein7 
mean 
Men 
0.16 + 0.076 
0.05 ± 0.026 
0.17 ±0.09" 
0.35 + 0.18 
0.06 + 0.066 
0.33+0.196 
26.0 + 5.56 
40.2 + 12.26 
0.32±0.176 
±SD 
Women 
0.19 + 0.08 
0.05 ± 0.02 
0.22 ±0.13 
0.3710.18 
0.08 ± 0.06 
0.40 ± 0.25 
27.6 ±6.6 
49.9 ±13.4 
0.47 ±0.31 
Rlut3 
Men 
-
0.644 
0.294 
0.001 
0.384 
0.304 
0.234 
0.184 
0.464 
Women 
-
0.644 
0.464 
0.14s 
0.454 
0.414 
0.254 
0.294 
0.534 
R 
Men 
0.375 
0.28s 
0.16" 
-0.01 
0.254 
0.234 
0.04 
0.154 
0.294 
mac4 
Women 
0.10 
0.07 
0.02 
0.07 
-0.004 
-0.05 
0.21" 
0.204 
-0.007 
1
 Lutein, P-cryptoxanthin, a-carotene, P-carotene, a-tocopherol in serum and fat biopsies 
were not normally distributed; variables were log-transformed before Mest and correlation 
analyses; umol/L unless stated otherwise. 2 Partial correlation between serum lutein and 
other carotenoids and vitamins, adjusted for total cholesterol. 3 Partial correlation between 
MP density and carotenoids and a-tocopherol, adjusted for total cholesterol. Correlation 
between MP density and vitamin C and adipose tissue lutein is not cholesterol adjusted.4 P 
< 0.05.5 P < 0.06.6 Significantly different from women.7 Adipose tissue samples; u.mol/kg 
wet weight: 89 men, 98 women. 
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In men, MP density correlated positively with serum lutein, zeaxanthin (P < 0.06), 
P-cryptoxanthin, a-carotene, (3-carotene (P < 0.05), after adjustment for total 
cholesterol. Vitamin C was significantly correlated with MP density in men and 
women. The partial correlation between MP density and a-tocopherol adjusted for 
total cholesterol was significant in women. Serum lutein and zeaxanthin were not 
associated with MP density in women (Table 3). Furthermore, adipose lutein 
concentrations were positively associated with MP density in men but not women 
(Table 3). 
Regression modeling 
Serum lutein and zeaxanthin 
Serum lutein and zeaxanthin appeared to be relevant predictors of MP density in 
men after adjustment for age (Models la and lb, Table 4). In the model in which 
serum lutein and zeaxanthin were both included, serum lutein, but not zeaxanthin, 
predicted MP density in men (Model lc, Table 4). In women, serum lutein and/or 
zeaxanthin were not associated with MP density (Models la-lc, Table 4). 
BMI changed the magnitude of the regression coefficient of lutein both in men and 
women and was, therefore, included in the adjusted models. Smoking status 
changed the magnitude of the regression coefficient of serum lutein in women and 
was therefore included in the adjusted models of men and women. Total 
cholesterol was included in the multivariate model, because of the correlation 
between serum lipids and serum carotenoids. From the multivariate model with 
serum lutein and zeaxanthin (Model 2c, Table 4) we can conclude that a serum 
lutein increment of 0.1 umol/L is associated with a 0.064 higher MP density (18% 
of the mean) in men after adjustment for age, total cholesterol, BMI and smoking 
status. 
In women, serum lutein and zeaxanthin concentrations were not associated with 
MP density in the adjusted models (Model 2a-2c, Table 4). We calculated mean 
MP density values across quartiles of lutein divided by total cholesterol. In men, 
MP density was 0.28 ± 0.12, 0.31 ± 0.11, 0.37 ± 0.15 and 0.44 ± 0.17 across 
quartiles. In women, MP density was 0.31 ± 0.12, 0.30 ± 0.14, 0.30 ± 0.16 and 0.34 
±0.15 across quartiles. 
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Table 4 Multivariate regression models to evaluate the association between serum lutein 
and/or zeaxanthin and macular pigment density 
Model la1 
Model lb2 
Model lc3 
Model 2a4 
Model 2b4 
Model 2c4 
Lutein 
Zeaxanthin 
Lutein 
Zeaxanthin 
Lutein 
Zeaxanthin 
Lutein 
Zeaxanthin 
Men 
P(SE) 
0.081 (0.017)5 
0.227 (0.062)5 
0.071 (0.022)6 
0.055 (0.082) 
0.080 (0.018)5 
0.241 (0.065)5 
0.064 (0.023)6 
0.091 (0.083) 
R2 
0.12 
0.07 
0.12 
0.17 
0.14 
0.18 
Women 
P(SE) 
0.016(0.013) 
0.062 (0.046) 
0.009(0.017) 
0.041 (0.060) 
0.022 (0.014) 
0.068 (0.049) 
0.016(0.017) 
0.034(0.061) 
R2 
0.01 
0.01 
0.01 
0.05 
0.04 
0.05 
1
 Model la: MP density = serum lutein (0.1 umol/L) + age (years); 177 men, 199 women. 
2
 Model lb: MP density = serum zeaxanthin (0.1 umol/L) + age (years); 177 men, 199 
women. 3 Model lc: MP density = serum lutein (0.1 umol/L) + serum zeaxanthin (0.1 
umol/L) + age (years); 177 men, 199 women.4 Models 2a-c: adjusted for age (years), BMI 
(kg/m2), total cholesterol (mmol/L), and smoking (0: no smoking; 1: < 1 cigarette/day; 2: 1-
5 cigarettes/day; 3: 6-10 cigarettes/day; 4: 11-15 cigarettes/day; 5: > 15 cigarettes/day).5 P 
<0.001; 6P<0.010. 
Figure 2 shows predicted individual MP density values with increasing serum 
lutein concentration for men and women separately after fitting a model with serum 
zeaxanthin, age, total cholesterol, BMI and smoking status. These regression lines 
are based on a model based on the total group, including sex and the sex x lutein 
interaction term and confounders as independent variables. 
After adjustment for other serum carotenoids, vitamin C and a-tocopherol, the 
regression coefficient of serum lutein was lower (0.053 ± 0.025) in men, but did 
not change in women (0.016 ± 0.018). In women, vitamin C was positively 
associated with MP density (0.02 ± 0.008 per 10 umol/L increment). 
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Figure 2 Predicted individual MP density values for men (squares) and women (circles) 
after fitting a model with zeaxanthin, age, smoking status, total cholesterol and BMI with 
increasing serum lutein concentrations. The dotted line represents the predicted MP density 
for women and the solid line represents men1 
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A possible explanation for the absence of a significant correlation among women is 
the heterogeneity of the female group, which included both pre- and 
postmenopausal women. Plasma carotenoids fluctuate by phase of the menstrual 
cycle (Forman et al, 1996). To evaluate whether these fluctuations did influence 
individual carotenoid concentrations, we divided the group into women < 50 years 
(« = 143) or > 50 years (« = 56) and included an interaction term (older or younger 
then 50 years x lutein) in the model. The regression coefficients of lutein and 
zeaxanthin were not associated with MP density in both pre- and postmenopausal 
women. 
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Adipose lutein 
Next, the association between adipose lutein concentrations and MP density was 
investigated. In accordance with serum lutein, adipose lutein concentrations were 
positively associated with MP density in men, but not women. The regression 
coefficients for adipose lutein after adjustment for age were 0.028 ± 0.010 (P = 
0.01) and -0.006 ± 0.005 (P = 0.25) per increment of 0.1 ^mol/kg wet weight in 
men and women, respectively. BMI and smoking status changed the magnitude of 
the regression coefficients in men and were both included. After adjustment for 
age, BMI and smoking status the regression coefficients of adipose lutein were in 
men 0.021 ± 0.010 (P = 0.04) and in women -0.006 ± 0.005 (P = 0.27). Figure 3 
shows the predicted individual MP density values with increasing adipose lutein 
concentrations after fitting a model with age, BMI and smoking status, for men and 
women, separately. 
Figure 3 Predicted individual MP density values for men (squares) and women (circles) 
after fitting a model with age, smoking status and BMI with increasing adipose tissue lutein 
concentrations. The dotted line represents the predicted MP density for women and the 
solid line represents men1 
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To compare the subjects from whom we took an adipose sample and the total 
group, we evaluated the association between serum lutein and MP density in the 
subgroup in whom we had collected adipose tissue samples (89 men, 98 women). 
After adjustment for age, total cholesterol, BMI and smoking, the coefficients of 
serum lutein were higher in men (P = 0.088, SE = 0.026, P < 0.01, n = 89) and in 
women (P = 0.049, SE = 0.024, P = 0.04, n = 97) in comparison with the total male 
and female group. In this subgroup, the associations between serum lutein and MP 
density in women are weaker than in men. The interaction term serum lutein x sex 
was not significant, which suggests that the associations were not significantly 
different between men and women. We evaluated the difference in confidence 
intervals of the regression coefficients of serum lutein between the subgroup of 
women of whom we had adipose tissue samples and the remaining female subjects 
(n =101). The regression coefficients of serum lutein in these two groups were 
0.049 (95% CI 0.0020 - 0.096) and 0.0025 (-0.033 - 0.038), respectively. 
Exclusion of samples below the detection limit did not change the results. 
Discussion 
This study was conducted to assess the cross-sectional associations between the 
serum carotenoids lutein and zeaxanthin and MP density. In addition to biomarkers 
reflecting short-term (serum) intake of carotenoids, we also evaluated, as a 
biomarker of long-term intake, the associations of lutein in adipose tissue with MP 
density. 
Serum and adipose concentrations of lutein are significantly higher in women, but 
their MP density is lower than in men. The relationships of serum lutein, serum 
zeaxanthin and adipose lutein with MP density are higher in men than in women. 
The strength of this study was the large study group. This large study group 
enabled us to compare men and women. MP density was been assessed with an 
objective non-invasive measuring technique, in contrast to most other studies, 
which used a technique that was rather demanding for subjects (Hammond et al, 
1996a; Johnson et al, 2000; Landrum et al, 1997b; Hammond et al, 1997; 
Hammond et al, 1996b). 
There were several limitations of this study that may attenuate the results of this 
study. We aimed to select Dutch volunteers with high and low fruit and vegetable 
consumption in order to reach a wide range in carotenoid exposure. In the end, the 
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range of serum lutein concentrations in men and women was 0.06 - 0.41 u.mol/L 
and 0.06 - 0.65 u.mol/L, respectively. These ranges are approximately similar to 
the ranges of serum lutein concentrations of male and female subjects in the 
Netherlands with ranges of 0.07 - 0.42 u.mol/L and 0.08 - 0.51 u.mol/L, 
respectively (Olmedilla et al, 2001). However, serum lutein concentrations in 
subjects from the United States or South European countries (Spain and Italy) are 
higher than in the Netherlands (Mares-Perlman et al, 2001; Hammond et al, 
1996a; Olmedilla et al, 2001). In a global context, we have to consider that the 
range in serum carotenoids in the present study is narrow in comparison to the 
differences in carotenoid concentrations between populations by the interpretation 
of our results. This difference is possibly caused by the intake of supplements, 
fortified foods or fruit and vegetables. 
We did not perform duplicate MP density measurements in each subject. A 
previous study showed a within subject variation coefficient of 17% (Berendschot 
et al, 2000). This measurement error could have attenuated the associations 
between concentrations of carotenoids in serum, adipose tissue and macula 
pigment density. A possible source of bias is that we allocated volunteers to the 
adipose tissue sampling group. They had the possibility to refuse this measurement. 
When comparing the volunteers with or without data on adipose tissue lutein 
concentrations, we observed that men who gave an adipose tissue sample had 
somewhat higher MP density values. But no differences in other characteristics, 
including BMI, were observed between the group with and without data on adipose 
tissue lutein concentrations in either men or women. We evaluated the association 
between serum lutein and MP density in the subgroup in which we had collected 
adipose tissue samples and compared it with the associations in the total study 
group. In women, the differences in these associations between the total group and 
subgroup is difficult to explain and possibly due to chance or caused by selection 
bias. 
In contrast with other studies (Hammond et al, 1996b; Hammond and Caruso-
Avery, 2000), we did not find associations between smoking status and MP 
density. A possible explanation for this discrepancy is the classification of smoking 
status in categories of cigarettes per day. We did not have information on smoking 
duration or smoking history. The covariate 'iris color' was not associated with MP 
density in the total population, contrary to results of two studies that found 
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significant differences in MP densities among iris categories (Hammond et ah, 
1996c; Hammond and Caruso-Avery, 2000). Our volunteers fell predominantly in 
iris color category 1 (blue/gray). However, we found a positive association 
between iris color and MP density in men. This was largely attributable to men in 
iris category 5 (dark brown) with a high MP density (0.50 + 0.19). We did not find 
an association with age. Another study found a slight decline of MP density with 
age (Hammond and Caruso-Avery, 2000). 
A previous study (Hammond et ah, 1996a) also found stronger correlations 
between plasma lutein and MP density for men (r = 0.62; P < 0.005) than for 
women (r = 0.3, P < 0.05). The baseline results of a study with lutein 
supplementation showed that plasma lutein concentrations were highly correlated 
with MP density (r = 0.82, P < 0.001) in men (Berendschot et ah, 2000). Our 
results are in line with the sex differences found in other studies, but our 
correlations are generally weaker. Past studies with feeding extra lutein sources 
have shown an increase in macular pigment density in women (Hammond et ah, 
1997). The narrow range of serum lutein concentrations in the present study, 
relative to past studies may explain the weaker associations between serum lutein 
and MP density in this study. In cross-sectional studies variables are determined at 
one point in time. Therefore, it is difficult to assess the temporal relationship 
between nutritional factors, for example serum lutein and the dependent variable, 
in this case MP density. Furthermore, our study group consisted of both pre- and 
postmenopausal women and serum carotenoids fluctuate by phase of menstrual 
cycle (Forman et ah, 1996; Forman et ah, 1998). Therefore, the serum lutein 
concentrations in women may be a less good reflection of the past lutein intake. 
However, serum lutein was not associated with MP density in postmenopausal 
women. By comparison of MP density values across quartiles of lutein divided by 
total cholesterol, MP density showed a linear relation in men, but not in women. In 
women, MP density was higher in the last quartile of serum lutein adjusted for total 
cholesterol. This could suggest that in women serum lutein is associated with MP 
density only at high serum lutein concentrations. 
Blood vitamin C concentrations were positively associated with MP density in 
women. Vitamin C is abundant in the eye, including the retina and the lens. 
Vitamin C may participate with other antioxidants in electron transfer reactions to 
reduce oxidative stress in the eye, but the exact mechanism is not evident (Mares-
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Perlman and Klein, 1999). We hypothesize that because of this antioxidant 
capacity, vitamin C is positively associated with MP density. It could spare the 
antioxidants lutein and zeaxanthin in the MP. Furthermore, this positive association 
between vitamin C and MP density could reflect that vitamin C and carotenoids 
travel in the same foods. Therefore, vitamin C could function as marker of 
carotenoid intake. Observational epidemiological studies are inconclusive as to the 
role of vitamin C in the prevention of AMD (Seddon et al, 1994; Mares-Perlman 
and Klein, 1999). 
Both, concentrations of fat-soluble vitamins in adipose tissue and plasma (serum) 
concentrations could be used as markers of dietary intake. Since both take into 
account variations in absorption and metabolism, it may be better to talk about 
markers of internal dose instead of dietary intake (Kardinaal et al, 1995). The 
results of the association between adipose tissue concentrations and MP density 
were in line with the associations between serum lutein concentrations and MP 
density in both men and women. Lutein and zeaxanthin are dynamic components 
of tissues and therefore the metabolism of lutein may differ between men and 
women (Johnson et al, 2000). A previous study showed a negative correlation 
between MP density and adipose tissue lutein in women, but a positive one in men 
(Johnson et al, 2000). However, this study was limited by the small number of 
subjects studied (13 women, 8 men). In our study with a larger number of adipose 
tissue samples (89 men, 98 women), we found a positive association between 
adipose tissue lutein and MP density in men and a slightly negative association in 
women (Figure 3). Because of this slightly negative association between adipose 
lutein concentrations and MP density in women, our findings do not contradict the 
suggestion that adipose tissue competes with macular pigment for carotenoids more 
effectively in women than in men (Johnson et al, 2000). As far as we know, the 
exact mechanism of uptake of lutein and zeaxanthin in the retina has remained 
elusive. 
In summary, men had lower concentrations of serum and adipose lutein, but had a 
higher MP density. From these findings we can conclude that a serum lutein 
increment of 0.1 u,mol/L is associated with a 0.064 higher MP density (18% of the 
mean) in men. We suggest, therefore, that dietary intervention to increase MP 
density may have effect in men. In women, no significant association between 
serum lutein and MP density was found in the total female group. In the female 
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group that gave an adipose tissue sample, a positive association between serum 
lutein and MP density was found, but this association was weaker than in men. 
Adipose tissue could be an important factor in the association between serum lutein 
and MP density. Carotenoid concentrations in adipose tissue have to be taken into 
account to elucidate the influence of lutein intake on MP density. If MP density has 
a protective effect against AMD, our results in the total population are in line with 
the notion that men are at lower risk for AMD than women (Beatty et al, 1999). 
Dietary intervention studies are necessary to investigate the influence of lutein 
intake on MP density and AMD in men and women. 
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Abstract 
Objective: To investigate, whether nutritional factors and possible risk factors for 
cataract influence the density of the lens (LD). 
Design: 376 subjects, aged 18-75 years were recruited. In a cross-sectional design, 
serum was analyzed for lutein, zeaxanthin, vitamin C, cc-tocopherol and 
cholesterol. Adipose tissue (n = 187) was analyzed for lutein. Lens density (LD) 
and macular pigment (MP) density were measured by spectral fundus reflectance. 
Results: LD at 420 nm was 0.52 ± 0.17. It showed a significant association with 
age (P = 0.0085, P < 0.001) and MP density (p = -0.096, P = 0.019). For subjects 
below 50 years (LD = 0.45 ± 0.11), we found only a single significant P-coefficient 
for age of 0.0063 (P < 0.001). For subjects above 50 years (LD = 0.68 ± 0.16), we 
found significant P-coefficients for age of 0.011 (P < 0.001) and for MP density of 
-0.25 (P = 0.005). Controlling for age, we found no associations between LD and 
other possible risk factors of age-related cataract, nor with serum or adipose tissue 
concentrations of carotenoids, vitamin C and a-tocopherol. 
Conclusions: Macular pigment is composed of lutein and zeaxanthin, the only 
carotenoids that have been found in human lenses. Inverse relationship between LD 
and MP density suggests that lutein and zeaxanthin may retard aging of the lens. 
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Introduction 
Age-related cataract is the leading cause of visual disability (Apple et al, 2000). A 
number of nutritional determinants possibly influence age-related cataract. 
Vitamins C and E and the carotenoids lutein and zeaxanthin have been shown to be 
present in human lenses, with vitamin C at levels several fold that of plasma 
(Yeum et al, 1995; Bates et al, 1996; Yeum et al, 1999). They all can reduce 
oxidative stress, which has been shown to influence the development of cataract 
(Gerster, 1989; Bunce et al, 1990; Jacques and Taylor, 1991). Low vitamin C 
content in the lens appeared to be a good indicator of cataract severity (Tessier et 
al, 1998). 
Plasma levels of vitamin C were not associated with risk of cataract (Libondi et al, 
1991; Vitale et al, 1993; Gale et al, 2001). Studies on a possible association 
between plasma levels of vitamin E and risk of cataract showed conflicting results 
(Libondi etal, 1991; Vitale etal, 1993; Gale etal, 2001; Lyle etal, 1999a). Self-
reported consumption of vitamins C and E supplements was shown to be associated 
with reduced risk of cataract (Robertson et al, 1991; Jacques and Chylack, 1991; 
Mares-Perlman et al, 1995a; Simon and Hudes, 1999). However, studies on 
consumption of vitamin C supplements showed controversial results (Hankinson et 
al, 1992a; Jacques et al, 1997; Van der Pols, 1999; Mares-Perlman et al, 2000; 
Chasan-Taber et al, 1999a). Conflicting results were also reported for 
multivitamin or vitamin E use (Leske et al, 1991; Leske et al, 1998; AREDS, 
2001). 
Intake of foods, rich in lutein and zeaxanthin like spinach and broccoli, was 
associated with a lower relative risk of cataract (Lyle et al, 1999a; Hankinson et 
al, 1992a; Tavani et al, 1996; Brown et al, 1999; Chasan-Taber et al, 1999b; 
Lyle et al, 1999b; Mares-Perlman et al, 1995b). Lutein and zeaxanthin are also 
components of macular pigment (MP) in the eye (Bone et al, 1988; Handelman et 
al, 1988). A significant association has been found between MP density and 
concentrations of serum and adipose tissue lutein (Berendschot et al, 2000; Bone 
et al, 2000), be it that there are significant differences between men and women 
(Hammond etal, 1996; Johnson etal, 2000). Further, intake of lutein modifies the 
MP density (Berendschot et al, 2000; Hammond et al, 1997a; Landrum et al, 
1997). MP density is probably a better measure of the lutein and zeaxanthin content 
in the eye, than serum and adipose tissue values of carotenoids. 
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Besides nutritional determinants, other factors might influence cataract. Smoking 
has been identified to increase cataract risk (Simon and Hudes, 1999; Leske et al, 
1991; West et al, 1989; West et al, 1992; Hankinson et al, 1992b; Klein et al, 
1993; West et al, 1995; Christen et al, 2000). However, smoking is also 
associated with diminished carotenoid and vitamin C status (Russell-Briefel et al, 
1985; Schectman et al, 1989), and there appeared to be a diminished risk for 
cataract in smokers who used multivitamins in comparison with smokers not using 
multivitamins (Seddon et al, 1994). Both height and abdominal adiposity have 
been shown to be independent risk factors for cataract (Caulfield et al, 1999; 
Schaumberg et al, 2000). The association between body mass index (BMI) and 
cataract is controversial (Leske et al, 1991; Mohan et al, 1989; Tavani et al, 
1995; Hankinson et al, 1993; Glynn et al, 1995; Hiller et al, 1998; Klein et al, 
1998a). Subjects with darker colored irises tend to have higher risk of cataract 
(Collman et al, 1988; Taylor et al, 1988; The Italian-American Cataract Study 
Group, 1991). Finally, women have a somewhat higher incidence of cataract than 
men (Leske et al, 1997; Klein et al, 1998b; Chen et al, 1986; Klein and Klein, 
1982). 
There is a strong relation between lens aging and cataract, the latter being the end 
stage of deterioration of the aging lens (Sample et al, 1988; Young, 1991; Bron et 
al, 2000). Lens senescence can be quantified by the increase in lens density, which 
has been studied extensively (Sample et al, 1988; Pokorny et al, 1987; Johnson et 
al, 1993; Delori and Burns, 1996; Van Norren and Vos, 1974; Cook et al, 1994; 
Gaillard et al, 2000). Although these studies showed strong positive associations 
between lens density and age, there are substantial individual differences at each 
age. The aim of this study was to investigate, whether nutrition and possible risk 
factors for cataract mentioned above, could account for part of these individual 
differences. Fundus reflectance has been shown to yield reliable estimates of the 
lens density (Delori and Burns, 1996; Van de Kraats et al, 1996). It was used in 
this study, having the advantage that the density of the macular pigment was 
obtained simultaneously. 
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Methods 
Subjects 
The subjects in our study were recruited from the pool of volunteers of TNO 
Nutrition and Food Research and through advertizing in local and regional 
newspapers and on television. The cross-sectional data analyzed here were 
gathered during the baseline measurements of an intervention study designed to 
test an unrelated hypothesis. Advertizing aimed at recruiting people who have a 
general interest in participating in nutrition studies. Respondents who expressed 
potential interest received a questionnaire eliciting data on daily fruit and vegetable 
consumption and lifestyle factors. This questionnaire was designed for ranking 
subjects according to their intake and not for quantitative measurements. 
Respondents in the highest quintile of fruit and vegetable consumption and those in 
the lowest tertile (calculated in the total group) were invited for an oral briefing and 
screening. In the lowest stratum vitamin supplement users were excluded. The 
major inclusion criteria were age between 18-75 years, and consumption of an 
average Western diet. The main exclusion criteria were pregnancy and/or lactation, 
or wishing to become pregnant, serum cholesterol > 7.5 and/or triacylglycerol > 2.3 
mmol/L if not under stabilized hypercholesterolemia/hyperlipidemia treatment, and 
anticoagulant therapy. A total of 380 volunteers entered the study. Two volunteers 
squinted too much during the reflectance measurement. Further, one measurement 
failed for other reasons and one subject withdrew from the study before the 
reflectance measurement. Data from these 4 subjects were not included in the 
statistical analyses. Eight subjects were measured in the left eye instead of the right 
eye. Their measurements were included in the analysis, because there is a good 
correlation between both eyes (Hammond and Fuld, 1992). The final study group 
comprised 177 men and 199 women. The study was performed according to ICH 
(International Conference on Harmonization of Technical Requirements of 
Registration of Pharmaceuticals for Human Use) guidelines for good clinical 
practice, and was approved by an external Medical Ethical Committee. Informed 
consent was obtained from all subjects. 
Blood and adipose tissue sampling 
Blood samples from subjects were obtained between 800 and 93Oh after an 
overnight fast. For the analysis of carotenoids and a-tocopherol blood was 
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collected in tubes containing clot activator and gel (Becton Dickinson, Vacutainer 
systems). These tubes were immediately stored in a closed box, to avoid 
breakdown of carotenoids by UV light. Tubes were centrifuged within 15-30 min 
after collection at approximately 2000 x g for 10 min at ca. 4°C to obtain serum. 
After centrifugation serum was removed and stored at ca. -80°C. Before storage, 
all serum was handled in subdued light. 
For the analysis of vitamin C, blood was collected in tubes containing lithium 
heparin (Becton Dickinson, Vacutainer systems). A 0.5 mL aliquot of blood was 
added to 2 mL metaphosphoric acid (50 g/L; Mallinckrodt Baker, Deventer, The 
Netherlands) before freezing to preserve the vitamin C concentration during 
storage. This mixture was stored at ca. -80°C. 
For the analysis of total cholesterol, blood was collected in tubes containing clot 
activator and gel (Becton Dickinson, Vacutainer systems). Tubes were centrifuged 
within 15-30 min after collection at ca. 2000 x g for 10 min at ca. 4°C to obtain 
serum. After centrifugation serum was removed and stored at ca. -20°C. 
Subcutaneous adipose tissue was obtained by needle biopsy from the lateral 
buttock (Beynen and Katan, 1985), using a 16-gauge needle attached to a plastic 
container in which the tissue was collected by connecting a vacuum tube. Samples 
were kept in the plastic container, immediately placed on dry ice and stored at ca. -
80°C. 
Chemical analyses 
All carotenoids, a-tocopherol and vitamin C were analyzed by HPLC. The 
coefficient of variation (CV) for the analysis of lutein, zeaxanthin and a-tocopherol 
were 3.7%, 11.5%, 2.8%, respectively (at mean concentrations of 0.16, 0.03, 20.9 
umol/L in the quality control samples, respectively). The CV for the analysis of 
vitamin C was 10%. Total cholesterol was analyzed by enzymatic conversion to a 
stable chromogen, which could easily be detected by colorimetry (commercial 
available kit; Boehringer, Mannheim, Germany). For more details see Broekmans 
et al. (in press). 
Measurement of density of the lens and the macular pigment 
Spectral fundus reflectance was measured with the Utrecht Retinal Densitometer 
(Van Norren and Van de Kraats, 1989). Briefly, a rotating wheel (14 revolutions 
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per second) offered a sequence of 14 interference filters in the range 430 to 740 nm 
to enable quasi-simultaneous measurement of the reflectance across the visual 
spectrum. Light reflected from the fundus was measured in a detection field of 
1.5°, concentric within the illumination field of 1.8°. To obtain an estimate of the 
mean lens and MP density in this area, spectral fundus reflectance was measured in 
two conditions: (1) with the instrument's entry and exit pupils aligned to the peak 
of the Stiles-Crawford (SC) function, and (2) 2 mm temporal to the SC peak (Van 
de Kraats et al., 1996). A detailed optical model of foveal reflection was used to 
arrive at individual estimates of parameters as equivalent thickness of blood layer 
and densities of MP, lens and melanin (Van de Kraats et al., 1996). In short, the 
incoming light was assumed to reflect at the inner limiting membrane, the disks in 
the outer segments of photoreceptors and the sclera. Using known spectral 
characteristics of the different absorbers within the eye (lens, MP, melanin, blood), 
the densities of the pigments and percent reflectance at the interfaces were 
optimized, to fit the measured data at all wavelengths. The spectral characteristic of 
the lens density was composed of a non-aging and an aging part (Pokorny et al., 
1987). Only the aging part was optimized in the fit procedure. The subjects' pupils 
were dilated with tropicamide 0.5%. 
Measurement of other characteristics 
Smoking status was obtained by a questionnaire. Iris color was graded by a set of 
four standard photographs, providing a five-grade classification system (Seddon et 
al., 1990). Weighing the subject wearing indoor clothing, without shoes, wallet and 
keys, assessed body weight. Height was measured without shoes. Body mass index 
(BMI) was calculated with the formula body weight (kg)/ body height squared 
(m2). 
Statistical analyses 
The SPSS statistical software package (Version 8.0.2) was used for data analysis. 
Pearson correlation coefficients were calculated between continuous variables. To 
adjust for age effects we also calculated partial correlation coefficients, controlling 
for age. Students' T-tests and ANOVA were used to evaluate possible differences 
in continuous variables between men and women, between smokers and non-
smokers, between subjects with high and low fruit and vegetable intake, and 
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between subjects with the different iris colors. Chi-square tests were used to 
evaluate possible differences between categorical baseline characteristics (gender, 
iris color, smoking, fruit and vegetable intake). If variables were not normally 
distributed, they were log-transformed. Regression analysis was used to evaluate 
the association between categorical variables (gender, iris color, smoking), 
covariates (age, MP density, vitamins, lutein, zeaxanthin, cholesterol) and lens 
density. 
Results 
Mean lens density was 0.52 ± 0.17. Study group characteristics are presented in 
Tables 1 and 2. For ranking, pre-study participants were classified into those with a 
diet low in fruit and vegetables, fruit juices included (57% of the study sample) and 
those with diet rich in these foods (43% of the study sample). The latter group 
consisted of significantly more women (62%>) than the former (46%>, P = 0.001). 
The percentage of male smokers (32%) did not differ from that of female smokers 
(28%; P = 0.33). Lens density did neither differ significantly between men and 
women, nor between the groups with high and low fruit and vegetable intake, nor 
between smokers and non-smokers (Table 1). 
Iris color was classified in 331 participants. The participants predominantly (65%) 
had blue or gray irises. The distribution of subjects in the five iris categories did 
not differ between men and women (P = 0.72). Lens density did not differ among 
the iris categories (Table 1). 
Serum and blood concentrations were significantly lower in men than in women for 
lutein and zeaxanthin, vitamin C, and total cholesterol. Lutein concentration in 
adipose tissue was also significantly lower in men than in women. MP density was 
significantly higher for men than for women (Table 2) 
Age correlated most significantly with lens density (r = 0.71, P < 0.001), 
explaining 50% of the variance. Further, serum and adipose lutein, serum a-
tocopherol, height, BMI and total cholesterol also correlated significantly with lens 
density (Table 2, column 5). Other previously mentioned characteristics (MP 
density, serum zeaxanthin and blood vitamin C) showed no association with lens 
density. We also found a significant correlation between age and serum lutein, 
serum a-tocopherol, adipose tissue lutein, BMI, height and total cholesterol (Table 
2, column 6). Therefore, we calculated the partial correlation coefficient between 
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all parameters and lens density, controlling for age (Table 2, column 7). All 
aforementioned correlations disappeared. 
Table 1 Characteristics and mean lens optical density at 420 nm (± SD) per category 
Lens optical density P-value 
Gender 
Men 
Women 
Smoking 
No 
Yes 
177 
199 
264 
112 
Fruit and vegetable consumption' 
Low 
High 
Iris color 
Blue or gray 
Blue, gray or green 
Green or light brown 
Brown 
Dark brown 
obtained pre -study. 
214 
162 
216 
52 
25 
26 
12 
0.52 ±0.17 
0.52 + 0.16 
0.52 ±0.17 
0.52 ±0.17 
0.51 ±0.15 
0.54 ±0.19 
0.52 + 0.17 
0.53 ±0.18 
0.57 ±0.19 
0.55 ±0.14 
0.46 ±0.16 
0.98 
0.66 
0.16 
0.42 
Only MP density showed a small significant negative correlation with lens density 
(r = -0.12, P = 0.019). This could imply that MP density provided more detailed 
information on lutein/zeaxanthin content in the lens than serum lutein, serum 
zeaxanthin and adipose tissue lutein. To test this hypothesis, we used linear 
regression analysis to identify factors that are associated most significantly with 
lens density. We used the forward conditional method with default selection 
criteria, P < 0.05 to enter and P > 0.10 to remove. Age, serum lutein, serum 
zeaxanthin, adipose tissue lutein, MP density, serum vitamin C and a-tocopherol 
were used as independent variables and lens density as dependent variable. Total 
cholesterol was included, because of its correlation with serum carotenoids, a-
tocopherol, height and BMI. Height, BMI, gender, smoking and iris color were also 
included. 
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We only found significant p-coefficients for age of 0.0085 + 0.0004 (P < 0.001; 
CI: 0.0076, 0.0094; 16% per 10 years) and for MP density of -0 .096 ± 0.041 (P = 
0.019; CI: -0.177, -0.016; -2 .7% per SD in MP density). 
Table 2 Descriptive characteristics (mean ± SD) for the total study group and men and 
women separately 
Age (y) 
MP density (at 460 nm) 
Serum lutein (|imol/L) 
Serum zeaxanthin 
((imol/L) 
Blood vitamin C 
((imol/L) 
Serum cc-tocopherol 
((imol/L) 
Adipose tissue lutein 
(|imol/kg wet weight)6 
Height (m) 
BMI (kg/m2) 
Total cholesterol 
(mmol/L) 
Total 
(n = 376) 
42 ±14 
0.33 ±0.15 
0.18 + 0.08 
0.049 + 0.020 
45 ±14 
26.8 ±6.1 
0.40 ± 0.26 
1.75 ±0.10 
24.7 ±4.3 
5.53 ±0.95 
Men 
(«=177) 
42 ±15 
0.35 ±0.15 
0.16 ±0.07 
0.046 ±0.018 
40+12 
26.0 ±5.5 
0.32 ±0.17 
1.82 ±0.08 
24.5 ±3.5 
5.39 + 0.96 
Women 
(n = 199)a 
41 ±13 
0.31 ±0.14' 
0.19±0.082 
0.052 ± 0.0232 
50±133 
27.6 ±6.6' 
0.47±0.313 
1.69±0.073 
25.0 ±4.9 
5.67 ± 0.922 
rb 
0.713 
-0.06 
0.193 
0.06 
0.03 
0.303 
0.12' 
-0.182 
0.142 
0.343 
rc 
0.037 
0.263 
0.051 
-0.048 
0.453 
0.05 
-0.213 
0.223 
0.453 
rd 
-0.121 
0.003 
0.039 
0.090 
-0.030 
0.12 
-0.047 
-0.021 
0.043 
'Significant at the P = 0.05 level, Significant at the P = 0.01 level, Significant at the P = 
0.001 level. "Significance values refer to a comparison between men and women with the 
Students' T-test. bCorrelation with lens optical density. Correlation with age. dCorrelation 
with lens optical density, controlling for age (partial correlation). eAdipose tissue lutein was 
only determined in 187 subjects (men: n = 89, women: n = 98). 
Hammond et al. (1997b) observed for older subjects (r = -0.47, n = 39, range 
48-82 years) also an inverse relationship between lens density and MP density. For 
younger subjects (r = 0.07, n = 12, 24-36 years) they found no relationship. We 
added an interaction term age x MP density in the regression analysis, but it did not 
contribute significantly. We also stratified our data (under and above 50 years) and 
applied the regression analysis on both strata. Lens density was 0.68 ±0.16 for the 
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older subjects and 0.45 ±0.11 for the younger subjects. MP density was 0.34 ± 
0.16 and 0.32 ± 0.14 respectively. For the older subjects (n = 114) we found 
significant p-coefficients for age of 0.0111 ± 0.0021 (P < 0.001; CI: 0.007, 0.015) 
and for MP density of-0.240 ± 0.086 (P = 0.005; CI: -0.410, -0.071; -5.6%). For 
the younger subjects (« = 262) we only found a significant P-coefficient for age of 
0.0063 ± 0.0007 (P < 0.001; CI: 0.0041, 0.0077), and no association between lens 
density and MP density. 
Discussion 
As expected, lens density increased significantly with age. MP density showed an 
inverse relationship with lens density after adjustment for age. Like others, we 
found a significantly higher MP density in men than in women, despite lower 
serum and adipose tissue levels (Hammond et al, 1996; Hammond et al, 2000a). 
Further, like others, we also found a higher correlation between MP density and 
concentrations of serum and adipose tissue lutein in men than in women 
(Hammond et al, 1996; Johnson et al, 2000). Thus, the ability to transport lutein 
and zeaxanthin from the blood into the eye seems less in women than in men. It 
may be the reason that we found lens density to show an inverse association with 
MP density, rather than with serum and adipose tissue values of lutein and 
zeaxanthin. It may also be an explanation for the higher incidence of cataract in 
women than in men, apart from the impact of oestrogen (Snow and Seddon, 2000). 
Similar to Hammond et al. (1997b) we stratified our data (under and above 50 
years). Only for the older subjects we found a significant association between lens 
density and MP density. To study this in more detail, we added an interaction term 
age x MP density in the regression analysis. However, the interaction term did not 
contribute significantly. It could be due to a nonlinear dependence of the lens 
density on age, not accounted for in the linear model analysis. Pokorny et al. 
(1987) determined, for subjects after age 60, a threefold increase in the rate at 
which the lens density changes as a function of age. In this study we found the P-
coefficient for age to be 1.76 ± 0.39 times larger for subjects older than 50 years, 
than for the younger subjects. For a cut point at age 60 we found the p-coefficient 
for age to be 2.09 ± 0.81 times larger for older subjects than for the younger 
subjects. We added an extra quadratic age term in General Linear Model analysis, 
which indeed turned out to contribute significantly. However, the age x MP density 
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interaction term remained non-significant. Thus, in the total study group we could 
not find a significant change in the regression coefficient for the MP density with 
age, although in the stratified data the regression coefficient was only significant 
for the older subjects. 
The inverse association between MP density and lens density could reflect the 
greater likelihood of subjects with high MP density to have other healthy 
behaviours that retard lens aging. We found a significant correlation between MP 
density and serum vitamin C (r = 0.12, P = 0.021). However, serum vitamin C and 
other markers for a healthy lifestyle, and which are possible risk factors for age-
related cataract, like BMI and smoking, have been included in the regression 
analysis. Only MP density showed a significant contribution. 
We found no difference in lens density between smokers and non-smokers. 
Hammond et al. (1999) studied lens density in relation to smoking behavior in 
younger subjects (n = 41), without cataract. They found a significant dose-response 
relationship between smoking frequency and lens density. Their data indicate that 
smoking is directly related to age-related increases in lens density throughout life, 
and that these increases persist even after smoking cessation. We had no 
information on duration of smoking and also no information of ex-smokers. This 
may have lessened the strength of our analysis. 
Hammond et al. (2000b) also found significantly higher lens optical densities in 
subjects with dark irises in comparison with subjects with light irises. We similarly 
divided our study group and found a mean lens density of 0.52 ±0.17 for subjects 
with light irises (n = 268, the first two categories) and of 0.54 ±0.17 for subjects 
with dark irises (n = 63, the last three categories). Although lens density was higher 
in subjects with dark irises, this difference was not significant (P = 0.42). 
Hammond et al. (2000b) found only differences in lens density between light and 
dark irises for older subjects (> 45 years). Younger subjects showed no differences 
in lens density. We could not find any age effect in our study group. Model 
analysis of the reflectance spectra yielded a retinal melanin density of 0.87 ±0.18 
for subjects with light irises and of 1.02 ± 0.27 for subjects with dark irises (P < 
0.001). The spectral absorbance of melanin and the aging component of the lens 
density both show a slow decrease with increasing wavelength, without any 
characteristic spectral features. However, due to choroidal blood absorption, 
melanin shows its spectral fingerprint only for wavelengths > 600 nm, whereas the 
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lens density is determined for wavelengths < 600 nm. As a consequence their 
absolute values can be determined independently and reliably, and there is no 
indirect covariance between iris color and lens density form our parameter fitting. 
In summary, lens density showed a significant association with age and MP 
density. MP is composed of lutein and zeaxanthin, the only carotenoids that have 
been found in human lenses. MP density is associated with serum lutein and 
adipose lutein and can be modified by lutein intake. Inverse relationships between 
MP density and lens density suggest that lutein and zeaxanthin in the eye may 
retard aging of the lens. 
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Abstract 
Background: Acute effects of UV irradiation include UV-induced erythema. 
Sunlight plays an important role in the development of skin cancer. Several 
predictive factors of UV-induced erythema could also be predictive for skin cancer. 
Objective: Our objective was to quantitatively assess phenotypical and nutritional 
determinants of sensitivity to UV-irradiation, as assessed by the minimal erythema 
dose (MED). 
Design: We conducted a cross-sectional study among 335 volunteers. Sensitivity to 
UV irradiation was established through assessment of the MED. Phenotypical 
determinants, including skin melanin content, hair color and iris color were 
determined by skin reflectance spectrometry, a subjective questionnaire and an 
objective classification system, respectively. Furthermore, dietary exposure was 
measured by carotenoids, vitamin C, retinol and a-tocopherol in serum. 
Results: Male subjects were found to be more sensitive to UV irradiation, i.e. the 
MED was significantly lower compared to female subjects. Skin melanin content, 
which was positively associated with iris color in both sexes and with hair color in 
men, was the main phenotypical determinant of sensitivity to UV-irradiation. No 
associations were found between serum carotenoids and MED in the total study 
group. Vitamin C was inversely associated with MED. However, associations 
between carotenoids concentrations and MED showed a positive trend in subjects 
with melanin values above and a negative trend in subjects below the median after 
adjustment for gender and total cholesterol. 
Conclusions: Skin melanin content and gender are important determinants of 
sensitivity to UV-irradiation. No relation was found between serum carotenoids 
and MED in the total study group. The inverse association between vitamin C and 
MED was against our hypothesis. For the modifying effect of melanin on the 
association between carotenoids and MED we do not have a clear biological 
explanation. 
74 
Serum carotenoids and minimal erythema dose 
Introduction 
The effects of solar irradiation on human health predominantly result from 
ultraviolet (UV) light absorption by the skin and eyes. An important beneficial 
effect is the stimulation of production of vitamin D3 in the skin, which is essential 
for calcium absorption and bone formation (Bickle and Pillai, 1993). Sun exposure 
may also stimulate the physical and mental condition of people (Meesters et al, 
1990). On the other hand, UV irradiation could also cause damage in light-exposed 
tissues; in the skin this may lead to sunburn, skin aging, immunosuppression and 
skin cancer (Lapiere, 1990; Brash et al, 1991; Kripke et al, 1992; Vink et al, 
1996). 
Sunburn is a well-known acute effect of excessive UV exposure. Low dose or short 
exposure to UV irradiation is tolerated by the skin without noticeable or clinically 
relevant changes. Only after reaching a certain threshold, a delayed and prolonged 
vasodilation develops allowing passage of lymphocytes and macrophages into the 
tissue and inducing an inflammatory response, which is clinically visible as 
erythema (Luger and Schwarz, 1990; Boelsma et al, 2001). 
Erythema is the most clinically apparent component of a sunburn reaction. A 
frequently used measure for the skin's sensitivity to UV irradiation is the minimal 
erythema dose (MED). One MED is the minimal amount of energy required to 
induce visible erythema, which can be defined as a uniform, clearly demarcated or 
a just perceptible redness at 16-24 h after UV exposure. Thus, a low MED 
indicates a high sensitivity to sunburn (Boelsma et al, 2001). 
Several factors, such as skin type and hair color may be predictive of UV-induced 
erythema (Azizi et al, 1988). In epidemiological studies on skin cancer it has been 
found that phenotypical factors, such as eye color, hair color, skin type and skin 
color are major determinants of skin cancer risk (Lock-Andersen et al, 1999; Bliss 
et al, 1995; Amstrong and Kricker, 2001). 
Besides these phenotypical determinants, nutritional compounds are likely to 
influence the UV-induced erythema reaction by modulation of the inflammatory 
response. This may be mediated by diet-derived compounds, capable of scavenging 
reactive oxygen species (ROS), which are generated during the UV-induced 
inflammatory response (Bast et al, 1998). 
The effects of several nutritional compounds on MED, including carotenoids and 
vitamins E and A have been studied in small intervention studies. The results of 
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these studies were, however, inconclusive and contradictory (Stahl et al, 2000; Lee 
et al, 2000; Gollnick et al, 1996; Garmyn et al, 1995; Wolf et al, 1988; Eberlein-
Konig etal, 1998; Fuchs et al, 1998; La Ruche and Cesarini, 1991; Werninghaus 
et al, 1994). Moreover, all these studies used synthetic (pure) compounds in 
relatively high dosages compared to the normal physiological range of vitamins 
and carotenoids. 
The objective of the present study was to quantitatively assess phenotypical and 
nutritional determinants at a usual exposure level of skin sensitivity to UV-
irradiation. To address the objectives the associations between skin color, iris color, 
hair color and skin sensitivity to UV irradiation were evaluated. Furthermore, we 
investigated whether carotenoids and vitamins were associated with skin sensitivity 
to UV irradiation in subjects with normal dietary intake levels. 
Subjects and methods 
Subjects 
The subjects in our study were recruited from the pool of volunteers of TNO 
Nutrition and Food Research and through advertizing in local and regional 
newspapers and on television. The cross-sectional data analyzed here were 
gathered during the baseline measurements of an intervention study designed to 
test an unrelated hypothesis. Advertizing aimed at recruiting people with a general 
interest in participating in nutrition studies. Respondents who expressed potential 
interest received a questionnaire eliciting data on daily fruit and vegetable 
consumption and lifestyle factors, such as smoking habits and alcohol 
consumption. This questionnaire was designed for ranking subjects according to 
their intake and not for quantitative measurements. A total of 2734 out of 6900 
questionnaires were returned. Respondents in the highest quintile of fruit and 
vegetable consumption and those in the lowest tertile (calculated in the total group) 
were invited for an oral briefing and screening. In the lowest stratum vitamin 
supplement users were excluded. The major inclusion criteria were an age of 18-75 
years and consumption of an average Western diet. The main exclusion criteria 
were pregnancy and/or lactation or wishing to become pregnant, serum cholesterol 
> 7.5 and/or triacylglycerol > 2.3 mmol/L if not under stabilized 
hypercholesterolemia/hyperlipidemia treatment, and anticoagulant therapy. 
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Three hundred and eighty volunteers entered the study. Informed consent was 
obtained from all subjects. 
The study was performed according to ICH (International Conference on 
Harmonization of Technical Requirements of Registration of Pharmaceuticals for 
Human Use) guidelines for good clinical practice, and was approved by an external 
Medical Ethical Committee. The study was conducted at the Department of 
Nutritional Physiology of TNO Nutrition and Food Research, Zeist. 
UV skin sensitivity test 
The minimal erythema dose (MED) of each volunteer was assessed to determine 
the sensitivity to UV irradiation. Six areas (1 cm2 each) within a total area of 35 
cm2 on the buttock skin were irradiated with a 150W Xe arced equipped solar 
simulator (Oriel, Stratford, USA) with incremental doses using 1.25 geometric 
progression between each successive UV (UVB and UVA) dose. The test sites 
were free from blemishes and had an even color tone. During exposure the subject 
was in a sitting and upright position. The following day, i.e. 20 ± 4 hours after the 
irradiation, the dose resulting in a just perceptible redness was recorded as each 
volunteer's personal MED (MED). 
A PMA2100 dosimeter (Solar Light, Philadelphia, USA) equipped with a 
biologically weighted UVB sensor (PMA2103) was used to determine the dose of 
biologically effective UV irradiation. The sensor's spectral response followed 
closely the erythema action spectrum (McKinlay and Diffey, 1987). 
One standard MED (sMED) was the effective dose of irradiation (this is usually 
not on buttock skin) capable of causing minimum erythema in an average skin type 
2. The relationship between sMED/h and radiometric units was as follows: 1 
sMED/h = 5.83 u.W/cm2; i.e., 1 sMED equals 210 J/m2at 297 nm. 
Determination of skin melanin 
Melanin content was measured on the non-exposed buttock skin using a 
Mexameter (MX 16, Courage & Khazaka Electronic GmnH, Cologne, Germany) 1 
year after MED determination in 341 volunteers. In this instrument, light was 
emitted at three defined wavelengths 568 nm (green), 660 nm (red) and 880 nm 
(infrared). A photodetector measured the light reflected by the skin. A melanin 
index (brown color) was computed from the intensity of the absorbed and the 
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reflected light at, respectively, 660 and 880 nm. Melanin indices were expressed as 
arbitrary units (a.u.). 
Determination of iris color 
Iris color was graded by a five-grade classification system, performed by one 
single investigator (Seddon et al, 1990). Briefly, blue and gray irises were 
classified as grade 1 or 2. These grades were distinguished by assessing the 
proportion of total iris area with brown or yellow pigment. A green iris was 
assigned grade 2 or 3. Similarly, these grades depended on the extent of brown or 
yellow pigment in the iris. A predominantly brown iris was assigned grade 3, 4 or 
5, depending on the intensity of the yellow or brown pigment. 
Determination of hair color 
Subjects were asked to indicate their natural (un-dyed) hair color in accordance 
with a six-point scale (red, light blond, dark blond, brown, black or gray). If they 
had gray hair, they had to indicate their original hair color (red, light blond, dark 
blond, brown, and black). The original hair colors of the volunteers were used in 
the analyses. 
Blood sampling 
For the analysis of carotenoids, retinol and a-tocopherol, blood was collected in 
tubes containing clot activator and gel (Becton Dickinson, Vacutainer systems, 
Netherlands). These tubes were immediately stored in a closed box, to avoid 
breakdown of carotenoids by UV irradiation. Tubes were centrifuged within 15-30 
min after collection at ca. 2000 x g for 10 min at ca. 4°C to obtain serum. After 
centrifugation serum was removed and stored at ca. -80°C. All serum handling 
before storage was done in subdued light. 
For the analysis of vitamin C, blood was collected in tubes containing lithium 
heparin (Becton Dickinson, Vacutainer systems). A 0.5 mL aliquot of blood was 
added to 2 mL metaphosphoric acid (50 g/L; Mallinckrodt Baker, Deventer, 
Netherlands) before freezing to preserve the vitamin C concentration during 
storage. This mixture was stored at ca. -80°C. 
For the analysis of total cholesterol, LDL cholesterol, HDL cholesterol and 
triacylglycerol blood was collected in tubes containing clot activator and gel 
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(Becton Dickinson, Vacutainer systems). Tubes were centrifuged within 15-30 min 
after collection at ca. 2000 x g for 10 min at ca. 4°C to obtain serum. After 
centrifugation serum was removed and stored at ca. -20°C. 
Analysis of carotenoids, retinol and a-tocopherol in serum 
At the day of analysis serum samples were thawed and mixed well. Samples were 
deproteinized by adding 500 u.L sample to 500 u,L ethanol (Nedalco, Bergen op 
Zoom, Netherlands) containing tocol (Matreya, Pleasant Gap, USA) which was 
used as internal standard. After mixing, the samples were allowed to stand for 15 
min at room temperature to complete precipitation of proteins. Subsequently, 1.0 
mL H-hexane (Merck, Darmstadt, Germany) was added and vortexed for 4 min. 
After centrifugation (2000 x g, 10 min, 4°C), 0.5 mL of the upper hexane layer was 
evaporated to dryness. The residue was dissolved in 0.5 mL of a mixture of 
methanol (Rathburn Chemicals, Walkerburn, UK), acetonitrile (Biosolve, 
Valkenswaard, Netherlands) and dichloromethane (Mallinckrodt Baker, Deventer, 
Netherlands). A 50 uX portion was injected on the HPLC system. Quality of the 
measurements was assessed by analyzing plasma quality control samples in each 
batch. The coefficients of variation in the quality control samples were for the 
analysis of lutein 3.7% (mean concentration: 0.16 jimol/L), zeaxanthin 11.5% (0.03 
u,mol/L), P-cryptoxanthin 8.3% (0.11 u.mol/L), a\\-trans lycopene 6.2% (0.31 
ujmol/L), a-carotene 14.9% (0.05 |umol/L), P-carotene 5.8% (0.25 (imol/L), a-
tocopherol 2.8% (20.9 umol/L) and retinol 2.5% (1.6 |imol/L). 
The HPLC system consisted of the following equipment: a Waters 2690 solvent 
delivery/injection system (Waters, Etten-Leur, Netherlands), a Waters 996 diode 
array and a Jasco 920 fluorescence detector (Jasco Benelux, Maarssen, 
Netherlands). System control and data acquisition /processing was performed by 
Millennium32 chromatography manager version 3.05 (Waters). 
Separation was obtained by two CI8 reversed-phase columns (250 mm x 4.6 mm, 
5 |4.m) in series, thermostatically controlled at 30°C. The samples were eluted using 
a gradient consisting of methanol, acetonitrile, 2-propanol (Mallinckrodt Baker) 
and milliQ® (Millipore, Etten-Leur, Netherlands) at a flow rate of 1.5 mL/min. 
This HPLC system allowed simultaneous detection of retinoids, tocopherols and 
carotenoids as well as their isomers. Additionally, the diode array data provided 
spectral information for confirmation of the identity of the analytes. 
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Analysis of vitamin C in blood 
Vitamin C was extracted from whole blood using metaphosphoric acid 
(Mallinckrodt Baker). Samples were allowed to stand for 20 min at 4°C to 
precipitate the proteins and to oxidize ascorbic acid to dehydroascorbic acid. After 
centrifugation samples were subsequently derivatized with 1,2-diaminobenzene 
(Merck) and injected on the HPLC system. In each series blood quality control 
samples were analyzed to check for reproducibility. The reproducibility of the 
assay was 10%. HPLC analysis was performed on an isocratic reversed-phase 
system consisting of a Gilson 234 injector (Meyvis, Bergen op Zoom, 
Netherlands), a Gynkotek model 300 pump (Separations, Hendrik-Ido-Ambacht, 
Netherlands), a CI8 column (125 mm x 4.6 mm, 5 \im) and a Jasco 920 
fluorescence detector. Mobile flow rate was 1.1 mL/min and consisted of methanol 
and buffer pH 7.8. Data acquisition and processing were performed by Turbochrom 
version 6.1.2.0.1:D19 (PerkinElmer Instruments, Nieuwerkerk a/d IJssel, 
Netherlands). 
Analysis of serum lipids 
Serum triacylglycerols were analyzed by enzymatic hydrolysis with subsequent 
enzymatic determination of the liberated glycerol by colorimetry (commercial 
available kit; Boehringer, Mannheim, Germany). Total cholesterol was analyzed by 
enzymatic conversion to a stable chromogen, which can easily be detected by 
colorimetry (Boehringer, Mannheim, Germany). HDL cholesterol was analyzed by 
precipitation with polyethylene glycol, centrifugation and enzymatic detection by 
colorimetry (Boehringer, Mannheim, Germany) and LDL cholesterol was 
calculated using the Friedewald formula (Friedewald et al, 1972). 
Statistical analyses 
The statistical software package SAS/STAT (release 6.12, SAS Institute, Cary, 
North Carolina, USA) was used for data analysis. For analysis, variables were 
subdivided in phenotypical determinants (skin melanin content, hair color and iris 
color), life-style and demographic factors (gender, smoking, age and fruit and 
vegetable intake) and nutritional determinants (serum carotenoids and vitamins). 
Linear regression modeling (General Linear Model (GLM)-procedure) was used to 
evaluate the associations between MED and these variables separately. 
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Furthermore, the contribution of nutritional determinants to MED, after adjustment 
for potential confounders was evaluated starting with the maximum model, 
including melanin index, total cholesterol, gender and the interaction terms 
(carotenoids/vitamins x gender) and (carotenoids/vitamins x melanin index). 
Because of the significant interaction term P-carotene x melanin, a class variable 
was created for melanin at the median level (< and > 470 a.u.) and the analyses 
were repeated. The influence of melanin on the associations between carotenoids 
and MED was not our hypothesis, but a possibly relevant finding to present. 
Data of 6 volunteers were not included because 4 volunteers were not irradiated 
and 2 volunteers showed erythema responses at all irradiation doses. Iris color and 
hair color were not classified for all participants, so we presented the results of 290 
volunteers for hair color of 322 volunteers for iris color. Two volunteers had a very 
high melanin index value (> 3 SD of the mean). We repeated the analyses after 
exclusion of the data of these two volunteers. All regression equations were the 
same. 
Results 
Study population 
We aimed at recruiting a study population with a wide range of fruit and vegetable 
intake, including fruit juices. In the end, significantly higher serum levels of 
carotenoids and vitamins were found in the group, selected on high fruit and 
vegetable intake in comparison with the low fruit and vegetable group. However, in 
comparison with other countries, for example the United States and South 
European countries (Olmedilla et ah, 2001; Mares-Perlman et ah, 2001) the range 
in serum carotenoids was rather narrow. 
The mean MED as was measured in 335 volunteers was 0.56 ± 0.20 x sMED 
(114.5 J/m2). Life style and demographic factors of the study population and 
associations with MED are presented in Table 1. Men displayed approximately 
16% lower MED values than women (P = 0.0001). No differences were observed 
in MED values between age categories (P = 0.40), between smokers and non-
smokers (P = 0.86) and between low and high fruit and vegetable consumption 
categories (P = 0.07). 
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Gender 
Men 
Women 
Smoking 
No 
Yes 
Age 
Low (18-30 y) 
Middle (31-50 y) 
High (51-75 y) 
Fruit and vegetable consumption 
Low 
High 
161 
174 
236 
99 
85 
152 
98 
193 
142 
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Table 1 Mean MED values for men and women, smokers and non-smokers, different age 
categories and high and low fruit and vegetables consumers 
Characteristics n MED1 
0.51+0.182 
0.61 ±0.20 
0.56 ± 0.20 
0.56 ± 0.20 
0.54 ±0.17 
0.57 ±0.19 
0.57 ± 0.23 
0.54 + 0.18 
0.58 ±0.22 
1
 MED: personal minimal erythema dose, expressed in standard MED (mean ± SD). 2 
Significantly different from women; P = 0.0001. 
Phenotypical determinants 
Mean values of MED for the different categories of phenotypical determinants 
(skin melanin index, hair color and iris color) in men and women are presented in 
Table 2. Skin melanin index was associated with iris color both in men and women. 
Hair color was associated with skin melanin index in men only. Of course, these 
determinants are related to common genetic factors, resulting in interrelations. 
Positive associations between hair color, iris color and MED were found in men 
only. Skin melanin index was associated with MED in both men and women. Hair 
color and iris color may serve as proxy measurements of skin melanin index. 
Melanin index was measured in the skin, the target organ of the MED 
measurement. Therefore, we included skin melanin index in the regression models. 
The regression coefficient (± SE) of melanin index was 0.36 ± 0.04 per 100 a.u. in 
the univariate model with an explained variance (R2) of 17%. In the multivariate 
model including melanin index and gender, the regression coefficients were 0.39 ± 
0.04 per 100 a.u. and -0.12 ± 0.02 (men), respectively (R2 = 27%). Regression 
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coefficients of iris color classes or hair color classes in the model including 
melanin index and gender were not significant, did not contribute to the explained 
variance and did not affect the regression coefficients of melanin and gender. 
Both skin melanin index and gender were important independent predictors of 
MED and were included in the regression models to further evaluate the influence 
of nutritional determinants on MED. 
Table 2 Mean personal minimal erythema dose (MED) per category of phenotypical 
determinants in men and women 
Variable 
Hair color 
Red 
Light blond 
Dark blond 
Brown 
Black 
Iris color 
Blue or gray 
Blue, gray or green 
Green or light brown 
Brown 
Dark brown 
Skin melanin index 
< 470 a.u. 
> 470 a.u. 
Men 
N 
1 
11 
78 
30 
14 
98 
28 
11 
13 
6 
72 
89 
MED1 
0.30 
0.43 ± 0.07 
0.50 + 0.16 
0.47 ±0.13 
0.67±0.312 
0.48 + 0.14 
0.51 ±0.23 
0.42 ±0.11 
0.61 ±0.17 
0.78 + 0.393 
0.46 ±0.14 
0.55±0.202 
Women 
n 
4 
18 
88 
39 
7 
113 
22 
15 
12 
4 
97 
77 
MED1 
0.76 ± 0.20 
0.59 ± 0.25 
0.60 + 0.20 
0.62 ± 0.22 
0.57 + 0.14 
0.60 ±0.19 
0.62 ± 0.23 
0.59 ±0.24 
0.62 ± 0.21 
0.73 ± 0.25 
0.52 ± 0.20 
0.70 ± 0.203 
1
 MED: personal minimal erythema dose, expressed in standard MED.2 Variable associated 
with MED in linear regression modeling; P < 0.01. 3 Variable associated with MED in 
linear regression modeling; P < 0.001. 
Nutritional determinants 
Mean concentrations of serum carotenoids and vitamins and regression coefficients 
in relation to MED are presented in Table 3. No significant associations between 
MED and serum carotenoids or vitamins A and E after adjustment for total 
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cholesterol and gender were found in the total study group. Only vitamin C was 
inverse associated with MED after adjustment for gender. 
The contribution of serum carotenoids and vitamins separately on MED were 
evaluated after adjustment for melanin index, gender and total cholesterol. Firstly, 
the model with the independent variables gender and total cholesterol and the 
interaction terms (carotenoids/vitamins x gender) and (carotenoids/vitamins x 
melanin index). The regression coefficients (P) of the interaction term gender x 
carotenoids was not significant for the different carotenoids, except for a-carotene 
The interaction term carotenoids/vitamins x melanin index was significant for (3-
carotene. 
Because of the significant interaction term P-carotene x melanin, a class variable 
was created for melanin at the median level (< and > 470 a.u.). 
In the model with the class variable for melanin, significant interaction terms were 
found between serum lutein, zeaxanthin, p-cryptoxanthin, a-carotene, P-carotene 
and the class variable for melanin. The interaction terms P-carotene x gender and 
a-carotene x gender were significant. 
Table 3 shows the regression coefficients of the model with the variables gender 
and total cholesterol of the carotenoids and vitamins in subjects with high and low 
melanin values. Positive trends were observed for subjects with high skin melanin 
values and negative trends for subjects with low skin melanin values. The 
regression coefficients in the low skin melanin group for a-carotene, P-carotene 
were -0.032 ± 0.031 (P = 0.31) and 0.006 ± 0.007 (P = 0.41) in women and -0.057 
± 0.036 (P = 0.11) and -0.018 ± 0.009 (P = 0.04) in men, respectively. In the high 
skin melanin group the regression coefficients for a-carotene, P-carotene were 
0.129 ± 0.035 (P = 0.0004) and 0.026 ± 0.011 (P = 0.02) in women and -0.034 ± 
0.030 (P = 0.26) and -0.0005 ± 0.011 (P = 0.96) in men, respectively. 
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Table 3 Serum carotenoids and vitamins concentrations in 335 volunteers and regression 
coefficients in relation to minimal erythema dose (MED) after adjustment for gender and 
total cholesterol in the total group and in the high and low melanin group 
Lutein 
Zeaxanthin 
P-Cryptoxanthin 
Lycopene 
a-Carotene 
P-Carotene 
a-Tocopherol 
Retinol 
Vitamin C 
Serum 
mean ± SD 
umol/L 
0.1810.08 
0.05 1 0.02 
0.20 + 0.12 
0.3610.18 
0.07 1 0.06 
0.37±0.22 
26.8 + 6.1 
2.04 + 0.45 
45114 
Total group 
P i S E 3 
/'-value 
0.00510.015 
0.72 
-0.01410.054 
0.79 
0.005 1 0.009 
0.59 
0.006 10.006 
0.30 
0.011 ±0.017 
0.55 
0.006 ± 0.005 
0.24 
0.00110.002 
0.74 
-0 .011 0.02 
0.68 
-0.002 10.001 
0.04 
Low melanin1 
P I S E 3 
/'-value 
-0.03310.017 
0.06 
-0.1210.062 
0.055 
-0.01610.011 
0.15 
-0.00410.007' 
0.56 
-0.04110.023 
0.08 
-0.00210.006 
0.75 
-0.00210.003 
0.49 
0.008 10.027 
0.77 
-0.00110.001 
0.16 
High melanin2 
P I S E 3 
/'-value 
0.04410.021 
0.04 
0.11 10.080 
0.17 
0.02310.013 
0.08 
0.007 + 0.008 
0.43 
0.031+0.023 
0.18 
0.01110.008 
0.12 
0.003 10.003 
0.41 
-0.029 1 0.037 
0.43 
-0.002 1 0.001 
0.15 
1
 n = 169. 2 n = 166. 3 regression coefficient and standard error per 0.1 umol/L for 
carotenoids and per 1 umol/L for vitamins; models are adjusted for gender and total 
cholesterol. Model for vitamin C is adjusted for gender. 
The interactions between melanin and carotenoids could be influenced by gender 
differences in skin melanin content, but after exclusion of gender from the model, 
the product terms melanin x carotenoids did not change. Therefore, we concluded 
that this interaction could not be explained by the difference in the gender 
distribution in skin melanin index. The regression coefficient of the class variable 
for melanin changed more than 10% after exclusion of gender. This could 
implicate confounding by gender. 
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The differences in MED values between men and women could be influenced by 
different serum concentrations of carotenoids. However, the regression coefficient 
(± SE) of gender in the multivariate model with gender, total cholesterol and 
carotenoids, separately was —0.10 ± 0.02. The regression coefficient of gender was 
the same as the regression coefficient in the bivariate model with only gender and 
total cholesterol as independent variables ((3 = -0.10, SE = 0.02). This means that 
difference between men and women in MED values cannot be explained by 
differences in serum carotenoid concentrations. 
In summary, the main phenotypical determinant of UV-sensitivity was skin 
melanin and men were more sensitive to UV-irradiation than women. Associations 
between serum carotenoids and MED showed a positive trend in subjects with 
melanin values above and a negative trend in subjects below the median after 
adjustment for gender and total cholesterol. For serum a-carotene and (3-carotene, 
this pattern was only seen in women. 
Discussion 
The mean MED in this general population with a 'normal' dietary intake was 0.56 
± 0.20 x sMED. Men had a lower MED value than women, which reflects higher 
sensitivity to UV-irradiation. Skin melanin content was the main predictor of the 
MED in our study. Vitamin C was inversely associated with MED against our 
hypothesis. Serum lutein, zeaxanthin, P-cryptoxanthin and lycopene concentrations 
were positively associated with MED after adjustment for gender and total 
cholesterol in subjects with high skin melanin and negatively associated in subjects 
with low skin melanin values. For serum a-carotene and P-carotene, this pattern 
was only seen in women. 
These results are based on a large study group with a normal dietary intake. The 
serum concentrations of carotenoids and vitamins could reflect the usual dietary 
intake. There were several limitations of this study that may attenuate the results of 
this study. We selected Dutch volunteers with high and low fruit and vegetable 
consumption in order to aim a broad range in carotenoid exposure. The absolute 
range in serum carotenoids is narrow in comparison with serum carotenoid 
concentrations in the United Stated and South European countries (Olmedilla et al., 
2001; Mares-Perlman et al, 2001). The evaluation of a large number of 
associations could cause that significant results are chance findings. Previous 
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intervention studies showed both positive effects of supplementation of either P-
carotene or a combination of carotenoids on UV sensitivity (Stahl et ah, 2000; Lee 
et ah, 2000; Gollnick et ah, 1996) or no effect on UV sensitivity (Garmyn et ah, 
1995; Wolf et ah, 1988). The duration of the supplementation might be an 
important factor. In the studies, which showed a protective effect, the duration of 
the study was more than 10 weeks. All of these supplementation studies used a 
very high dosage of carotenoids and selected the volunteers on skin type. However, 
in a cross-sectional design it is difficult to assess the temporal relationship between 
nutritional factors, for example carotenoids and the dependent variable, in this case 
minimal erythema dose. 
Evaluation of the association between carotenoids and vitamins within a normal 
physiological range and MED were based on concentrations of these substances in 
serum but not in the target tissue skin. However, it was previously shown that 
plasma and skin concentrations of carotenoids and a-tocopherol showed significant 
correlations, suggesting that the status of these micronutrients in skin may be 
estimated from the plasma concentrations (Peng et ah, 1993; Peng et ah, 1995; 
Stahl et ah, 1998). 
The mean MED (0.56 x sMED) being below one sMED, may indicate that: 1) the 
Dutch subjects recruited in this study are on average more sensitive than a 
phototype II, or, more likely, 2) the buttock skin used for the MED test is more 
sensitive than the skin usually used for such a test. 
In our study, men had a lower MED value than women, which reflects higher 
sensitivity to UV-irradiation in men. Several factors may account for this 
difference. One factor could be a difference in skin melanin index between men 
and women, suggesting that subjects with higher melanin content are less sensitive 
to UV-light and have therefore higher MED values. Skin melanin content was 
significantly higher in men than in women in this study, 478 ± 26 and 472 ± 19 (P 
= 0.03), respectively which seemed to be in contrast to the lower MED observed in 
men. However, after exclusion of two male volunteers with a high skin melanin 
content, there was no difference in skin melanin content between men and women, 
476 ± 20 and 472 ± 19 (P = 0.08) respectively. This exclusion did not affect the 
significant higher MED values in women in comparison with men. Skin melanin 
content was the main predictor of the MED in our study. Melanin is a 
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photoprotective agent in the target tissue skin and therefore protects against the 
effects of UV irradiation (Riley, 1997). 
In addition to melanin, antioxidants in skin (carotenoids and vitamins) may play an 
important role in skin protection against UV irradiation. The possible protective 
mechanisms are reflection, reaction with active oxygen species and quenching of 
radicals (Bast etal, 1998). 
Associations between serum carotenoids concentrations and UV-sensitivity after 
adjustment for gender and total cholesterol were dependent on a theshold value of 
melanin. The influence of the serum carotenoids on UV sensitivity was not 
concealed in the gender effect, because the regression coefficient of gender did not 
change after inclusion of serum carotenoids, separately. 
We do not have a clear biological explanation for the finding of a threshold value 
for skin melanin content on the association between serum carotenoids and MED. 
Although a role of melanin was not hypothesized in the association between 
carotenoids and MED, it is a possibly relevant finding to present. The combination 
of high melanin concentrations and carotenoids could be an important mechanism, 
especially where the maintenance of the carotenoid concentrations is vital to avoid 
deleterious effects of UV light, such as in the retina of the eye and the skin (Edge et 
al, 2000). Therefore, it could not be excluded that melanin content might have an 
influence on the association between carotenoids and MED. However, the role of 
melanin on the association between serum carotenoids and MED could also be a 
chance finding. 
All carotenoids are present in the skin, including lycopene with very high 
concentrations in the skin. Concentrations of [3-carotene and lycopene in the skin 
are approximately 216 ± 97 and 126 ± 90 ng/g wet tissue in non-smokers (Peng et 
al, 1995). We could not confirm the strong positive influence of lycopene on 
erythema according to a nutritional supplementation study (Stahl et al., 2001). 
They reported a protection against UV light-induced erythema in humans after 
consumption of tomato paste (approximately 16 mg/d lycopene). 
Although the efficacy of protection is not comparable to the protection factor of 
sunscreens, dietary intake of carotenoids could increase the basal protection of skin 
against erythema, suggested by others (Stahl et al, 2001). In our study, this basal 
protection was only attributable to subjects with high skin melanin content. More 
research to investigate the influence of nutritional compounds on sensitivity to UV-
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light is necessary. Also the possible influence of skin melanin on the association 
between nutritional compounds and sensitivity to UV-light has to be studied. 
From our results we conclude that men are more susceptible to UV irradiation than 
women. No associations between serum carotenoids and MED were found in the 
total study group. However, this association was modified by skin melanin content, 
although we do not a have a clear biological explanation for this. Serum carotenoid 
concentrations in a normal physiological range showed a positive trend with UV 
sensitivity in subjects with high melanin index and negative trend in subjects with 
low melanin index values. Dietary intervention studies are necessary to study the 
influence of nutritional compounds on the skin sensitivity to solar irradiation in 
both men and women and the possible interaction between nutritional compounds 
and melanin. 
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Abstract 
Background: The vascular endothelium is the primary site of dysfunction in 
atherosclerosis. Endothelial cell dysfunction may be related to an increase in 
cellular oxidative stress. Carotenoids and vitamins could have an antioxidant 
mediated tempering influence on endothelial function and inflammation, thereby 
reducing the risk of atherosclerosis. The objective of this study was to test the 
hypothesis that serum carotenoids and vitamins are associated with markers of 
endothelial function and inflammation. 
Methods: We measured serum carotenoids, a-tocopherol and vitamin C 
concentrations in 379 subjects sampled from the general population. High-sensitive 
C-reactive protein (CRP), fibrinogen (Fbg) and leucocytes were measured as 
markers of inflammation. Furthermore, soluble intercellular adhesion molecule-1 
(sICAM-1) and flow-mediated vasodilation (FMD) were measured as markers of 
endothelial function; the latter in a subset of 165 subjects. Relationships between 
serum carotenoids and vitamins and markers of endothelial function and 
inflammation were analyzed after adjustment for confounding, notably age, gender, 
body mass index (BMI), total cholesterol and smoking status (current vs non-
current). 
Results: Most of the carotenoids and markers of endothelial function and 
inflammation were associated with age, gender, smoking status, BMI and total 
cholesterol. In the total study group, lutein and lycopene were inversely related to 
sICAM-1 with regression-coefficients of-0.38 ± 0.19 (P = 0.04) and -0.16 ± 0.08 
(P = 0.04) per 1 umol/L, respectively. P-Carotene was inverse related to leucocytes 
(-0.23 ± 0.07; P = 0.007) and CRP (-1.09 ± 0.30; P = 0.0003) per 1 umol/L. 
Vitamin C was inverse related to CRP (-0.01 ± 0.005; P = 0.04) per 1 umol/L, 
whereas a-tocopherol was positively related to CRP (0.03 ± 0.01; P = 0.02) per 1 
umol/L. Zeaxanthin was inversely related to FMD (31.2 ± 15.3; P = 0.04) per 1 
umol/L. No significant relations associations were found between carotenoids, 
vitamins and fibrinogen. 
Conclusion: The inverse relations between carotenoids, vitamin C and sICAM-1, 
CRP and leucocytes may help to explain the possibly protective effect of 
carotenoids and vitamin C on atherosclerosis through an influence on inflammatory 
processes and endothelial function. 
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Introduction 
The vascular endothelium is the primary site of dysfunction in atherosclerosis. The 
endothelium is an active and dynamic organ and is essential in the processess of 
cell adhesion and migration, thrombosis, and fibrinolysis (Brown and Hu, 2001). In 
humans the endothelium is continuously exposed to pro-oxidative and anti-
oxidative factors, which are normally in balance (Hennig and Toborek, 2001). 
Endothelial cell dysfunction may be related to an increase in cellular oxidative 
stress, an imbalance between pro- and anti-oxidative factors. Oxidative stress can 
activate transcription factors, which promote cytokine production, expression of 
adhesion molecules and acute phase molecules and thus intensify an inflammatory 
response in atherosclerosis (Navab et al, 1991; Marui et al, 1993; Berliner et al, 
1995; Ross, 1999). In simple terms, a high oxidative stress may be related to 
endothelial dysfunction, elevated levels of adhesion molecules and elevated levels 
of inflammatory factors. 
There is growing interest in the role of antioxidants in preventing oxidative stress 
and modulating endothelial cell function, thereby reducing the risk of vascular 
dysfunction. Evidence to support the importance is based on an inverse association 
between low carotenoid concentrations and risk of cardiovascular disease (Gey et 
al, 1993, Kardinaal et al, 1993, Street et al, 1994). In addition, inverse 
associations have been found between [3-carotene and inflammation in patients 
with inflammatory diseases (Curran et al, 2000) and healthy subjects (Erlinger et 
al, 2001). 
Dynamic endothelial function can be assessed by measurement of flow-mediated 
vasodilation (FMD). Impaired FMD has been related to established risk factors, but 
the predictive value has not been established (Celermajer et al, 1994). There is 
overwhelming evidence to link elevated adhesion molecules, such as soluble 
intercellular adhesion molecule-1 (sICAM-1) to unfavorable levels of 
cardiovascular disease risk factors such as smoking, blood pressure, HDL and total 
cholesterol (Demerath et al, 2001). Also sICAM-1 has been shown to predict 
cardiovascular disease in some studies (Ridker et al, 2000; Blankenberg et al, 
2001). Several inflammation markers, including C-reactive protein (CRP), 
fibrinogen (Fbg) and leucocyte count, have consistently been shown to predict 
cardiovascular heart disease (Danesh et al, 1998; Tracy et al, 1999, Ridker et al, 
2000). Because of previous findings, we hypothesize that antioxidants are 
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associated with endothelial function and inflammation processes. To test this 
hypothesis we evaluated the association between serum antioxidants (carotenoids 
and vitamins) and markers of endothelial function (sICAM-1 and FMD) and 
inflammation (CRP, Fbg, leucocytes). 
Methods 
Study population 
The 380 subjects in our study were recruited from the pool of volunteers of TNO 
Nutrition and Food Research and through advertizing in local and regional 
newspapers and on television. The cross-sectional data analyzed here were 
obtained during baseline measurements for a dietary intervention study designed to 
test an unrelated hypothesis. Advertizing aimed at recruiting people who had a 
general interest in participating in nutrition studies. Subjects who expressed 
potential interest received a questionnaire on daily fruit and vegetable consumption 
and lifestyle factors. A total of 2734 out of 6900 questionnaires were returned. 
Subjects in the highest quintile of fruit and vegetable consumption and those in the 
lowest tertile (calculated in the total group) were invited for an oral briefing. In the 
lowest stratum, vitamin supplement users were excluded. After the oral briefing, 
589 subjects were interested to participate and were screened. 
The major inclusion criterium was an age between 18-75 years and consumption of 
an average Western diet. The main exclusion criteria were pregnancy and/or 
lactation or wishing to become pregnant; cholesterol > 7.5 mmol/L and/or 
triacylglycerol > 2.3 mmol/L if not under stabilized hypercholesterolemia 
/hyperlipidemia treatment, and anticoagulant therapy. A total of 413 volunteers 
were allocated to an entry number. Before the start of the study, 33 subjects 
withdrew from the study. At day one, 380 volunteers (179 men, 201 women) 
entered the study. Written informed consent was obtained from all subjects. 
The study was performed according to ICH (International Conference on 
Harmonization of Technical Requirements of Registration of Pharmaceuticals for 
Human Use) guidelines for good clinical practice, and was approved by an external 
Medical Ethical Committee. The study was executed at the Department of 
Nutritional Physiology of TNO Nutrition and Food Research, Zeist, and the 
measurements were performed from June 29 to September 16, 1998. 
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The final study group comprised 178 men and 201 women (pre and 
postmenopausal). Of these volunteers 165 volunteers (85 men, 80 women) 
underwent a flow-mediated vasodilation measurement. 
Blood sampling 
Blood samples were obtained between 800 and 930h after an overnight fast. For the 
analysis of carotenoids and a-tocopherol, total cholesterol, HDL cholesterol, 
triacylglycerol, C-reactive protein, blood was collected in tubes containing clot 
activator and gel (Becton Dickinson, Vacutainer systems). These tubes were 
immediately stored in a closed box, to avoid breakdown of carotenoids by UV 
light. Tubes were centrifuged within 15-30 min after collection at ca. 2000 x g for 
10 min at ca. 4°C to obtain serum. After centrifugation serum was removed and 
stored at -80°C. All serum handling before storage was done in subdued light. For 
the analysis of vitamin C and sICAM-1, blood was collected in tubes containing 
lithium heparin (Becton Dickinson, Vacutainer systems). A 0.5 mL aliquot of 
blood was added to 2 mL metaphosphoric acid (50 g/L; Mallinckrodt Baker, 
Deventer, Netherlands) before freezing to preserve the vitamin C concentration 
during storage. This mixture was stored at -80°C. Thereafter, tubes were 
centrifuged within 30 min after collection at ca. 2000 x g for 20 min at ca. 4°C to 
obtain plasma. After centrifugation plasma was removed and stored at -80°C. For 
the analyses of leucocytes, blood was collected in tubes containing K3EDTA. 
About 0.5 mL blood at room temperature was used for determination of leucocytes. 
Chemical analyses 
Serum carotenoids (CVs 3.7-14.9%), retinol (CV 2.5%), a-tocopherol (CV 2.8%) 
and vitamin C (CV 10%) were quantified by reversed phase HPLC (Broekmans et 
ah, in press). Serum triacylglycerols were analyzed by enzymatic hydrolysis and 
subsequent enzymatic determination of the liberated glycerol by colorimetry 
(commercial available kit; Boehringer, Mannheim, Germany). Total cholesterol 
was analyzed by enzymatic conversion to a stable chromogen, which can easily be 
detected by colorimetry (Boehringer, Mannheim, Germany). HDL cholesterol was 
analyzed by precipitation with polyethylene glycol, centrifugation and enzymatic 
detection by colorimetry (Boehringer, Mannheim, Germany) and LDL cholesterol 
was calculated using the Friedewald formula (Friedewald et ah, 1972). Fibrinogen 
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was measured according to Clauss (1957) using the STA Fibrinogen kit on a STA 
analyzer. CRP was analyzed in plasma by an enzyme-immunoassay using 
polyclonal antibodies (Dako, Copenhagen, Denmark) with a low detection limit to 
detect basal levels in serum. (De Maat et al, 1996). Soluble ICAM-1 in plasma 
was determined with an immunoenzymometric method (Gearing et al, 1992) in 
plasma. The leucocyte count was measured using the Sysmex K-1000. 
Flow-mediated vasodilation measurement 
Flow-mediated vasodilation (FMD) of the brachial artery was measured by a 
method described by de Roos et al (2001). In short, the diameter of the artery at 
rest and at maximum vasodilation was assessed and the percentage increase from 
baseline was calculated. All measurements were done at end diastole (images were 
triggered on the use of the R-wave of the electrocardiogram). The ultrasound 
images were obtained by one technician with a 7.5 MHz linear array transducer of 
an Ultramarktm 9HDI duplex scanner. All images were stored on super-VHS 
videotapes for off-line analysis. Off-line readings were performed as described 
elsewhere (De Roos et al, 2001). In short, the ultrasound interfaces were traced 
manually of each B-mode image that was stored each 15 seconds after ischemia for 
a duration of 5 minutes. 
Other measurements 
Body weight was assessed by weighing the subject wearing indoor clothing, 
without shoes, wallet and keys. Height was measured without shoes. Body mass 
index (BMI) was calculated with the formula body weight (kg)/ body height 
squared (m2). Smoking status was obtained by a questionnaire; non-smoking and 
smoking. The use of contraceptives was registered. 
Statistical analyses 
The SAS statistical software package SAS/STAT (Version 6, SAS Institute, Cary, 
NC, USA) was used for data analysis. The influence of potential confounders of 
the relation between carotenoids/vitamins and markers of inflammation and 
endothelial function was evaluated in univariate linear regression models. 
Variables that were not normally distributed were natural log-transformed (CRP, 
sICAM-1 and leucocytes). 
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Multiple linear regression (GLM procedure) was used to evaluate the associations 
between carotenoids/vitamins and markers of endothelial function (sICAM-1 and 
FMD) and markers of inflammation (CRP, Fbg and leucocytes) after adjustment 
for potential confounding. 
Interactions by smoking status, gender and carotenoids or vitamins were evaluated 
in a general linear model with continuous values of carotenoids and multiplicative 
interaction terms. If the P-value was less than 0.05, the regression coefficients of 
the variables were considered as significant. 
Results 
General characteristics of subjects 
Table 1 shows the general characteristics of the 379 subjects, 178 men and 201 
women. 
Table 1 General characteristics of study group1 
Smoking (%) 
Age (y) 
BMI (kg/m2)2 
Total cholesterol (mmol/L) 
LDL (mmol/L) 
HDL (mmol/L) 
Triacylglycerols (mmol/L)2 
Contraceptives 
Men («= 178) 
33 
42 ±15 
24.0(20.2-28.4) 
5.4 ±1.0 
3.5 ±0.9 
1.4 ±0.3 
1.07(0.63-1.87) 
n.a. 
Women (« = 201) 
27 
41 ±13 
24.2(19.9-30.9) 
5.7 ±0.9 
3.4 ±0.9 
1.8 ±0.4 
0.98(0.57-1.89) 
34% 
Total (n = 379) 
30 
42 ±14 
24.1 (20.0-29.7) 
5.5 ±1.0 
3.5 ±0.9 
1.6 ±0.4 
1.01(0.59-1.88) 
n.a. 
Mean ± SD unless stated otherwise. Median (10 -90 percentile), n.a.: not applicable. 
Table 2 shows the concentrations of carotenoids, vitamin C and oc-tocopherol in 
men, women and the total group. Table 3 shows the mean (+ SD) or median (10th -
90th percentile) values in the total group and in men and women for FMD, sICAM-
1, CRP, Fbg, and leucocytes. One hundred and sixty-five subjects, randomly 
selected, underwent a flow-mediated vasodilation measurement. 
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Table 2 Serum carotenoid, vitamin C and oc-tocopherol concentrations (umol/L) for men, 
women and total study group1 
Men (ft =178) Women (n = 201) Total (n = 379) 
Lutein 0.17 ±0.07 0.19 ±0.08 0.18 + 0.08 
Zeaxanthin 0.05 ±0.02 0.05 ± 0.02 0.05 ±0.02 
P-Cryptoxanthin 0.17 + 0.09 0.23+0.13 0.20 ±0.12 
Lycopene 0.35 ±0.18 0.37 ±0.18 0.36 ±0.18 
cc-Carotene 0.06 ±0.06 0.08 + 0.06 0.07 ±0.06 
P-Carotene 0.33 + 0.19 0.41 ±0.25 0.37 ±0.23 
Vitamin C 40.1 ± 12.3 50.0 ± 13.4 45.3 ± 13.8 
q-Tocopherol 26.0 ± 5.5 27.7 ±6.6 27.0 ± 6.2 
1
 Mean ± SD. 
Table 3 Flow-mediated vasodilation (FMD) values and concentrations of soluble 
intercellular adhesion molecule (sICAM-1), C-reactive protein (CRP), fibrinogen (Fbg), 
leukocytes in men, women and total group1 
Men(«=178) Women (n = 201) Total (n = 379) 
sICAM-1 (ng/mL)2 225.5(175-344) 209(165-323) 215(169-328) 
FMD(%) 3.9±3.9(« = 85) 5.1 + 3.7 (n = 80) 4.5 ± 3.9 (n = 165) 
CRP(mg/L)2 0.9(0.2-5.9) 1.3(0.2-7) 1.1(0.2-6.7) 
Fibrinogen (g/L) 3.2 ±0.7 3.3 ±0.6 3.2 ±0.6 
Leucocytes (109/L)2 5.5(3.9-7.5) 5.4(3.8-8.7) 5.5(3.9-8.1) 
1
 Mean ± SD unless stated otherwise.2 Median (10th - 90th percentile). 
Potential confounders 
In the total study group, age was positively related to serum lutein, a-carotene, P-
carotene and a-tocopherol. Age was inverse related to serum lycopene and was not 
related to zeaxanthin, P-cryptoxanthin and vitamin C. Women showed higher 
serum carotenoids than men. Non-smokers showed higher concentrations of 
carotenoids than smokers. Total cholesterol was positively associated with all 
carotenoids and a-tocopherol. BMI was inversely related to lutein and P-carotene 
and positively related to a-tocopherol. Contraceptive use was inversely related to 
serum P-carotene, a-carotene and lycopene in women. 
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In the total study group, age was positively related to concentrations of CRP and 
Fbg. Women showed higher concentrations of CRP and Fbg than men. FMD was 
lower in men than in women (P = 0.053). Smokers showed significantly higher 
concentrations of Fbg, leucocytes and sICAM-1 than non-smokers. Positive 
relations were found between total cholesterol and CRP, Fbg and sICAM-1. BMI 
was positively related to CRP, fibrinogen, leucocytes and sICAM-1. In women, 
contraceptive use was positively related to CRP and leucocytes. 
Multivariate analyses 
Age-adjusted and multivariate models adjusted for age, gender, smoking, total 
cholesterol and body mass index with sICAM-1 and FMD as dependent variables 
are presented in Table 4. Vitamin C was not adjusted for total cholesterol. 
Significant inverse relations were found between lutein, lycopene and sICAM-1 
concentrations after adjustment. Other carotenoids showed a negative trend with 
sICAM-1. Only, zeaxanthin was positively related to FMD after adjustment. 
Age- and multivariate adjusted models for CRP, fibrinogen and leucocytes are 
presented in Table 5. After adjustment for age, gender, smoking status, BMI and 
total cholesterol, P-carotene was inversely and a-tocopherol was positively related 
to CRP. Vitamin C was inverse related to CRP. None of the carotenoids/vitamins 
was related to fibrinogen. Only P-carotene was inversely related to leucocytes after 
adjustment in the multivariate models. 
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Table 4 Regression coefficients ± SE (P-value) of serum carotenoids and vitamins by 
markers of endothelial function per 1 ijmol/L1 
sICAM-12 FMD 
Lutein 
Age adjusted -0.57 ±0.19 (P = 0.003) 2.08 ± 4.88 (P = 0.67) 
Multivariate -0.38 ± 0.19 (P = 0.04) 1.94 ± 5.14 (P = 0.71) 
Zeaxanthin 
Age adjusted -1.23 ± 0.68 (P = 0.07) 27.4 ± 14.8 (P = 0.07) 
Multivariate -0.72 ± 0.66 (P = 0.28) 31.2 ± 15.3 (P = 0.04) 
P-Cryptoxanthin 
Age adjusted -0.29 ± 0.12 (P = 0.01) 4.46 ± 2.44 (P = 0.07) 
Multivariate -0.15 ± 0.12 (P = 0.22) 3.20 ± 2.61 (P = 0.22) 
Lycopene 
Ageadjusted -0.11 ±0.08 (P = 0.18) -3.12 ± 1.64 (P = 0.06) 
Multivariate -0.16 ± 0.08 (P = 0.04) -2.63 ± 1.71 (P = 0.13) 
a-Carotene 
Ageadjusted -0.48 ± 0.23 (P = 0.04) -6.10 ± 5.40 (P = 0.26) 
Multivariate -0.31 ± 0.22 (P = 0.16) -8.74 ± 5.70 (P = 0.13) 
P-Carotene 
Ageadjusted -0.15 ± 0.06 (P = 0.02) -0.57 ± 1.44 (P = 0.69) 
Multivariate -0.08 ± 0.06 (P = 0.19) -1.95 ± 1.57 (P = 0.22) 
Vitamin C3 
Age adjusted -0.003 ± 0.001 (P = 0.006) 0.03 ± 0.02 (P = 0.27) 
Multivariate -0.001 ± 0.001 (P = 0.28) 0.009 ± 0.02 (P = 0.70) 
a-Tocopherol 
Ageadjusted 0.004 ± 0.003 (P = 0.14) 0.005 ± 0.06 (P = 0.92) 
Multivariate 0 ± 0.003 (P = 0.99) 0.05 ± 0.07 (P = 0.51) 
Multivariate models: adjusted for age, gender, smoking, total cholesterol and BMI unless 
stated otherwise. 2 Log transformed. 3 Multivariate model: adjusted for age, gender, 
smoking and BMI. 
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Table 5 Regression coefficients ± SE (/"-value) of serum carotenoids and vitamins by 
markers of inflammation per 1 umol/L1 
CRP2 Fbg Leucocytes 
Lutein 
Age adjusted 
Multivariate 
Zeaxanthin 
Age adjusted 
Multivariate 
P-Cryptoxanthin 
Age adjusted 
Multivariate 
Lycopene 
Age adjusted 
Multivariate 
a-Carotene 
Age adjusted 
Multivariate 
P-Carotene 
Age adjusted 
Multivariate 
Vitamin C3 
Age adjusted 
Multivariate 
a-Tocopherol 
Age adjusted 
Multivariate 
-1.89+0.91(^=0.04) 
-0.95±0.90(/>=0.29) 
-2.31+3.30(^=0.48) 
-1.42+3.21(^=0.66) 
-0.65±0.59(P=0.27) 
-0.58±0.58(P=0.31) 
-0.28±0.38(P=0.46) 
-0.42±0.40(i>=0.25) 
-1.67+1.13(^=0.13) 
-1.07±1.08(^=0.32) 
-1.33±0.30(/>=0.001) 
-1.09+0.30(/>=0.0003) 
-0.009±0.005(P=0.08) 
-0.01+0.005(P=0.04) 
0.05+0.0 l(f=0.0001) 
0.03±0.01(P=0.02) 
-0.67±0.43(P=0.12) 
-0.36±0.44(/'=0.41) 
0.20±1.55(/>=0.90) 
0.80±1.56(P=0.61) 
0.03±0.27(P=0.91) 
0.16+0.28(P=0.57) 
-0.1310.18(^=0.48) 
-0.19±0.18(/M).29) 
-0.37±0.53(/,=0.48) 
-0.11±0.52(P=0.83) 
-0.23±0.15(P=0.11) 
-0.08±0.15(^=0.58) 
-0.33±0.20(/>=0.10) 
-0.08+0.20(P=0.68) 
0.04±0.72(P=0.95) 
0.7710.7l(/>=0.28) 
-0.29+0. 13(/>=0.03) 
-O.U±0.\3(P=0.27) 
-0.002±0.08(P=0.98) 
0.003±0.08(P=0.97) 
-0.50+0.25(/>=0.047) 
-0.28±0.24(P=0.25) 
-0.32±0.07(/>=0.001) 
-0.23±0.07(/>=0.007) 
0.0004+0.002(P=0.87) -0.002±0.001(P=0.05) 
0.0008±0.002(P=0.74) -0.0009±0.001(/>=0.40) 
0.01+0.01(^=0.08) -0.004±0.003(P=0.16) 
-0.0005±0.007(/J=0.95) 0.0003±0.003(P=0.93) 
1
 Multivariate models: adjusted for age, gender, smoking, total cholesterol and BMI unless 
stated otherwise. 2 Log transformed. 3 Multivariate model: adjusted for age, gender, 
smoking and BMI. 
A significant interaction between serum a-carotene and smoking status in the 
model with leucocytes as dependent variable was found. Stratification showed that 
there was an inverse trend between a-carotene and leucocytes in smokers with a 
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regression coefficient of-2.23 ± 0.80 (P = 0.006) per ^mol/L and no relation in 
non-smokers (0.004 ± 0.23; P = 0.99). There were significant interactions between 
a-tocopherol, P-carotene and lycopene and gender in the model with CRP as 
dependent variable. Stratification showed that there was a positive relation between 
a-tocopherol and CRP in men (regression coefficient ± SE: 0.08 + 0.02 per 
jxmol/L; P = 0.001) and no relation in women (0.02 ± 0.02 per (imol/L; P = 0.34). 
An inverse relation between lycopene and CRP (-1.14 ± 0.54 per (xmol/L; P =0.04) 
was found in men and not in women (0.50 ± 0.50 per umol/L; P = 0.32). After 
adjustment for contraceptive use the relation between lycopene and CRP in women 
was 0.08 ± 0.44 per umol/L (P = 0.85). P-Carotene was inversely related to CRP 
(-1.38 ± 0.39 per umol/L; P = 0.0003) in women and not related in men (-0.19 ± 
0.51; P = 0.71). However, after adjustment for contraceptive use in women, the 
relation was attenuated (-0.58 ± 0.35 per umol/L; P = 0.10). 
FMD values were inversely associated with CRP (regression coefficient ± SE: -1.8 
± 0.7 per 10 mg/L; P = 0.02), sICAM-1 (-0.13 ± 0.04 per 10 ng/mL; P < 0.01) and 
fibrinogen (-7.8 ± 4.6 per 10 g/L; P = 0.06). Adjusted for age, gender, smoking, 
BMI and total cholesterol the regression coefficients for CRP, sICAM-1 and 
fibrinogen were -1.9 ± 0.7 per 10 mg/L (P < 0.01), -0.14 ± 0.04 per 10 ng/mL (P < 
0.01) and -7.2 ± 4.5 per 10 g/L (P > 0.05), respectively. 
Discussion 
We evaluated in a large population based study group the associations between 
serum carotenoids and vitamins and markers of endothelial function and 
inflammation. The inverse relations between carotenoids, vitamin C and sICAM-1, 
CRP and leucocytes may help to explain the possibly protective effect of 
carotenoids and vitamin C on atherosclerosis through an influence on inflammatory 
processes and endothelial function. 
There were several limitations of this study. Firstly, fruit and vegetables contain 
multiple agents that could convey benefit to humans, for example fiber, folic acid 
and polyphenols. In our study, serum carotenoids and vitamins could be a 
reflection of other compounds in the blood, that are the real substances or variables 
related to the markers of cardiovascular disease risk. Secondly, residual 
confounding occurs if confounders are not or insufficiently accounted for in the 
analysis. Insufficient control for confounders can occur as a result of 
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misclassification of the confounding factors. Smoking is an important extraneous 
factor that is associated with both the dependent variables (markers of 
inflammation and endothelial function) and independent variables (carotenoids). In 
our models, we included smoking as yes or no and we had no information on ex-
smokers, duration of smoking or pack-years smoking. Therefore, we cannot 
exclude the possibility that the effects could be caused by residual confounding of 
smoking (Rothman, 1998). Thirdly, the evaluation of a large number of 
associations could cause that significant results are possibly due to chance. 
Dietary antioxidants may protect against oxidative stress by scavenging free 
radicals and by inhibiting the activation of oxidant-sensitive transcription factors, 
such as NF-KB, resulting in decreased production of cytokines and therefore 
decreased expression of cell adhesion molecules and an attenuated inflammatory 
response (Navab et al, 1991; Marui et al, 1993; Berliner et al, 1995). The 
significant inverse relation between lutein, lycopene and sICAM-1 are in line with 
the results of Martin et al. (2000). In this in vitro experiment, pre-treatment of 
human aortic endothelial cells (HAEC) with lycopene, lutein and P-carotene 
significantly reduced the expression of sICAM-1. However, in the present study we 
did not observe significant inverse associations between P-carotene, a-tocopherol 
and sICAM-1 as reported in in vitro studies (Martin et al, 2000; Wu et al, 1999). 
Lycopene and lutein have recently received attention for their potential role in 
preventing cardiovascular disease in humans. A low serum and adipose tissue 
lycopene concentration are associated with an excess incidence of acute coronary 
events, stroke and myocardial infarction, respectively (Rissanen et al, 2001; 
Kohlmeier et al, 1997). Furthermore, both plasma lycopene and lutein are 
associated with early atherosclerosis, as measured by intima-media thickness 
(Rissanen et al, 2000; Dwyer et al, 2001). Our regression analyses shows that 
serum lutein and lycopene concentrations at the 10th percentile are associated with 
approximately 7% higher sICAM-1 concentrations than serum concentrations at 
the 90th percentile. The relevance of a difference of approximately 16-18 ng/mL in 
sIC AM-1 concentrations between the 10th and 90th percentiles of serum carotenoids 
is difficult to estimate. In a study of Blankenberg et al. (2001) patients with 
coronary heart disease with future death from cardiovascular disease had 66 ng/mL 
higher concentrations of sICAM-1 in comparison with patients with coronary heart 
disease who stayed alive during the study period. In a study of Ridker et al (1998) 
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healthy subjects at baseline in the highest quartile of sICAM-1 (> 260 ng/mL) had 
80% higher risk of myocardial infarction than subjects in the lowest quartile (< 193 
ng/mL). Malik et al. (2001) concluded that measurement of adhesion molecules is 
unlikely to add much predictive information to that provided by more established 
risk factors on coronary heart disease. However, these data should not reduce the 
enthusiasm for targeting endothelium bound sICAM-1 as a potential method for 
therapy of cardiovascular disease as suggested by others (Ridker, 2001). 
Our results did not confirm a protective effect of antioxidants on endothelial 
function measured by FMD measurement. Only zeaxanthin showed an inverse 
association, probably a chance finding. On the other hand, we found significant 
inverse associations between CRP, sICAM-1 and FMD. 
In this study, the acute phase reactant C-reactive protein (CRP) was measured as 
marker of systemic inflammation. Surprisingly, because a negative association was 
expected, we observed a positive association between a-tocopherol and CRP in 
men. De Maat et al. (2000) found also a positive correlation between a-tocopherol 
concentrations and interleukin-6 (11-6), another inflammation marker. At the 
moment these observations cannot be explained. 
Previous studies found strong associations between P-carotene and CRP (Erlinger 
et al, 2001; Kritchevsky et al, 2000). We could confirm this positive association 
in the total group and we reported an inverse relation between lycopene and CRP in 
men only. Comparable with the results of Erlinger et al. (2001) we found an 
inverse relation between p-carotene and leucocytes. It has been suggested that in 
studying the relation between fruit and vegetable intake and cardiovascular disease 
risk, inflammation processes have to be taken into account as an confounding 
factor (Erlinger et al, 2001; Kritchevsky, 1999; Kritchevsky et al, 2000). The 
inverse relations between carotenoids and inflammation markers can explained by 
the fact that concentrations of carotenoids could be a reflection of inflammatory 
processes or possible anti-inflammatory properties of carotenoids. 
In summary, we found inverse associations between lutein, lycopene and sICAM-
1. P-Carotene was inverse related to leucocytes and CRP. Vitamin C was inverse 
related to CRP and a-tocopherol was positively associated with CRP. These 
inverse relations between carotenoids, vitamin C and sICAM-1, CRP and 
leucocytes may help to explain the possibly protective effect of carotenoids and 
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vitamin C on atherosclerosis through an influence on inflammatory processes and 
endothelial function. 
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Abstract 
Background: Excessive consumption of calories and fat increases the risk for 
obesity. Replacement of fatty foods by foods containing low- or zero-energy fat 
substitutes may help in reducing the energy intake of the population. Snacks 
containing sucrose polyesters (SPE) as dietary fat replacer are now on the market 
in the US. SPE products have been shown to lower concentrations of serum 
carotenoids in short term studies. Experimental studies on the longer-term effects 
on health of decreased carotenoid concentrations are lacking. 
Methods: We performed a 1-year randomized, double blind, placebo-controlled 
parallel trial. We randomly assigned 380 subjects to the treatment with intakes of 0, 
7, 10 or 17 g/d SPE. SPE was given in the form of spreads (daily consumption), 
chips (snackwise consumption), or both. SPE products were enriched with vitamin 
A, D, E and K according to the FDA regulation for olestra. We compared the 
groups with regard to body weight, serum carotenoids, vitamins and markers of 
oxidative damage (comet assay, LDL oxidation, carbonyl proteins, 8-epi-
prostaglanins F2a, minimal erythema dose), eye health (macula pigment density), 
cardiovascular health (serum lipids, flow-mediated vasodilation) and immune 
status (antibodies against hepatitis B vaccination). 
Results: After 1 year of intervention, serum lipid adjusted carotenoids showed the 
largest decrease in the group consuming both SPE chips and SPE spread (17 g/d) 
compared with the control group (a-carotene 33%; p-carotene 31%, lycopene 24%, 
p-cryptoxanthin 18%, lutein 18% (all P < 0.001) and zeaxanthin 13% (P < 0.05)). 
Consumption of SPE spread (10 g/d SPE) or SPE chips (7 g/d SPE) decreased 
carotenoid concentrations by 11% to 29% and 0.2% to 21%, respectively. In 
comparison with the control group serum lipid adjusted oc-tocopherol decreased 
significantly by 6-8% (all P < 0.001) in all SPE groups. No negative effects were 
observed on markers of oxidation, eye health, cardiovascular health, and immune 
status despite the decreased concentrations of carotenoids. 
Conclusion: This study suggests that substantial decreases in serum carotenoid 
concentrations do not imply an increased risk for chronic diseases. 
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Introduction 
A high intake of fat is associated with an increased risk of obesity. Replacement of 
fatty foods by foods containing low- or zero-energy fat substitutes may be effective 
in reducing the energy intake of the population. A few years ago, low fat savory 
snacks containing sucrose polyester (SPE) as fat replacer (Olean®, Olestra) were 
introduced on the US market. It has been shown that products with SPE fat 
substitutes can lower concentrations of serum carotenoids (Weststrate and Van het 
Hof, 1995) and fat-soluble vitamins (Kelly et al, 1998; Schlagheck et al, 1997). 
Since SPEs hampers the absorption of fat soluble nutrients, the FDA requires the 
addition of vitamins A, D, E, and K to foods made with olestra (Federal Register, 
1996). Addition of carotenoids was not mandatory because health effects of 
carotenoids are less well understood (Rock, 1997). 
Carotenoids are fat-soluble compounds and occur naturally in fruit and vegetables. 
In addition to the best established function of p-carotene and to a lesser extent a-
carotene and P-cryptoxanthin as precursor of vitamin A (Van Vliet et al, 1996; 
Parker, 1996), carotenoids have other biological functions and actions (Van den 
Berg et al, 2000). Carotenoids demonstrate in vitro antioxidant activity (Palozza 
and Krinsky, 1992; Sies and Krinsky, 1995; Krinsky, 1998), protect the skin 
through their singlet oxygen-quenching capacity (Mathews-Roth, 1993). 
Furthermore, cell-to-cell communication (Stahl and Sies, 1998) and 
immunomodulatory effects (Fuller et al, 1992; Santos et al, 1996) have been 
reported. Accumulation of lutein and zeaxanthin in the macula pigment of the 
retina could protect the eye by blue light filtering and singlet oxygen quenching 
(Seddon et al, 1994). It has been suggested that carotenoids through these 
biological functions and actions may protect against degenerative diseases, for 
example cardiovascular disease (Cooper et al, 1999; Kohlmeier and Hastings, 
1995), cancer (Cooper et al, 1999; Van Poppel and Goldbohm, 1995), and age-
related macular degeneration (Cooper et al, 1999; Seddon et al, 1994). 
In addition to SPE products, more foods which adversely affect carotenoids may be 
introduced. For instance, cholesterol lowering phytosterol and stanol products also 
reduce carotenoid concentrations to a lesser extent (Weststate and Meijer, 1998; 
Plat and Mensink, 2001). 
The longer-term effects as well as the functional consequences of decreased 
carotenoid concentrations have not been previously studied in detail in human 
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intervention studies. Therefore, we conducted a long-term human intervention trial 
to investigate the possible effects of SPE consumption on serum carotenoid and fat 
soluble vitamin concentrations and markers of oxidative damage and also 
functional markers of eye, cardiovascular health and immune status. 
Methods 
Subjects and study design 
Between June 29, 1998 and September 8, 1999 we conducted a double blind, 
randomized, placebo-controlled, parallel design trial with 4 treatment groups to 
study the effects of long-term SPE consumption. The study was performed 
according to ICH guidelines for good clinical practice. The protocol was approved 
by an external Medical Ethical Committee. 
Subjects were recruited through advertizing. Respondents who expressed potential 
interest received information and a questionnaire on fruit and vegetable 
consumption and lifestyle (Broekmans et ah, in press). The main exclusion criteria 
were age not between 18-75 years, pregnancy (wish) and/or lactation, serum 
cholesterol > 7.5 and/or triacylglycerol > 2.3 mmol/L if not under stabilized 
hypercholesterolemia/hyperlipidemia treatment, anticoagulant therapy, and 
vegetarians and vegans. 
A total of 2734 out of 6900 questionnaires were returned. Respondents ranked in 
the highest quintile of fruit and vegetable consumption (n = 547) and those in the 
lowest tertile (n = 775) were invited for an oral briefing. This pre-selection was 
made in order to select volunteers with a relatively high and low serum carotenoid 
status. Five hundred and eighty-nine volunteers gave their informed consent and 
filled in a questionnaire on personal data, life style, medical history and dietary 
habits. Fifty-four volunteers were excluded on criteria for serum cholesterol and/or 
triacylglycerol. One hundred and fifty-five volunteers withdrew before the start of 
the study, leaving a total of 380 volunteers in this study at day 01. 
Subjects were randomly assigned to one of the four treatment groups. High/low 
fruit and vegetable consumption, age, gender and smoking habit (yes/no) were used 
as randomization parameters. Eighty-five subjects entered the study in June 1998, 
115 subjects entered in August 1998 and 180 subjects entered the trial in 
September 1998. 
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The subjects consumed SPE in different concentrations and food products, e.g. 
spread and chips (deep-fried potato slices). The four treatment groups consumed 
control spread and control chips (control group), or SPE spread and control chips 
(SPE spread group), or control spread and SPE chips (SPE chips group), or SPE 
spread and SPE chips (SPE spread + SPE chips group), respectively. The content 
of SPE and triacylglycerol (TAG) of the products is given in Table 1. All data in 
Table 1 are weighed averages over all portions consumed from the various product 
batches. 
Table 1 Composition of study substances in units per gram study substance (averages 
weighed over the number of portions consumed per batch) 
Sucrose Polyester (g) 
Triacylglycerol (g) 
Vitamin A (ng)1 
Vitamin D (ng)2 
Vitamin E (mg)3 
Vitamin Kl (ng)4 
Carotene (ng) 
Total tocopherols (ng) 
Control 
-
0.330 
10.5 
69.0 
0.17 
-
6 
528 
spread SPE spread 
0.501 
0.344 
47.2 
145 
1.17 
3.4 
6 
183 
Control 
-
0.327 
-
-
0.06 
-
4 
433 
chips SPE chips 
0.244 
0.004 
36.0 
129 
0.86 
3.0 
4 
221 
1
 94.2 ng retinyl palmitate/g SPE in SPE spread and 147.5 ng retinyl palmitate/g SPE in 
SPE chips (FDA requirement: 93.0 ug retinyl palmitate/g SPE). 2 290 ng cholecalciferol/g 
SPE in SPE spread and 529 cholecalciferol ng/g SPE in SPE chips (FDA requirement: 300 
ng cholecalciferol /g SPE). 32.34 mg d-a-tocopheryl acetate/g SPE in SPE spread and 3.51 
mg d-a-tocopheryl acetate/g SPE in SPE chips (FDA requirement: 2.07 mg d-a-tocopheryl 
acetate/g SPE). 46.7 ng 3-phytyl menadione/g SPE in SPE spread and 12.2 (j.g 3-phytyl 
menadione/g SPE in SPE chips (FDA requirement: 8.0 ng 3-phytyl menadione/g SPE). 
Chips containing SPE (olestra) were bought on the US market. Control chips were 
bought on the Dutch and US markets. All chips were repacked in neutral bags in 
weekly portions of 200 gram. Spreads were produced on pilot plant votator 
equipment at Unilever R&D Vlaardingen, according to regular spread processing 
procedures. The test spread contained 50% SPE and 35% TAG. The control spread 
was a low-fat spread containing 35% TAG. More detailed data are given in Table 
1. The average portion size of one tub of each spread was 140 gram, intended for 
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consumption within one week. SPE raw materials for use in the test spreads were 
also produced at Unilever according to methods comparable to those described for 
the production of Olestra. 
The spreads were consumed as part of a normal dietary intake with an intended 
daily dosage of 20 g/d (thus either 0 or 10 g SPE per day, plus 7 g TAG). Subjects 
were instructed not to use the spread for cooking or baking. The chips were to be 
consumed as a snack in an amount of 200 g/wk, without a daily usage requirement. 
This lead to an average consumption of 7 g/d SPE in test chips or 9 g/d TAG in 
control chips. The SPE dose of the chips is comparable to the dose used by the 
FDA to estimate chronic (lifetime) Olestra intake by the 90th percentile snack eater. 
We have estimated the SPE intake from spreads at an intake level, somewhat above 
the fat intake from an average margarine intake in the US, which is 11 g/d of 
margarine, or about 8 g/d of fat. 
The SPE spreads were enriched with vitamin A, D, E and K at vitamin/SPE levels 
required by the FDA for the use of olestra in chips. It was assumed that the same 
vitamin levels were present in the SPE chips taken from the market, but analyses 
showed that the test chips on average in fact contained 170% of the mandatory 
vitamin levels. The control spreads were enriched with vitamins A and D at levels 
(on product) as required by the Dutch law. The control chips were not fortified. 
The detailed vitamin composition of the study substances is given in Table 1. 
Distribution of the study products occurred in monthly intervals with four 140 g 
tubs (weekly portion) of spread and four bags of 200 g chips. Returned spread tubs 
and chips bags were counted and registered and when a tub or a bag was not 
empty, the amount left was weighed and registered. 
Fasting morning blood samples were taken at baseline and after 13, 26 and 52 
weeks. Serum and plasma was stored at -20°C or -80°C. 
During the 52 week study, 39 subjects dropped out because of several reasons, 
generally not treatment related: control group 10; SPE chips group 8; SPE spread 
group 9; SPE spread + SPE chips group 12. 
Analyses of products 
The total fat content and the content of SPE and TAG in the products were 
analyzed using gel permeation chromatography after extraction of the total fat 
phase, according to internal methods. The vitamin content of the study substances 
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was analyzed at the RIKILT-DLO institute in Wageningen, The Netherlands. 
Following extraction with heptane the carotene and total tocopherols content were 
analyzed by HPLC. Several other analyses were carried out to check the quality 
and consistency of the various product batches. 
The SPE raw materials used for the production of test spreads were analyzed for all 
parameters used in the specification of olestra by the FDA. The stiffness and the 
degree of esterification (of fatty acids on sucrose) were slightly different from the 
specification, all other parameters were within the specifications. The composition 
of the olestra material in the test chips was not analyzed. 
Body weight 
Body weight was assessed by weighing subjects wearing indoor clothing, without 
shoes, wallet and keys at monthly intervals. 
Biochemical analyses 
Serum carotenoids (CVs 3.7-14.9%), retinol (2.5%), a-tocopherol (2.8%) and 
vitamin C (10%) were quantified by reversed phase HPLC (Broekmans et al, in 
press). Vitamin D (25-hydroxycholecalciferol) was quantified by competitive 
protein-binding assay according to Edelstein et al. (1974) with slight modifications 
(CV 11%). Vitamin Kl (Phylloquinone) in serum was assessed by HPLC with 
2',3'-dihydrophylloquinone as internal standard (CV 8%). 
LDL-oxidation was measured according to Esterbauer et al. (1989). DNA damage, 
measured as the comet assay after induction with hydrogen peroxide (H2O2), was 
conducted as described by Collins et al. (1993). Plasma 8-epi-prostaglandin F2a 
was measured according to a method described by Nourooz-Zadeh et al. (1995) 
with some modifications. Plasma protein carbonyl content was quantified using an 
enzyme-linked immunosorbent assay as previously described (Buss et al, 1997). 
Subjects known not to be vaccinated against hepatitis B received i.m. (m. 
Deltoideus) standard doses (20 p.g HbsAg/dose) of hepatitis B vaccine (Engerix-
B®, SmithKline Beecham Farma BV, Rijswijk, The Netherlands) on week 39, 43, 
and 48 of the study. Anti-HBs antibodies were determined using ELISA in serum 
samples at week 39, 43, 48 and 52 (Hepanostika® Anti-HBs microELISA test kit, 
Organon Teknika N.V. Turnhout, Belgium). 
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Total cholesterol, HDL cholesterol and triacylglycerol were analyzed by enzymatic 
techniques (Boehringer, Mannheim, Germany). LDL cholesterol was calculated 
according to the Friedewald formula (Friedewald et al, 1972). 
Other measurements 
Macular pigment density was measured as a marker of lutein and zeaxanthin in the 
eye by spectral reflectance analysis with the Utrecht Retinal Densitometer (Van de 
Kraats et al, 1996). A previous study using the same method showed a within 
subject variation coefficient of 17% (Berendschot et al, 2000). 
The minimal erythema dose (MED) quantifies the sensitivity of the skin to solar 
ultraviolet (UV) irradiation by exposing the skin to increasing UV dosages as 
described previously (Broekmans et al, submitted) with a CV < 12.5%. 
Flow-mediated vasodilation (FMD) of the brachial artery was measured as a 
marker of endothelial function (De Roos et al, 2001). The diameter of the artery at 
rest and at maximum vasodilation was used to calculate the percentage FMD. 
Adverse events were classified according to "The ICD-10: International statistical 
classification of diseases and related health problems 10th revision" WHO 1993. 
Gastrointestinal symptoms were reported by a self-reporting questionnaire. 
Statistical analyses 
Data were expressed as mean ± standard deviation (SD) for each treatment. In 
order to correct for changes in serum lipid concentrations, we present percentual 
changes in lipid standardized carotenoid and a-tocopherol concentrations. Serum 
lipid adjusted carotenoid concentrations were calculated as follows: [carotenoid 
concentration / (total cholesterol + triacylglycerol)]. Overall, differences in changes 
(week 52 - week 0) between groups were tested by ANOVA with treatment as 
factor using the F-test on a a = 5% significance level (PROC GLM, SAS/STAT 
software, version 6.12, SAS Institute, Cary, N.C.). If a significant overall treatment 
effect was detected, the least significant difference (LSD) using a two-sided 
significance level of a = 5%, based on the ANOVA mean squared error, was used 
to determine which groups were different. If data were not normally distributed, 
data were natural log transformed before ANOVA. 
Antibodies against Hepatitis B are presented at week 52. Effects were evaluated by 
assessment of the amount of antibodies formed and by counting the number of 
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subjects who were seroconverted (Hbs antibodies > 10 IU/L). If volunteers were 
already seroconverted for hepatitis B at week 39 they were excluded from 
statistical analysis. 
Results 
Baseline characteristics 
The baseline characteristics of the four treatment groups were similar (Table 2). 
Three hundred and forty one subjects (164 men and 177 women) completed the 
study. 
Table 2 Baseline characteristics of the 341 volunteers, who completed the study1 
Men/women (n/n) 
BMI (kg/m2) 
Age (y) 
Low F&V consumption (%)2 
Smoking (%) 
SPE intake (g/day) 
Control 
43/43 
24.4 + 4.2 
42.6 ±14.5 
57 
33 
0 
SPE chips 
43/44 
25.0 + 4.5 
41.6+14.0 
56 
29 
7 
SPE spread 
38/49 
24.814.0 
43.0 ±13.4 
55 
30 
10 
SPE spread 
+ SPE chips 
40/41 
24.2 ±3.4 
40.6 ±14.0 
60 
27 
17 
1
 Mean ± standard deviation unless stated otherwise. 2 Lowest tertile of ranked respondents 
of fruit and vegetable consumption questionnaire (see method section). 
Adverse events and gastrointestinal effects 
No differences in adverse events were observed between the treatment groups. 
Three serious adverse events occurred, that were considered to be unlikely related 
to the treatment (control group 1; SPE spread group 1; SPE spread + SPE chips 
group 1). The GI questionnaire showed no clear effects of SPE consumption 
(details are available on request). 
Compliance and eating moment 
Consumption of spread and chips was evaluated after 13, 26 and 52 weeks and did 
not differ between the groups. The overall compliance was good, > 98.8% in all 
groups. Spreads were consumed mostly on bread. Approximately 10% of the 
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consumers also used the spread with dinner. Chips were mostly consumed as a 
snack in a frequency of three to five times per week. 
Effects on body weight 
During the year the mean body weight (± SD) increased with 1.5 + 2.9 kg (2.0 ± 
3.8%) in the control group, 0.5 ± 3.4 kg (0.7 ± 4.5%) in the SPE chips group, 1.2 ± 
2.4 kg (1.6 ± 3.2%) in the SPE spread group and 0.5 ± 3.2 kg (0.7 ± 4.2%) in the 
SPE spread + SPE chips group (P > 0.05). 
Effects on carotenoids and vitamins 
Figure 1 shows that mean carotenoid concentrations were significantly decreased 
after 52 weeks and for most of the carotenoids a steady state was achieved at week 
13. Baseline concentrations of carotenoids and the time required to reach a steady 
state were comparable between the groups consuming SPE. 
Figure 1 Mean (± SE) carotenoid concentrations at week 0, 13 and 52 in the SPE spread + 
SPE chips group (n = 81) 
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Table 3 presents the mean lipid standardized values of carotenoids and ot-
tocopherol for the treatment groups. 
Table 3 Effects on serum carotenoid (nmol/mmol) and a-tocopherol concentrations 
(umol/mmol) corrected for total cholesterol (TC) and triacylglycerol (TG) following one 
year consumption of control products, SPE chips, SPE spread and both SPE spread and 
chips8 
Lutein/ 
(TC+TG) 
Zeaxanthin/ 
(TC+TG) 
P-Crypto-
xanthin/ 
(TC+TG) 
a-Carotene/ 
(TC+TG) 
|3-Carotene/ 
(TC+TG) 
Lycopene/ 
(TC+TG) 
oc-Toco-
pherol/ 
(TC+TG) 
Time 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
Control 
25.5 ±9.4 
24.7 + 8.5 
-0.8 ± 6.73'4 
7.2 + 3.3 
7.2 ±3.3 
0.02 ± 2.42-3'4 
28.9 ± 20.3 
23.6 ±17.6 
-5.3±10.03 '4 
9.8 ±8.4 
9.5 ±5.4 
-0.3 ± 6.62'3'4 
55.5 ±32.8 
48.9 ±26.3 
-6.6 ± 20.42'34 
54.5 ± 26.7 
50.6 ±24.9 
-3.9±21.63 '4 
3.9 ±0.6 
3.8 ±0.5 
-0.05 ± 0.42'3'4 
SPE chips 
27.1 ±12.1 
24.0 ±10.2 
-3.0±7.04 
7.8 ±3.0 
7.0 ±2.8 
-0.8 ±2.3' 
30.0 ±16.8 
25.2 ±18.4 
-5.2 ± 12.93'4 
10.8 ±9.7 
8.5 ±6.4 
-2.3 ±5.7' 
53.5 ±30.8 
42.7 ± 27.9 
-11.6 ± 17.51-3-4 
52.3 ±24.6 
44.0 ± 20.6 
-8.4±21.74 
4.2 ±0.6 
3.8 ±0.4 
-0.3 ±0.4' 
SPE spread 
26.4 ± 10.3 
23.0 ±10.0 
-3 .4±7 .0 M 
7.7 ±3.4 
6.7 ±2.4 
-0.9 ±2.6' 
29.8 ±17.7 
19.4 ±11.2 
-10.4±12.3' '2 
10.7 ±8.5 
7.7 ±7.6 
-3.1 ±7.0' 
59.5 ±40.6 
38.0 ±28.7 
-21.5±29.7U2 
55.7 ±29.2 
43.2 ±26.7 
-12.5 ±23.6' 
4.1 ±0.7 
3.8 ±0.6 
-0.3 ± 0.41 
SPE spread 
+ SPE chips 
28.2 ±11.3 
22.3 ±10.1 
-5.9 ± 9.012'3 
7.4 ±3.0 
6.5 ±3.0 
-0.9 ±2.7' 
31.1 ±18.7 
18.0 ±10.0 
-13.0±15.0' '2 
11.2+ 10.3 
7.7 ±6.4 
-3.5 ±7.6' 
57.6 ±35.1 
34.2 ±24.3 
-23.4 ± 26.1'-2 
57.1 ±32.4 
41.1 ±22.7 
-16.1 ± 23.61 2 
4.0 ±0.5 
3.7 ±0.5 
-0.4 ±0.4' 
§Mean ± standard deviation. ' Significantly different from control;2 Significantly different 
from SPE chips; 3 Significantly different from SPE spread; 4 Significantly different from 
SPE spread + SPE chips. 
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The greatest reductions were observed for a-carotene (-0.02 ± 0.05 urnol/L), P-
carotene (-0.15 ±0.17 umol/L) and lycopene (-0.10 ±0.15 u.mol/L) in the SPE 
spread + SPE chips group. Compared with the control group lipid standardized 
concentrations of carotenoids decreased by 33% (P < 0.0001) for a-carotene, 
followed by p-carotene (31%; P < 0.0001), lycopene (24%; P < 0.001), P-
cryptoxanthin (18%; P < 0.0001), lutein (18%; P < 0.0001) and zeaxanthin (13%; 
P < 0.001) in the SPE chips + SPE spread group. 
In the SPE spread group a-carotene, P-carotene and lycopene decreased by 0.02 ± 
0.05, 0.13 ± 0.19 and 0.07 ± 0.17 u.mol/L, respectively. Lipid standardized serum 
carotenoid concentrations decreased significantly by 11% for lutein and zeaxanthin 
(P < 0.05), 14% (P < 0.05) for p-cryptoxanthin, 19% (P < 0.05) for lycopene, 25% 
(P < 0.0001) for p-carotene and 29% (P < 0.0001) for a-carotene (P < 0.0001) in 
comparison with the control group. 
Lipid standardized serum zeaxanthin, a-carotene, P-carotene decreased 
significantly by 11% (P < 0.05), 21% (P < 0.05), 12% (P < 0.05) in the SPE chips 
group in comparison with the control group, respectively. No significant 
differences between the control group and SPE chips group were found for lutein, 
P-cryptoxanthin and lycopene. 
Despite supplementation of test products with vitamin E, lipid standardized serum 
a-tocopherol decreased by 8% (P < 0.0001) in the SPE spread + SPE chips group, 
6% (P < 0.001) in the SPE spread group and 7% (P < 0.0001) in the SPE chips 
group compared to the control group. 
The changes in vitamin A (retinol), C, D and K concentrations were not 
significantly different between the groups (Table 4). 
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Table 4 Effects on serum vitamin A (retinol), D and K and blood vitamin C concentrations 
following one year consumption of control products, SPE chips, SPE spread and both SPE 
spread and chips5 
Retinol 
(|amol/L) 
25-OH-
Vitamin D 
(nmol/L) 
Vitamin C 
(p.mol/L) 
Vitamin Kl 
(pmol/L) 
Time 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
Control 
2.01 ±0.42 
2.04 ± 0.42 
0.03 ± 0.27 
77 + 24 
87 + 24 
9± 15 
43.9113.6 
52.4+15.6 
8.6 ±12.8 
1378 ±1998 
1100 ±966 
-228 ±2053 
SPE chips 
2.07 ± 0.39 
2.19±0.37 
0.12 ±0.32 
81 ±29 
93128 
12118 
45.2 ±14.9 
54.6 ±15.9 
9.4 ±13.3 
1212 ±1060 
11491951 
-5211412 
SPE spread 
2.03 ±0.52 
2.07 ±0.50 
0.04 ±0.31 
77 ±22 
91+30 
15 + 22 
46.2 ±14.5 
58.0 ±15.7 
11.8112.9 
141012278 
9671 825 
-4541 1979 
SPE spread 
+ SPE chips 
2.07 1 0.49 
2.1110.49 
0.0510.31 
78 ±27 
91 ±25 
13 ± 18 
45.3 ±11.3 
54.9 ±13.6 
9.6114.1 
132512399 
933 ±593 
-392 ±2340 
§Mean ± standard deviation. 
At three time points post study (15-35; 41-58; 64-91 days after study) mean serum 
carotenoids and a-tocopherol concentrations were not significantly different 
between the control group and SPE spread + SPE chips group. 
Effects on serum lipids 
Total cholesterol in the group consuming SPE chips increased significantly more 
(8.5%) than in the control (2.6%; P < 0.05) and SPE spread + SPE chips groups 
(1.6%; P< 0.001). 
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Table 5 Effects on serum lipid concentrations following one year consumption of control 
products, SPE chips, SPE spread and both SPE spread and chips8 
Total 
cholesterol 
(mmol/L) 
LDL 
(mmol/L) 
HDL 
(mmol/L) 
Triacylgly-
cerol 
(mmol/L) 
Time 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
Control 
5.61 + 1.00 
5.71 + 1.02 
0.10±0.622 
3.8510.98 
3.8910.97 
0.0410.572 
1.61+0.41 
1.6410.43 
0.03 1 0.25 
1.125 + 0.568 
1.22010.580 
0.095 + 0.525 
SPE chips 
5.4710.93 
5.9111.06 
0.42 1 0.741-4 
3.7810.96 
4.0511.08 
0.271 0.73 M 
1.5410.41 
1.61 10.44 
0.06 1 0.20 
1.12210.466 
1.40110.684 
0.283 1 0.4973'4 
SPE spread 
5.6410.90 
5.85 + 0.88 
0.2210.62 
3.8810.93 
4.06 1 0.94 
0.1710.634 
1.6010.42 
1.64 + 0.43 
0.04 + 0.23 
1.14110.493 
1.18210.509 
0.041 10.4172 
SPE spread 
+ SPE chips 
5.43 1 0.98 
5.47 1 0.84 
0.0410.612 
3.6710.91 
3.6410.87 
-0.03 10.6523 
1.6010.47 
1.6210.39 
0.0210.27 
1.13910.692 
1.22710.786 
0.088 1 0.4672 
§Mean ± standard deviation. ' Significantly different from control; 2 Significantly different 
from SPE chips; 3 Significantly different from SPE spread; 4 Significantly different from 
SPE spread + SPE chips. 
Changes in LDL cholesterol coincided with those in total cholesterol: LDL 
cholesterol increased significantly more in the SPE chips group (8.4%) compared 
to the control group (3.2%; P < 0.05) and the SPE spread + SPE chips group 
(0.8%; P < 0.05). Also LDL cholesterol increased significantly more in the SPE 
spread group (6.4%; P < 0.05) in comparison with SPE spread + SPE chips group. 
The changes in HDL cholesterol were not significantly different between the four 
groups at week 52 (Table 5). 
Increases of triacylglycerol (TAG) were significantly higher in the group 
consuming SPE chips (31.4%) compared to the SPE spread group (9.6%; P < 0.05) 
and SPE spread + SPE chips group (13.8%; P < 0.05). Consumers of SPE spread + 
SPE chips or only SPE spread did not have a significantly different change after 52 
weeks of triacylglycerol, total, and LDL cholesterol concentrations compared to the 
control group (Table 5). 
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Effects on oxidation markers 
No differences were found between the four treatment groups for lagtime (LDL-
oxidation), protein carbonyls (protein oxidation), lipid peroxidation products (8-
epi-prostaglanins F2a) and DNA damage as measured by the comet assay (Table 6). 
The mean changes from baseline in minimal erythema dose (MED) were not 
significantly different between the four groups. In comparison with the control 
group, the mean MED scores decreased by 8% and 6.3% in the SPE chips group 
and SPE spread + SPE chips group, respectively. The mean MED increased by 3% 
in the SPE spread group in comparison with the control group (Table 6). 
Table 6 Effects on markers of oxidative damage (LDL-oxidation, protein carbonyls, 8-epi-
prostaglanins F2a, comet assay and MED) following one year consumption of control 
products, SPE chips, SPE spread and both SPE spread and chips§ 
Lagtime 
(minutes) 
Protein 
carbonyls 
(nmol/mg) 
8-epi-prosta-
glandins F2a 
(ng/L) 
Comet assay 
(H202) 
MED (x sMED) 
Time 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
§Mean ± standard deviation. 
Control 
90.7 ± 7.2 
88.8 ±6.6 
-1.6 ±5.8 
0.36 ±0.04 
0.35 ± 0.04 
-0.01 ± 0.03 
22.6 ±7.6 
21.4 ±8.5 
-1.3 ±7.9 
13.5 ± 11.2 
6.1+7.0 
-7.5 + 12.6 
0.56 ±0.20 
0.60 ± 0.26 
0.04 ±0.18 
SPE chips 
89.9 ±6.1 
89.0 ±6.5 
-0.9 ± 4.9 
0.36 ± 0.04 
0.36 ±0.03 
0 ± 0.04 
22.4 ±7.9 
21.2 ±7.6 
-1.2 ±8.5 
14.1 ±11.7 
6.8 ±8.2 
-7.3 ± 14.9 
0.56 ±0.21 
0.55 ±0.23 
-0.01 ±0.17 
SPE spread 
90.2 ±7.8 
88.6 ±7.6 
-1.515.1 
0.36 10.04 
0.36 ± 0.04 
0 1 0.03 
25.3111.6 
21.417.5 
-3.9110.9 
12.1113.8 
6.817.1 
-5.3115.3 
0.56 ±0.19 
0.61 ± 0.24 
0.05 ±0.18 
SPE spread 
+ SPE chips 
90.1 ±6.3 
88.8 ± 7.2 
-1.3 ±4.7 
0.35 ± 0.04 
0.36 ± 0.04 
0 ± 0.03 
23.8 ±9.9 
23.8 ±10.9 
0.1 ±10.7 
13.7 ±12.9 
6.6 ±9.0 
-7.1 ±15.2 
0.56 ±0.19 
0.56 ± 0.23 
0.00 ±0.16 
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Effects on functional markers 
The changes in macula pigment (MP) density were not significantly different 
between the groups. The median values (25th-75th percentiles) of the individual 
percentual changes of macular pigment density were 6.5% (-8.1 - 28.8), 3.8% 
(-14.3 - 34.7), 5.1% (-9.9 - 34.5) and 1.7 % (-16.9 - 36.0) in the control, SPE 
chips, SPE spread and SPE spread + SPE chips group, respectively (Table 7). 
Because of technical problems with the densitometer, 83 measurements were not 
performed in week 52. But within a 10-week period after week 52, MP density 
measurement was repeated in 45 subjects. Exclusion of these data did not affect 
previous results. 
There were no significant differences in changes in mean calculated endothelial 
function between the treatment groups as measured by flow-mediated vasodilation 
(Table 7). SPE consumption had no effects on immune function. The number of 
seroconverted subjects was not significantly different between the groups, nor was 
the antibody titer against Hepatitis B (Table 7). 
Table 7 Effects on markers of eye, cardiovascular health and immune status following one 
year consumption of control products, SPE chips, SPE spread and both SPE spread and 
chips8 
MP density 
FMD (%) 
Titer 
Hepatitis B 
(IU/L) 
Sero/non-
Converted 
{nlnf 
Time 
WeekO 
Week 52 
Change 
WeekO 
Week 52 
Change 
Week 52 
Week 52 
Control 
0.32 ±0.14 
0.3610.15 
0.03 + 0.10 
4.72 + 3.37 
4.60 ±3.70 
0.17 ±5.04 
449.7 ± 984.9 
55/12 
SPE chips 
0.33 + 0.14 
0.37 ±0.16 
0.04 + 0.15 
4.49 ±5.53 
3.62 ±4.03 
-1.00 ±6.18 
504.3 ± 1033.8 
63/10 
SPE spread 
0.34 ±0.15 
0.38 ±0.14 
0.03 ±0.12 
4.99 ± 5.60 
4.48 ±4.33 
0.13 ±5.78 
656.7 ±1513.9 
60/15 
SPE spread 
+ SPE chips 
0.31 ±0.16 
0.34 ±0.17 
0.02 ±0.13 
4.56 ±3.99 
4.05 ±3.74 
-0.64 ±5.01 
383.9 ±745.6 
46/10 
§Mean ± standard deviation unless stated otherwise a seroconverted (Hbs antibodies > 10 
IU/L). 
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Discussion 
This study provides, perhaps surprising, evidence that substantial serum carotenoid 
decreases do not imply increased risk for chronic diseases. 
Among the strengths of our study are the large study group, double blind placebo-
controlled 1-year study design, good reported compliance and the free-living 
conditions. Overall, a dose-response existed between SPE consumption and serum 
carotenoid concentrations. However, this difference in serum carotenoid changes 
could also be caused by consumption of different food products and consumption 
patterns. The reductions in serum carotenoids following SPE consumption reported 
here are comparable with the reductions reported for short-term trials (Weststrate 
and Van het Hof, 1995; Koonsvitsky et al, 1997; Schlagheck et al, 1997; Kelly et 
al, 1998). The most lipophylic hydrocarbon carotenoid concentrations (a-carotene, 
(3-carotene and lycopene) showed larger changes than the more polar oxygenated 
carotenoids lutein, zeaxanthin and P-cryptoxanthin. Results of short-term trials 
indicate that daily consumption of SPE may reduce the serum concentrations of 
carotenoids very rapidly, but a new steady state level is reached within four weeks. 
In this trial, we observed a steady state within 13 weeks, except for P-
cryptoxanthin (Figure 1). 
In the cohort of the Olestra Post Marketing Surveillance Study (OPMSS), 
reductions between baseline and follow-up of 1 year in the highest category of SPE 
consumption were 21 % for P-carotene (compared with 7% for nonconsumers) and 
7% for lycopene (compared with no change for nonconsumers). None of these 
effects in this analysis was significant and there were no dose-response 
relationships between olestra and serum carotenoids (Thoraquist et al, 2000). 
These smaller reductions in serum carotenoids are most likely due to a lower SPE 
consumption. 
In the present study, concentrations of lipid soluble vitamins retinol, 25-OH 
vitamin D and vitamin Kl were not affected by the study substances containing 
SPE enriched with vitamin A, D and K, suggesting that the mandatory enrichment 
with these vitamins was sufficient to offset any SPE effects on lipid soluble 
vitamin absorption, although the actual enrichment of SPE chips was higher than 
required by the FDA. However, we report that lipid adjusted serum concentrations 
of oc-tocopherol were affected by SPE consumption irrespective of product format 
despite the enrichment with a-tocopheryl acetate. This suggests that an adjustment 
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of the FDA regulation for a-tocopherol enrichment of Olestra containing savory 
snacks might be considered, particularly because the enrichment of SPE chips was 
70% higher than required. The major objective of this study was to examine the 
effects of substantial carotenoid decreases on possible markers of oxidative damage 
and functional markers related to eye, cardiovascular health and immune status. 
We did not observe any negative effects on these markers after 1 year. It should be 
noted that for almost all markers the relation between these markers and the final 
disease risk has to be established. 
Results of published supplementation studies with carotenoids are not completely 
consistent regarding the effect on biomarkers of oxidative damage. We did not 
observe an effect on these markers after significant decreases of carotenoid 
concentrations. Our results are in line with the observation that olestra consumption 
is not associated with reduced macular pigment optical density in a free-living 
population (Cooper et al, 2000). In this study serum lutein and zeaxanthin 
concentrations were not affected either, possibly because of a lower intake of SPE 
in comparison with our study. Both studies were limited by the duration of 1 year, 
however intervention studies which aimed to increase serum carotenoids show both 
an increase of MP density (Berendschot et al, 2000; Johnson et al, 2000) and 
MED (Stahl et al, 2001; Stahl et al, 2000) within several weeks. Johnson et al. 
(2000) showed that consumption of spinach and corn with the daily diet resulted in 
an increase of 0.07 (approximately 18%) in MP density after 15 weeks. In the study 
of Stahl et al. (2001) erythema was 40% lower in subjects consuming tomato paste, 
with serum lycopene being 2-fold higher after 10 weeks. A posteriori power 
analysis indicated that we could have detected a difference of 0.055 in MP density 
and 0.075 in MED between treatments. Our study showed that 18% decrease in 
serum lipid adjusted lutein and 24% decrease in serum lipid adjusted lycopene 
during 1 year did not have negative effects on MP density and MED. 
The present study does not demonstrate any negative effects of lower 
concentrations of serum carotenoid and a-tocopherol on FMD. However, it should 
be noted that the within subject variability of FMD is large, about 50% of the mean 
response (De Roos, 2001). With our number of subjects we could detect a 
difference of 3.3%-points in FMD with a probability of 0.05 and a power of 0.80. 
There are indications that the antioxidants p-carotene and vitamin E could have 
immuno-enhancing effects (Bendich, 1989; Hughes, 2001; Meydani, 1999). Our 
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results indicate no negative effects of carotenoid and a-tocopherol decreases on the 
primary adaptive immunity as measured by antibody production to a model 
infection mimicked by hepatitis B vaccination. In addition, we did not observe 
negative effects on clinical chemical parameters, hematological parameters, 
coagulation/fibrinolysis and inflammation markers (data not shown). 
Although this study was not specifically designed to evaluate the possible body 
weight and cholesterol lowering effect of SPE when as dietary fat replacers, we did 
not observe a clear impact on serum lipids concentrations and body weight after 
daily SPE consumption during a year. In an observational study, Patterson et al. 
(2000) reported that frequent consumers of olestra, those with 2 servings of chips 
per week for a year, experienced a decrease of 10% in total serum cholesterol and a 
reduction in dietary fat intake. In the study of Patterson et al. (2000) heavy users 
lost about a pound of weight, while weight remained stable among non-consumers. 
These authors suggested that olestra consumption is probably an indicator of a 
healthier lifestyle in general. 
In this study, we evaluated the effects in an average Dutch population, including 
subjects from subpopulations probably more at risk for the effects of carotenoid 
decreases such as elderly, smokers and habitual low fruit and vegetable consumers. 
Our observations show that in these subpopulations functional markers were not 
affected by the consumption of SPE either (data not shown). 
In observational studies it has consistently been shown that higher serum 
carotenoid concentrations are related to a decreased risk of chronic diseases. 
However, intervention studies which aimed to increase serum carotenoids by 
supplementation with p-carotene could not confirm this protective effect against 
chronic diseases. Our study suggests that a substantial and prolonged decrease in 
serum carotenoids does not imply an increased risk for chronic diseases and that 
SPE consumption during one year has no beneficial effects on serum lipids or body 
weight. 
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Abstract 
Observational epidemiologic studies have shown that a high consumption of fruits 
and vegetables is associated with a decreased risk of chronic diseases. Little is 
known about the bioavailability of constituents from vegetables and fruits and the 
effect of these constituents on markers for disease risk. Currently, the 
recommendation is to increase intake of a mix of fruits and vegetables ('five a 
day'). We investigated the effect of this recommendation on plasma carotenoids, 
vitamins and homocysteine concentrations in a 4-wk dietary controlled, parallel 
intervention study. Male and female volunteers (n = 47) were allocated randomly 
to either a daily 500 g fruit and vegetable ('high') diet or a 100 g fruit and 
vegetable ('low') diet. Analyzed total carotenoid, vitamin C and folate 
concentrations of the daily high diet were 13.3 mg, 173 mg and 228.1 |J.g, 
respectively. The daily low diet contained 2.9 mg carotenoids, 65 mg vitamin C 
and 131.1 ug folate. Differences in final plasma levels between the high and low 
group were as follows: lutein, 46% [95% confidence interval (CI) 28 - 64]; P-
cryptoxanthin, 128% (98 - 159); lycopene, 22% (8 - 37); a-carotene, 121% (94 -
149); P-carotene, 45% (28 - 62); and vitamin C, 64% (51 - 77) (P < 0.05). The 
high group had an 11% (-18 to -4) lower final plasma homocysteine and a 15% 
(0.8 - 30) higher plasma folate concentration compared with the low group (P < 
0.05). This is the first trial to show that a mix of fruits and vegetables, with a 
moderate folate content, decreases plasma homocysteine concentrations in humans. 
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Introduction 
Observational epidemiologic studies have shown that a high consumption of fruits 
and vegetables is associated with a decreased risk of human cancer at a number of 
common sites (Block et al, 1992; Miller, 1990; Negri et al, 1991; Steinmetz and 
Potter, 1991; Weisburger, 1991). A high consumption of fruits and vegetables may 
also be beneficial with respect to cardiovascular disease risk (Gey et al, 1993; 
Gramenzi et al, 1990; Hertog et al, 1993; Palgi, 1981). The potential health 
benefits of fruits and vegetables have been attributed to the effects of specific 
components therein, i.e., vitamins, minerals, dietary fiber and a wide range of 
secondary metabolites (phytochemicals) responsible for characteristics such as 
color, flavor and taste. Several of these components have been hypothesized to 
exert an important influence on human physiologic status (Tomas-Barberan and 
Robins, 1997). One possible defense mechanism of fruits and vegetables is the 
antioxidant capacity of several components, for example carotenoids and vitamin C 
and E. Plasma carotenoids have been associated with a decreased risk of cancer 
(Astorg, 1997) and cardiovascular disease (Palace et al, 1999). Two specific 
carotenoids, lutein and zeaxanthin, may be important for protecting the macula 
lutea in the eye (Eye Disease Case-Control Study Group 1992 and 1993). Another 
protective mechanism of fruit and vegetables could be the potential influence of 
folate on homocysteine metabolism. Observational epidemiologic research has 
shown that a high plasma concentration of homocysteine may be a risk factor for 
cardiovascular disease. Several intervention studies have shown that 
supplementation with folic acid is effective in reducing plasma homocysteine 
concentration (Brouwer et al, 1999a; De Bree et al, 1997; Ubbink et al, 1994). 
Previous studies on increased fruit and vegetable consumption have been 
published, but these focused on specific nutrients or products. Zino et al. (1997) 
and Yeum et al (1996) showed that plasma carotenoid and vitamin concentrations 
increased as a result of an increased intake of vegetables and fruits. However, fat 
intake, an important determinant of bioavailability of carotenoids, especially of 
lutein esters (unpublished observations), was not controlled in the study of Zino et 
al. (1997). Yeum et al (1996) controlled the diet for fat, but selected specifically 
carotenoid-rich vegetables and fruits. In contrast, De Pee et al (1995) suggested 
that P-carotene from vegetables may be poorly bioavailable in tropical diets. 
Brouwer et al (1999b) concluded that consumption of foods rich in folate 
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(vegetables and citrus fruits) could improve folate and homocysteine status. The 
current recommendation of health authorities (Steinmetz and Potter, 1996) is to 
increase fruit and vegetable consumption in general (e.g., 'five a day'). This is the 
first study to investigate the effects of this recommendation in a mixed population. 
The present study investigated whether an increased intake of a mix of fruit and 
vegetables with a controlled Western diet had effects in human volunteers on 
plasma carotenoids, vitamin C, a-tocopherol, plasma homocysteine, vitamin B-12 
and folate. 
Materials and methods 
Subjects 
Subjects aged 40-60 y were recruited from the pool of volunteers of the Institute 
and through an advertisement in a local newspaper. They were preselected on the 
basis of a low habitual fruit and vegetable consumption (< 250 g/d) and a regular 
Dutch food intake pattern according to a questionnaire. The protocol was explained 
to the volunteers before they gave their informed consent. The major inclusion 
criteria were a body mass index [BMI; body weight (kg) / height2 (m2)] < 35 kg/m2, 
alcohol consumption < 40 g/d ethanol (men) and 30 g/d ethanol (women), no use of 
vitamins or other food supplements, no metabolic or endocrine disease, no allergies 
to fruits and vegetables, not pregnant and/or lactating, no prescribed medication 
(except paracetamol and oral contraceptives) and a serum cholesterol concentration 
< 8 mmol/L. A total of 48 (24 men and 24 women) eligible volunteers entered the 
study; 12 smokers, 6 of each gender. 
Study protocol 
The study was performed according to the guidelines for Good Clinical Practice of 
the International Conference on Harmonization of Technical Requirements for 
Registration of Pharmaceuticals for Human Use, and was approved by an external 
Medical Ethical Committee. We performed a 4-wk randomized, single blind, 
parallel, diet-controlled intervention study. By design, participants were stratified 
for gender and smoking habits. Further, several random (high/low) allocations were 
generated by a computer program. The random solution on the group level that 
yielded the most homogeneous age and BMI distribution was then selected. 
Volunteers (n = 24) received a diet low in fruits and vegetables (100 g/d; 'low' 
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group); another 24 volunteers received a diet high in fruits and vegetables (500 g/d; 
'high' group) and also drank fruit juices (200 mL/d). 
Food intakes were monitored every day by consumption of the evening meal under 
supervision at the Institute between 1700 and 1900h. Remaining parts of the dinner 
were weighed and recorded. The rest of the daily diet (breakfast and lunch) was 
handed out to the volunteers in a box after the contents were checked. When the 
subjects returned the next evening, the consumption of breakfast and lunch was 
controlled and recorded by checking the box. The volunteers had to complete a 
form with the questions 'Did you consume the total supplied amount of food 
today?' and 'Did you consume foodstuffs and drinks other then the provided food 
and drinks?'. The study was executed at the Department of Nutritional Physiology 
of TNO Nutrition and Food Research, Zeist from September 1997 to October 1997. 
Diets 
All volunteers received the same basic diet with different energy levels according 
to their need (7.7, 8.7, 9.7, 10.7, 11.7 and 12.7 MJ/d). The energy intake of 
breakfast, lunch and snacks differentiated the energy levels of the diets. The diets 
were controlled for energy, fat, protein and carbohydrates. During the study period, 
body weights were measured twice weekly before the evening meal. If the 
measured body weight deviated > 1.5 kg compared with the reference body weight 
at day 0, the subjects were shifted to a diet one energy level higher or lower. 
Following the Dutch National Food Consumption Survey-2, fruits and vegetables 
normally consumed in the age group 40-60 y were selected. Table 1 shows the 7-
day menu cycle of fruits and vegetables of the two diets. 
Blood collection 
On day 1 and 29, blood samples were collected from fasting subjects. For the 
analysis of carotenoids, vitamin C and oc-tocopherol, blood was collected in tubes 
containing lithium heparin (Vacutainer systems, Becton Dickinson, Leiden, The 
Netherlands) and further prepared in yellow light. Within 30 min, the tubes were 
centrifuged (2000 x g, 10 min, 4°C). Metaphosphoric acid solution (50 g/L; J.T. 
Baker, Deventer, The Netherlands) was added to the plasma for the analysis of 
vitamin C. Samples were stored at -80°C until analysis. Blood was collected in 
tubes containing K3EDTA (Vacutainer systems, Becton Dickinson) for the analysis 
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of vitamin B-12, folate and homocysteine. Within 15 min blood was centrifuged 
(2000 x g, 10 min, 4°C). Plasma samples were immediately frozen in liquid 
nitrogen and stored at -80°C until analysis. Analyses were carried out after all 
samples were collected. 
Biochemical analyses 
Carotenoid profiles and ot-tocopherol in plasma were quantified by HPLC using a 
modified version of a method described previously (Van Vliet et ah, 1991). After 
precipitation of proteins by ethanol (J.T. Baker), carotenoids and tocopherols were 
extracted from plasma by «-hexane (Merck, Darmstadt, Germany) and separated by 
HPLC (Hyperchrome column; Bisschof, Leonberg, Germany). Two absorbency 
detectors (ABI Analytical Kratos Division, South Yorkshire, UK) were used in 
series for the colorimetric determination of carotenoid profiles (450 nm) and a-
tocopherol (286 nm). The CV was as follows: lutein, < 16.6%; zeaxanthin, < 
36.8%; P-cryptoxanthin, < 7.5%; lycopene, < 9.7%; a-carotene, < 23.4%; 0-
carotene, < 6.3%; and a-tocopherol < 3.2%. 
Vitamin C in plasma containing metaphosphoric acid was quantified by HPLC 
using a modified version of a method previously described (Speek et al, 1984). All 
ascorbic acid was oxidized to dehydro-L-ascorbic acid using ascorbate oxidase 
(Boehringer). Quinoxaline derivate was separated by reversed phase HPLC 
(Hyperchrome column, Bisschof) after condensation with 1,2-diaminobenzene 
(Merck). A fluorescence detector (Jasco, Tokyo, Japan) was used for the detection 
ofvitaminC(CV< 11.6%). 
Vitamin B-12 and folate were quantified by competitive protein-binding assay 
(Simultrac Radioassay Kit Vitamin B-12 [57Co] Folate [125I], ICN Pharmaceuticals, 
ICN Biomedicals, Zoetermeer, the Netherlands), according to Dunn and Foster 
(1973), Lau et al. (1965) and Kolhouse et al. (1978). In summary, vitamin B-12 
and folate in plasma were extracted by heat denaturation of the endogenous binding 
proteins. In the presence of potassium cyanide (ICN Biomedicals) cobalamins were 
converted to cyanocobalamin. To prevent oxidation of 5-methyltetrahydrofolic acid 
dithiotreitol (ICN Biomedicals) was added. After incubation with 57CoB-12, 125I 
folic acid, Intrinsic Factor (ICN Biomedicals) and a-lactoglobuline (ICN 
Biomedicals), the radioactivity was counted. The CVs were < 11.6% and < 13.0% 
for vitamin B-12 and folate, respectively. 
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Table 1 7-d menu cycle of fruits and vegetables (g) of the 'high' and 'low' groups during 
the dietary intervention period 
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Total plasma homocysteine was determined by HPLC with fluorescence detection 
using a method previously described (Ubbink et ah, 1991). Before reversed-phase 
HPLC analysis, the plasma thiols were derivatized with ammonium 7-fluorobenzo-
2-oxa-l,2-diazole-4-sulfonate (SBD-F), a thiolspecific fluorogenic probe that is 
commercially available. Retention of SBD-homocysteine was sensitive to pH, and 
a mobile phase pH of 2.1 ensured baseline separation of plasma thiols within 6 
min. The CV was < 4.5%. 
Chemical analyses of diet 
Total weekly high and low diets were mixed and homogenates were made. Because 
the meals differed in energy level according to the need of the volunteers, a high 
and a low diet with a calculated energy level of 10.7 MJ was used for analysis. The 
homogenates were used for the analysis of vitamin C, carotenoids, vitamin E, 
vitamin B-6, folate and total energy. Another part of the homogenate was freeze-
dried and ground, using a strainer. This freeze-dried homogenate was used for the 
analysis of protein, fatty acids, carbohydrates, sugars, fiber and glucosinolates. 
Flavonoids analyses were carried out only in fruits and vegetables with a 
measurable amount of flavonoids. All of these analyses were performed using 
standard methods. References are available upon request. 
Statistical analysis 
Data analyses were performed using the statistical software package SAS/STAT 
(Version 6, SAS Institute, Cary, NC, General Linear Models procedure). First, for 
description of our data, baseline values were compared between groups (t test), and 
baseline and final values within groups were examined by a paired t test. Second, 
to quantify the unbiased overall effect of the intervention we used ANOVA to 
calculate the differences in final values of each variable between the low and high 
group after adjustment for gender, smoking habits and baseline plasma 
concentrations of each variable. Analysis of covariance was used for statistical 
testing. Data are reported as mean ± SD unless stated otherwise and P < 0.05 
indicated significant difference. 
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Results 
The groups did not differ in age, BMI, total plasma cholesterol, systolic and 
diastolic blood pressure at baseline and in the habitual daily intake of vegetables 
and fruits before the start of the study (Table 2). 
Table 2 Characteristics of participants pre-study in the 'low' and 'high' groups' 
Age, y 
Men / women, n 
Smokers, % 
Intake of vegetables and fruits, g/d 
Body weight, kg 
Body mass index, kg/m2 
Height, cm 
Total plasma cholesterol, mmol/L 
Systolic blood pressure, mmHg 
Diastolic blood pressure, mmHg 
Intervention 
'Low' group 
5014.38 
12/11 
26 
158 + 54 
77.5 ±11.8 
25.212.9 
175.2 + 9.9 
6.010.9 
128119 
78111 
'High' group 
48.615.63 
12/12 
25 
162146 
79.5111.4 
26.3 13.3 
173.917.5 
5.910.9 
126120 
79114 
1
 Values are means ± SD unless stated otherwise. 
At baseline, plasma zeaxanthin concentrations were significantly different between 
the groups {P < 0.05). One participant in the low fruit and vegetable consumption 
group, a nonsmoking female, did not complete the study and was not replaced. 
Data for this subject were not used in the statistical analysis. The daily energy 
intakes of the low and high groups during the trial were 10.2 ± 1.6 and 10.1 ± 1.2 
MJ, respectively. The total energy content of both diets was similar. In both diets 
the energy percentages (en%) from fat, protein and carbohydrate were near those 
recommended for protein (12-13 en%), carbohydrate (40-55 en%) and fat (30-35 
en%). The amounts of vitamin C, total carotenoids, folate, glucosinolates and 
flavonoids were 1.7-, 3.6- 0.7-, 5.3-, 4.0-fold higher, respectively, in the high 
diet than in the low diet. The amount of vitamin E and vitamin B-6 were 
comparable in the two diets (Table 3). 
The overall compliance in both groups was good. The volunteers consumed 98.9 
and 99.7% of the provided energy of the high and low diets, respectively. The 
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compliance of fruit and vegetable intake separately was 99.7% of the energy in the 
high group and 99.8% of the energy in the low group. The changes in body weight 
after 25 days in the high and low groups were -1.5 and -1.7%, respectively (P < 
0.05). These small reductions in body weight did not differ between groups. 
In the low group, the concentrations of the carotenoids decreased significantly by 
31-67%, depending on the carotenoid (Table 4). Vitamin C concentrations 
decreased significantly by 13% (P < 0.05) and a-tocopherol concentrations 
decreased by 8% (P < 0.05) in this group. In the high group, there were significant 
increases in plasma concentrations of a-carotene (67%), vitamin C (50%) and P-
cryptoxanthin (28%), (P < 0.05). Plasma lutein and (3-carotene concentrations did 
not change, but plasma lycopene decreased by 56% (P < 0.05). Plasma a-
tocopherol concentrations decreased by 11% (P < 0.05), similar to change in the 
low group. 
After adjustment for gender, smoking habits and baseline plasma concentrations, 
the final plasma concentrations of the high in comparison with the low group were 
significantly higher for lutein +46% [95% confidence interval (CI) +28 to +64); P-
cryptoxanthin, +128% (+98 to +159); lycopene, +22% (+8 to +37); a-carotene, 
+121% (+94 to +149); p-carotene, +45% (+28 to +62); and vitamin C, +64% (+51 
to +77). 
No significant changes were found in either group for folate and vitamin B-12 after 
4 wk of dietary intervention. Plasma homocysteine concentrations decreased 
significantly by 10% (P < 0.05) in the high group (Table 5). Differences in final 
plasma levels between the high group and the low group ('high'-'low') were as 
follows: folate, +15% (+0.8 to +30; P < 0.05) and homocysteine and - 1 1 % (-18 to 
-4; P < 0.05). Plasma vitamin B-12 concentrations did not differ between the two 
groups. 
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Table 3 Daily intake of nutrients and energy during the dietary intervention period1 
Energy/nutrient 
Total energy, MJ 
Protein, en% 
Total fat, en% 
Carbohydrate, en% 
Saturated fatty acids, en% 
Monounsaturated fatty acids, en% 
Polyunsaturated fatty acids, en% 
Fiber, g 
Vitamin C, mg 
Total carotenoids, mg 
Lutein, mg 
Zeaxanthin, mg 
P-Cryptoxanthin, mg 
Lycopene, mg 
a-Carotene, mg 
P-Carotene, mg 
Vitamin E, mg 
Vitamin B-6, mg 
Folate, |xg 
Total glucosinolates, (imol 
Total flavonoids, mg 
Intervention 
'Low' diet 
11.2 
14.6 
32.7 
53.5 
14.4 
7.5 
6.5 
47.9 
65.0 
2.9 
0.5 
0.04 
0.04 
0.06 
0.27 
0.63 
17.6 
1.61 
131.1 
2.3 
0.75 
'High' diet 
11.4 
14.9 
29.9 
53.3 
13.1 
6.8 
6.0 
56.2 
172.5 
13.3 
2.0 
0.13 
0.27 
0.66 
1.33 
2.98 
19.9 
1.96 
228.1 
14.6 
3.74 
Values are based on the chemical analyses of weekly diets (see Materials and Methods). 
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Table 4 Effect of 100 g/d fruits and vegetables ('low' group) and 500 g/d fruits and 
vegetables ('high' group) on plasma carotenoids (a//-trans isomers), vitamin C (ascorbic 
acid) and cc-tocopherol concentrations in fasting humans during a 4-wk dietary intervention 
period1'2 
'Low' group 'High' group 
Baseline Change Baseline Change 'High' - 'Low' 
after study3 
|imol/L 
Lutein 0.35±0.16 -0.12 + 0.12 0.32±0.14 0.02 ±0.11 0.11 
(0.07-0.14)* 
Zeaxanthin 0.05 ±0.04 -0.02 ±0.02 0.04 + 0.02 -0.004 ±0.02 0.005 
(-0.004-0.01) 
P-Cryptoxanthin 0.13+0.07 -0.04 ± 0.04 0.18 ±0.20 0.05 ±0.14 0.13 
(0.11-0.16)* 
Lycopene 0.52 ±0.28 -0.35 + 0.20 0.39 ±0.26 -0.22 ±0.18 0.04 
(0.01-0.06)* 
a-Carotene 0.06 ±0.04 -0.02 ±0.04 0.06 ±0.02 0.04 ±0.02 0.06 
(0.04-0.06)* 
P-Carotene 0.43 ± 0.22 -0.17 + 0.13 0.37±0.19 -0.02±0.U 0.11 
(0.07-0.15)* 
oc-Tocopherol 33.2 ± 7.2 -2.7 ±4.9 33.2 ±7.7 -3.7 ±4.2 -1.0 
(-3.4-1.3) 
Vitamin C 51.0 ±20.5 -6.7 ±15.4 47.9 ±16.9 24.0 ±18.0 28.1 
(22.3-34.0)* 
Values are means ± SD unless stated otherwise;2 For some individual measurements, data 
are missing;3 Difference in final (95% confidence interval), corrected for gender, smoking 
habit and baseline values in the 'high' vs 'low' group, covariance analyses; *P < 0.05. 
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Table 5 Effect of 100 g/d fruits and vegetables ('low' group) and 500 g/d fruits and 
vegetables ('high' group) on plasma vitamin B-12, folate and homocysteine concentrations 
in fasting humans during a 4-wk dietary intervention period1'2 
'Low' group 
Baseline Change 
'High' group 
Baseline Change 'High' - 'Low' 
after study3 
Vitamin B-12 251.5+121.8 -0.14 ±40.7 270.8+85.2 -2.5 + 29.7 0.02 
pmol/L (-19.5-19.6) 
Folate 13.2 ±6.0 -0.96 ±4.18 15.5 ±10.2 0.14 ±4.64 1.99 
nmol/L (0.11-3.87)* 
Homocysteine 13.8 ±6.0 -0.56 ±3.03 12.1 ±3.6 -1.2 ±2.1 -1.36 
umol/L (-2.25 to -0.47)* 
1
 Values are means ± SD unless stated otherwise.2 For some individual measurements, data 
are missing. 3 Difference in final (95% confidence interval), corrected for gender, smoking 
habit and baseline values in the 'high' vs 'low' group, covariance analyses; *P < 0.05. 
Discussion 
The main findings of this study are that the consumption for 4 weeks of 500 g fruits 
and vegetables in comparison with 100 g fruits and vegetables resulted in 
significantly higher plasma carotenoids concentrations, including lutein (46%), P-
cryptoxanthin (128%), lycopene (22%), a-carotene (121%), P-carotene (45%) and 
vitamin C (64%). Other important findings are an 11% lower plasma homocysteine 
concentration in the high group than in the low group. Furthermore, we found a 
small but significant plasma effect on folate (15%). Plasma concentrations of 
zeaxanthin, a-tocopherol and vitamin B-12 were not affected by the intervention, 
as could be expected. In this single blind trial, volunteers were carefully 
prestratified and were administered a habitual Dutch diet, which was completely 
controlled for energy, fat, protein and carbohydrate content. Reported compliance 
was very good because the major part of the diet containing fruits and vegetables 
was consumed under supervision. After the consumption for 4 weeks of 100 g 
fruits and vegetables plasma concentrations of carotenoids and vitamins decreased. 
The selected volunteers had an initial consumption of roughly -150 g/d fruits and 
vegetables. The observed decrease of plasma concentrations is not surprising. Also, 
our brief questionnaire may have underestimated fruit and vegetable consumption 
somewhat. 
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Plasma lycopene concentrations of subjects that consumed 500 g of fruits and 
vegetables were 22% greater after 4 wk compared with subjects that consumed 100 
g fruits and vegetables. However, lycopene concentrations decreased in both 
groups. In a study of Yeum et al. (1996), lycopene concentrations increased 
significantly after consumption of a diet with a high carotenoid content (of the 16 
mg/d, 3.3 mg/d was lycopene). Possible explanations for the decrease of plasma 
lycopene during our study include a lower lycopene intake during the study in 
comparison with the prestudy period and a limited bioavailability of lycopene from 
the nonprocessed products (Van het Hof et al, 1998). The preselection of 
volunteers was based on fruit and vegetable intake as a whole. The lycopene intake 
cannot be estimated from this questionnaire. In the prospective cohort study on diet 
and cancer in the Netherlands, the mean daily intake of lycopene was 1.05 ± 1.56 
and 1.33 ± 1.88 mg/d for men and women, respectively (Goldbohm et al, 1998). 
These daily intakes are -0.4-0.7 mg/d higher that of the high diet. In a study of 
Van het Hof et al. (1999), plasma concentrations of lycopene decreased by -38% 
after consumption of 490 g/d vegetables with a lycopene content even higher (1.1 
mg/d) then that of our high diet. 
Concentrations of P-carotene showed a difference of +45% in the high group in 
comparison with the low group. However, the concentrations remained more or 
less stable in the high group and decreased significantly in the low group. Zino et 
al. (1997) performed a trial in which the intervention group was asked to increase 
their fruit and vegetable consumption to eight servings (-1000 g) per day. The 
plasma concentration of P-carotene was higher after 4 weeks compared with the 
present trial, but the P-carotene content of the intervention diet in the trial of Zino 
et al. (1997) was -1.5 mg/d higher than in our trial. Also, subjects in the Zino study 
continued to consume their freely chosen habitual diet, including processed foods. 
No difference between the changes in plasma zeaxanthin and a-tocopherol 
concentrations were observed between the low and high group. The CV for 
zeaxanthin measurements could be the reason for the lack of a significant 
difference. The daily dietary intake of vitamin E was comparable between the 
groups because fruits and vegetables do not contain a high amount of vitamin E. 
Therefore, no major differences between the diet treatments would be expected. 
The strength of this study in comparison with previously described trials is the 
completely controlled intervention period for energy, fat, protein and carbohydrate 
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intake and the good compliance. Therefore, effects on plasma (fat-soluble) 
vitamins and carotenoids can be attributed to the differences in fruit and vegetable 
consumption alone. We examined the effects of increased fruit and vegetable 
consumption as a whole and not an increase of a specific micronutrient and/or 
specific fruit or vegetable as is to be expected in a population. 
In this study the daily low diet contained 1.6 mg vitamin B-6 and 131 (xg folate, 
whereas the daily high diet contained 2.0 mg vitamin B-6 and 228 ug folate. These 
differences in intake could theoretically not be expected to have a major influence 
on plasma homocysteine. Minimal doses of supplemented folic acid of 250 \ig/d 
with a high bioavailability have been reported to lower homocysteine 
concentrations (Brouwer et ah, 1999a). Food contains folate polyglutamate 
derivatives, which are hydrolyzed to monoglutamate forms in the gut before 
absorption. Therefore the bioavailability of food folate is lower than the 
bioavailability of folic acid supplements. In the intervention trial of Brouwer et al. 
(1999b) folate status was improved by 7 nmol/L and homocysteine concentrations 
were decreased by 2 u.mol/L after consumption of vegetables and citrus fruits high 
in folate (560 u.g/d). In comparison, the high diet in our trial contained 228 fig/d. 
During the study the volunteers consumed a normal Dutch diet, not a diet with 
vegetables and fruits high in folate concentration. Although we can only speculate 
here, our results suggest that other components in fruits and vegetables may 
influence plasma homocysteine. 
The biological relevance of an 11% lower plasma homocysteine concentration, 
~1.4 |o.mol/L, is not clear, but observational epidemiologic studies have found an 
inverse relationship between plasma homocysteine and cardiovascular disease. 
Thus, it is advisable to increase fruit and vegetable consumption, which could 
lower homocysteine concentrations. 
In conclusion, our study suggests that a 4-week period of 500 g/d fruit and 
vegetable consumption in comparison with 100 g/d of fruits and vegetables with a 
diet controlled for energy, fat, protein and carbohydrates significantly increases 
plasma carotenoids, vitamin C, folate and decreases homocysteine concentrations, 
but has no effect on zeaxanthin, vitamin B-12 and a-tocopherol plasma 
concentrations. Extra consumption of fruits and vegetables (400 g) and 200 mL/d 
fruit juices with an equal fat consumption could increase plasma carotenoid and 
vitamin concentrations by 22-128% and influence plasma folate and homocysteine. 
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Plasma homocysteine (in addition to carotenoids) can be an important indicator of 
fruit and vegetable intake and is responsive to changes in the intakes of these 
foods. 
Whether changes in plasma concentrations of vitamins and carotenoids have an 
effect on disease risk remains to be established. High plasma homocysteine 
concentrations are considered to be a risk factor for cardiovascular disease (Hankey 
and Eikelboom, 1999). This is the first trial that shows that a mix of fruits and 
vegetables, with a moderate folate content, will decrease plasma homocysteine 
levels. 
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Abstract 
Objective: To evaluate the effect of fruit and vegetables consumption on markers 
of risk for cardiovascular disease. 
Design: Randomized, diet controlled, parallel study. 
Subjects: Forty-eight apparently healthy (40-60 y) volunteers with a low usual 
consumption of fruits and vegetables. Forty-seven of them completed the study. 
Interventions: During 4 weeks 24 volunteers consumed a standardized meal, 
consisting of 500 g/d fruit and vegetables and 200 mL/d fruit juice ('high' group) 
and 23 volunteers consumed 100 g/d fruit and vegetables ('low' group) with an 
energy and fat controlled diet. 
Results: Final total cholesterol was 0.2 (95% CI -0.5 - 0.03 mmol/L) lower in the 
high group than in the low group (P > 0.05). Final fibrinogen and systolic blood 
pressure were 0.1 (-0.1 - 0.4) g/L and 2.8 (-2.6 - 8.1) mmHg higher in the high 
group than in the low group (P > 0.05), respectively. Also, other final serum lipid 
concentrations, diastolic blood pressure and other hemostatic factors did not differ 
between both groups. 
Conclusions: This was a small randomized well-controlled dietary intervention 
trial of short duration with a considerable contrast in fruit and vegetable 
consumption. No effects on serum lipids, blood pressure and hemostatic variables 
were observed. 
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Introduction 
Cardiovascular disease is the main cause of mortality in The Netherlands and other 
Western countries. Risk factors include smoking, high blood pressure, high serum 
cholesterol levels and high levels of homocysteine. The development of 
atherosclerosis is multifactorial and relevant pathogenic processes include 
oxidative damage of low density lipoprotein (LDL) cholesterol (Steinberg et al, 
1989). 
Observational epidemiological studies have shown that a high consumption of fruit 
and vegetables may be associated with a decreased risk of cardiovascular disease 
(Ness and Powles, 1997). Fruit and vegetables contain vitamins, fibers and other 
active compounds. These phytochemicals have different mechanisms of action. For 
example, they may modulate cholesterol metabolism, reduce blood pressure and 
have antioxidant effects (Lampe, 1999). These effects have been investigated in 
cell cultures and animal experiments. 
Fruit and vegetables consumption may lower the concentration of plasma 
cholesterol because of high soluble dietary fiber, such as pectin (Stasse-Wolthuis et 
al, 1980). Dietary fiber and minerals may explain why a diet rich in fruit and 
vegetables may reduce blood pressure (Appel et al, 1997). Another additional 
mechanism is the influence of fruit and vegetables on blood platelet aggregation 
(Lampe, 1999). Furthermore, folate-rich fruit and vegetables could decrease 
homocysteine concentrations (Brouwer et al, 1999). 
The current recommendation of health authorities is to increase fruit and vegetables 
consumption in general (e.g. 'five a day'; Steinmetz and Potter, 1996). This results 
in more than 400 g fruit and vegetables per day. So far, experimental studies have 
not evaluated this recommendation, but have used either especially selected 
vegetables (Yeum et al, 1996) or very high quantities (approximately 7 
servings/day) of fruit and vegetables (Zino et al, 1997). Moreover, the association 
between health and vegetable consumption in epidemiological studies could be 
confounded by a generally healthier lifestyle and/or lower intake of energy and fat 
of high vegetable consumers (Willett, 1998). Further experimental studies in 
humans are therefore necessary to demonstrate that potential beneficial effects are 
due to a high, but realistic consumption of fruit and vegetables per se. Therefore 
we performed a human intervention trial with a diet controlled for energy, fat, 
carbohydrates and protein. This is the first study that investigates the effects of a 
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fruit and vegetables consumption, approximately compatible with the current 
dietary recommendation in a study group. We compared an intake of 500 g/d fruit 
and vegetables and 200 mL/d fruit juice with 100 g/d fruit and vegetables, which 
will reflect a difference of 400 g/d fruit and vegetables and 200 mL/d fruit juice. 
We evaluated effects on serum lipids, blood pressure and indicators of coagulation 
and fibrinolysis. 
Subjects and methods 
Study design 
The design of this randomized diet-controlled human intervention study was 
described previously (Broekmans et ah, 2000). In summary, subjects aged 40-60 y 
were recruited both from the pool of volunteers of the Institute and through an 
advertisement in a local newspaper. All participants had low habitual fruit and 
vegetable consumption (< 250 g/d) according to a questionnaire and did not use 
vitamins or other food supplements. By design, the volunteers were stratified for 
gender and smoking habits. Further, several random group allocations were 
generated by a computer program. The random solution on the group level that 
yielded the most homogeneous age and BMI distribution was then selected. The 
volunteers consumed either a diet low in fruits and vegetables (100 g/d; 'low' 
group) or a diet high in fruit and vegetables (500 g/d and 200 mL fruit juice/d; 
'high' group). The diets contained a variety of fruit and vegetables and were 
controlled for energy, fat, protein and carbohydrates. Food intake was monitored 
every day by consumption of the evening meal under supervision at the Institute 
between 1700 and 1900h. The rest of the daily diet (breakfast and lunch) was 
handed out to the volunteers in a box after the contents were checked. Fasting 
blood samples were collected before and after the 4 weeks of treatment for 
analyses of serum lipids and blood coagulation/fibrinolysis parameters. During the 
study blood pressure and body weight were measured. The study was executed at 
the Department of Nutritional Physiology of TNO Nutrition and Food Research, 
Zeist from September 1997 to October 1997. The study was performed according 
to the ICH (International Conference on Harmonization of Technical Requirements 
for Registration of Pharmaceuticals for Human Use) guidelines for Good Clinical 
Practice and was approved by a Medical Ethical Committee. 
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Blood parameters 
To analyze cholesterol and triacylglycerols levels blood was collected in tubes with 
clot activating silica particles. Approximately 30 min after collection, tubes were 
centrifuged for 10 min, 3000 x g, 4°C and stored at -20°C until the analysis. 
Serum triacylglycerols, total cholesterol and HDL cholesterol concentrations were 
analyzed with a commercially available kit (Roche, Almere, The Netherlands). 
Serum LDL cholesterol concentration was calculated using the formula by 
Friedewald et al. (1972): [LDL] = [total cholesterol] - [HDL] - 0.42 x 
[triacylglycerols]. 
For the analysis of fibrinolytic/coagulation factors, blood was drawn into ice-
chilled tubes and centrifuged for 20 min at 2000 x g and 4°C. Plasma was 
collected, immediately frozen by use of liquid nitrogen and stored at -80°C until 
analysis. 
For measuring tissue-type plasminogen activator (tPA-activity), blood was 
collected in Stabilyte tubes. tPA activity was measured by a biological 
immunoassay according to Meijer et al. (1992). In summary, the active tPA was 
isolated from plasma by binding it to a microtiter-plate-fixed monoclonal antibody 
for tPA that binds tPA so that the active centre remained effective. After washing, a 
mixture of plasminogen and chromogenic plasmin substrate was added and the 
conversion of plasminogen to plasmin by the bound tPA was recorded. Both the 
intra-assay CV and inter-assay CV were < 10%. 
To determine tPA antigen, F1+F2 and D-dimers blood was collected in tubes 
containing CTAD buffer. tPA antigen level was measured with an enzyme-linked 
immunosorbent assay (ELISA) using the Imulyse t-PA kit of Biopool (Ranby et al., 
1986). The intra-assay CV was < 10% and the inter-assay CV was < 12%. The 
amount of prothrombin fragment 1.2 (F1+F2) was detected by Sandwich ELISA, 
using Enzygnost® Fl+2 micro method from Dade-Behring, Marburg, Germany 
(Pelzer et al., 1991). F1+F2 in the sample was first bound to a solid phase rabbit 
anti F1+F2 antibodies coated on polystyrene Microelisa strips. After the second 
reaction with a rabbit antibody labelled with horseradish peroxidase, the color was 
spectrophotometrically determined. The inter- and intra-assay CV were < 10%. 
D-dimers were measured, using the Enzygnost® micro method from Dade-
Behring, Marburg, Germany (Estivals et al., 1991). First, D-dimers in the samples 
were bound to a solid phase murine anti D-dimer antibody coated on polystyrene 
157 
Chapter 8 
Microelisa strips. Subsequently, a second antibody was bound to the immobilized 
antibody antigen complex. This second antibody was a rabbit antibody directed 
against fibrinogen, labelled with horse-radish peroxidase. The color was 
spectrophotometrically determined. The intra- and inter-assay CV were < 10%. 
Fibrinogen was detected according to Clauss (1957) using the STA fibrinogen kit 
on a STA analyser. The diluted plasma was supplemented with a fixed amount of 
thrombin. This induced the conversion of fibrinogen to insoluble fibrin and resulted 
in clot formation. The speed of clot formation was dependent upon the 
concentration of fibrinogen in the sample. The STA analyser registered the clot 
formation as the viscosity of the solution. The intra-assay CV was < 5% and the 
inter-assay CV < 7%. 
For measuring the compliance of the diets, plasma vitamin C, folate and 
carotenoids were determined. The methods are previously described (Broekmans et 
ah, 2000). In summary, carotenoid profiles and vitamin C in plasma were 
quantified by HPLC. Folate was quantified by competitive protein-binding assay. 
Blood pressure 
During the study blood pressure was measured eight times: two times on days 1 
and 28 in the evening and twice at day 2 and 29 in the morning. Measurements of 
day 1 and 2 were averaged, as were the measurements of day 28 and 29. Both 
systolic and diastolic blood pressure and heart rate were measured oscillometrically 
by a Boso Oscillomat in a sitting position in the right arm after at least 5 min rest 
and recorded in mmHg and beats/minute respectively. 
Chemical analyses of the diets 
Total weekly 'low' and 'high' diets were mixed and homogenates were made. We 
used diets with an energy level of 10.7 MJ for the analysis. We measured vitamin 
C, carotenoids, vitamin E, vitamin B-6, folate and total energy in the homogenates. 
A freeze-dried homogenate was used to analyze protein, fatty acids, carbohydrates, 
sugars, fiber and glucosinolates. Flavonoids analyses were carried out only in fruit 
and vegetables with a measurable amount of flavonoids. All these analyses were 
performed using standard methods. References are available upon request. 
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Statistical analysis 
Data analyses were performed using the statistical software package (SAS/STAT 
Version 6, SAS Institute, Cary, NC, General Linear Models procedure). First, for 
description of our data, baseline values were compared between groups (t test), and 
baseline and final values within groups were examined by a paired t test. Second, 
to quantify the unbiased overall effect of the intervention, we used ANOVA to 
calculate the differences in final values of each variable between the 'low' and 
'high' group after adjustment for gender, smoking habits and baseline values of 
each variable. Analysis of covariance was used for statistical testing. Data are 
reported as mean ± SD unless stated otherwise and P < 0.05 indicates significant 
difference. A posteriori power analysis showed that the number of subjects was 
sufficient to observe a 0.45 mmol/L difference in final total cholesterol, a 0.45 g/L 
difference in final fibrinogen concentrations and a 9.4 mmHg difference in final 
systolic blood pressure with a power of 0.9 and a is 0.05 (two-sided). The analysis 
of covariance revealed minor deviations from normality assumptions for some 
variables. For these variables, analyses were repeated using logarithmically 
transformed data. These log transformed analyses yielded results that are virtually 
identical to the untransformed data-analysis as presented here. 
Results 
The groups were similar in age, BMI and in the mean habitual daily intake of 
vegetables and fruit before the start of the study (Table 1). 
Table 1 Characteristics of participants pre-study in the 'low' group and the 'high'group1 
Age, y 
Men / women, n 
Smokers, nonsmokers, n 
Intake of vegetables and fruits, 
Body weight, kg 
Body mass index, kg/m2 
Height, cm 
g/d 
Intervention 
'Low' group 
50 + 4.38 
12/11 
6/17 
158 ±54 
77.5 ±11.8 
25.2 ±2.9 
175.2 ±9.9 
'High' group 
48.6 ± 5.63 
12/12 
6/18 
162 ±46 
79.5 ±11.4 
26.3 ±3.3 
173.9 + 7.5 
1
 Values are means ± SD unless stated otherwise. 
159 
Chapter 8 
One participant of the 'low' fruit and vegetables consumption group, a non-
smoking female, did not complete the study and was not replaced. Data for this 
non-complier are not used in the statistical analysis. The mean daily provided 
energy intake of the 'low' and 'high' groups during the trial were 10.2 ± 1.6 MJ 
and 10.1 ± 1.2 MJ, respectively. 
Table 2 gives the analytical results for the diets designed at 10.7 MJ level. The 
actual energy level was slightly higher, but the total energy content of both diets 
was similar. In both diets the energy percentages from fat, protein and carbohydrate 
were near the recommended energy percentages (en%) for protein, carbohydrate 
and fat. 
The overall compliance in both groups was good. The volunteers consumed 98.9% 
of the provided energy of the 'high' diet and 99.7% of the provided energy of 'low' 
diet. After 25 days, the mean changes in body weight in the 'high' and 'low' 
groups were similar. The compliance of fruit and vegetable intakes separately was 
99.7% of the energy in the 'high' group and 99.8% of the energy in the 'low' 
group. 
Plasma concentrations of vitamin C, folate, carotenoids were also measured, the 
results of which have been presented elsewhere (Broekmans et al., 2000). Briefly, 
significant higher concentrations were observed in the 'high' group in comparison 
with the 'low' group for vitamin C (64%), folate (15%) and carotenoids, for 
example p-carotene (45%). 
Baseline values and changes in serum lipids, hemostatic variables and blood 
pressure per group are shown in Table 3. 
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Table 2 Daily intake of nutrients and energy during dietary intervention period1 
Energy/nutrient 
Total energy, MJ 
Protein, en% 
Total fat, en% 
Carbohydrate, en% 
Saturated fatty acids, en% 
Monounsaturated fatty acids, en% 
Polyunsaturated fatty acids, en% 
Fiber, g 
Vitamin C, mg 
Total carotenoids, mg 
Lutein, mg 
Zeaxanthin, mg 
P-Cryptoxanthin, mg 
Lycopene, mg 
a-Carotene, mg 
P-Carotene, mg 
Vitamin E, mg 
Vitamin B-6, mg 
Folate, |ig 
Total glucosinolates, nmol 
Total flavonoids, mg 
Intervention 
'Low' diet 
11.2 
14.6 
32.7 
53.5 
14.4 
7.5 
6.5 
47.9 
65.0 
2.9 
0.5 
0.04 
0.04 
0.06 
0.27 
0.63 
17.6 
1.61 
131.1 
2.3 
0.75 
'High' diet 
11.4 
14.9 
29.9 
53.3 
13.1 
6.8 
6.0 
56.2 
172.5 
13.3 
2.0 
0.13 
0.27 
0.66 
1.33 
2.98 
19.9 
1.96 
228.1 
14.6 
3.74 
1
 Values are based on the chemical analyses of weekly diets (see method section). 
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Table 3 Baseline values and changes of markers of cardiovascular risk profile during a 4 
week trial in fasting human volunteers assigned to either the 'low' (n = 23) or 'high' (« = 
24) fruit and vegetables group1,2 
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Values are means ± SD unless stated otherwise.2 For some individual measurements data 
are missing.3 Difference in final values (95% CI), corrected for gender, smoking habit and 
baseline values in the 'high' ra 'low' group, covariance analyses * Significant change 
within group, P < 0.05. 
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At baseline, only tPA activity values were higher in the 'low' group than in the 
'high' group (P < 0.05). All other values were similar. Figure 1 shows the 
percentage differences plus 95% CI between the 'high' and 'low' fruit and 
vegetable group for serum lipids, hemostatic variables, blood pressure, heart rate, 
respectively. The variables are subdivided in variables where a decrease would be 
desirable (triacylglycerols, total cholesterol, LDL cholesterol, LDL/HDL ratio, tPA 
antigen, F1+F2, D-dimers, fibrinogen, systolic blood pressure, diastolic blood 
pressure, heart rate) and variables where an increase would be desirable (HDL-
cholesterol and tPA activity). 
Figure 1 Percentage differences (95% CI) in serum lipids, hemostatic variables and blood 
pressure between 500 g/d fruit and vegetables + 200 ml fruit juice/d and 100 g/d fruit and 
vegetables after 4 weeks, subdivided in variables with a desirable decrease (open dots) and 
a desirable increase (filled dots). 
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TG: serum triacylglycerols; T-Chol: total serum cholesterol; LDL-C: serum LDL 
cholesterol; LDL/HDL: serum LDL cholesterol/ HDL cholesterol; tPAan: plasma tPA 
antigen; F1+F2: plasma prothrombin fragment 1.2; D-dimer: plasma D-dimers; fibrinogen: 
plasma fibrinogen; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart 
rate; HDL-C: serum HDL cholesterol; tPAac: plasma tPA activity. 
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Total cholesterol, HDL cholesterol and LDL cholesterol decreased both in the 
'high' and in the 'low' group. LDL/HDL ratios remained stable in both groups. 
After adjustment for baseline values, gender and smoking, there were no 
significant differences in the final serum concentrations between the 'high' in 
comparison with the 'low' group for triacylglycerols, total cholesterol, HDL 
cholesterol, LDL cholesterol and LDL/HDL ratio. Blood pressure and heart rate 
decreased in both groups. We could not demonstrate intervention effects on blood 
pressure and hemostatic variables. 
Discussion 
This small randomized well-controlled dietary intervention trial of short duration 
shows that increase with 400 g/d of fruit and vegetable and 200 mL/d fruit juice 
consumption did not materially affect serum lipids, blood pressure and hemostatic 
variables in apparently healthy volunteers. 
Elevated serum cholesterol, triacylglycerols, LDL cholesterol and reduced HDL 
cholesterol are risk factors for cardiovascular disease (Wald and Law, 1995; 
Criqui, 1998; Werner and Pearson, 1998; Jacobs et al, 1990). Although there was a 
tendency for the LDL cholesterol to be lower in the 'high' group (-4%) than in the 
'low' group, there was a similar lower concentration of HDL cholesterol (-5%). 
Both groups lost weight, but this was not different between the two groups. Weight 
loss could influence the serum levels of total cholesterol, LDL and HDL 
cholesterol. However, we did not find significant correlations between weight loss 
during the study and changes in total cholesterol, HDL and LDL cholesterol. The 
ratio LDL/HDL is more important as a cardiovascular risk indicator than individual 
LDL or HDL measurements. This ratio remained stable during the intervention of 
400 g fruit and vegetables and 200 mL fruit juice consumption. 
During the intervention in this study, serum lipids decreased in the 'high' as well as 
in the 'low' group. We did not measure energy and fat content of the habitual diet 
before the start of the study, but we may speculate that the 4-week controlled diet 
provided less energy and fat than the habitual diet consumed before the start of the 
study. Our results with regard to serum lipids are in agreement with other studies. 
In a diet-controlled study by Stasse-Wolthuis et al. (1980), total cholesterol 
decreased non-significantly by only 0.17 mmol/L with the diet of fruit and 
vegetables (1170 g/d) after 5 weeks. Two possible factors that could influence the 
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serum lipids are dietary fiber and dietary fat (Anderson, 1985). In our study dietary 
fat was controlled, whereas the fiber content was almost the same in both groups 
(Table 2). Zino et al. (1997) compared a recommendation of approximately 7 
servings/d with a habitual diet of 2 servings/d in an 8-week trial. The differences 
between groups for total cholesterol, LDL, HDL and triacylglycerols were minor 
and lower than in our study. 
It is possible to improve serum lipid profiles with a dietary intervention during 4 
weeks. For example, Kurowska et al. (2000) reported that consumption of 750 
mL/d but not 250 or 500 mL/d orange juice significantly increased HDL 
cholesterol and reduced the LDL/HDL cholesterol ratio in hypercholesterolemics. 
LDL cholesterol concentrations were not influenced. Potentially beneficial 
components in citrus juice could be folate, flavonoids and vitamin C. The content 
of folate and flavonoids in our 'high' and 'low' diets were not very high. However, 
vitamin C intake was much higher in the 'high' group and serum vitamin C was 
approximately 30 u.mol/L higher. In a cross-sectional analysis (Ness et al, 1996), 
plasma vitamin C was not correlated with serum total cholesterol or LDL 
cholesterol in men and women. In women, higher plasma vitamin C was associated 
with higher HDL cholesterol and lower triacylglycerols concentrations. Our trial 
could not confirm this association of vitamin C in serum with HDL cholesterol. 
Our study does not show a clear-cut beneficial effect of fruits and vegetables on 
hemostasis. However, our study was not specifically designed to test the effect of 
fruit and vegetables consumption on hemostatic variables. Evidence from large 
observational epidemiological studies links hemostatic variables to the risk of 
cardiovascular disease (Koenig, 1998; Kannell et al, 1987; Juhan-Vague, 1996; 
Rugman et al, 1994; Iacoviello et al, 1998). In our study, we used fibrinogen and 
prothrombin activation peptide fragment F1+2 as markers of coagulation (Rugman 
et al, 1994); and tPA activity and tPA antigen as markers of fibrinolysis (Koenig, 
1998) and D-dimers as a marker of fibrin turnover. It is thought that hemostatic 
factors could be influenced by changes in diet. Famodu et al. (1999) reported a 
decreased fibrinolytic activity, including higher fibrinogen concentrations in a non-
vegetarian group in comparison with vegetarian and semi-vegetarian groups. This 
difference is possibly attributed to the high consumption of dietary fiber because of 
availability of a large group of fresh vegetables in their diet. Ideally, for fruit and 
vegetables to positively influence hemostatic function, they should decrease tPA 
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antigen, F1+F2, fibrinogen and increase concentrations of tPA activity. In this 
study we did not see such a consistent beneficial pattern. We did observe a positive 
tendency for increased tPA activity and decreased F1+F2, but none of the effects 
are statistically significant. On the other hand, the non-significant shifts in tPA 
antigen and fibrinogen concentrations were not in line with the possible positive 
effects of fruit and vegetable consumption on hemostatic variables. Further 
research is necessary to investigate the mechanisms through which fruit and 
vegetables could influence the blood platelet aggregation, blood coagulation and 
fibrinolysis. 
This study did not find an effect on blood pressure. In contrast, in a previous study 
of Appel et al (1997) systolic blood pressure was 2% lower in a fruit and vegetable 
group in comparison with a control group; diastolic blood pressure was 1.3% 
lower. Furthermore, randomized controlled trials have confirmed that a vegetarian 
diet, including a high amount of fruit and vegetable consumption could also lower 
blood pressure (Rouse et al, 1983; Margetts et al, 1986). Our study did not have 
sufficient statistical power to pick up such small differences. As the confidence 
intervals for blood pressure overlap with the effect observed in the trial reported by 
Appel et al. (1997), the results cannot exclude a modest reduction in blood 
pressure. According to the lowest confidence limits, we suggest that the effect of 
our fruit and vegetable intervention was less than 2% and 4% for systolic and 
diastolic blood pressure, respectively. The absence of a significant difference 
between the groups in our study could thus be explained by number of participants 
or the duration of the study, which was not specifically designed to test a blood 
pressure hypothesis. The composition of the diets however may be a more likely 
explanation. The differences in the amount of potassium between the 'low' and 
'high' vegetable and fruit group were much higher in the trial of Appel et al 
(1997), 1700 and 4700 mg in both diets respectively in comparison with the 
amounts in our trial, 3228 and 4062 mg per day. Vitamin C is another compound 
that could have an effect on blood pressure (Ness and Sterne, 2000). In our trial, 
the 'high' group had much higher intakes of vitamin C (ca. 173 xs 65 mg) in 
comparison to the ' low' group, but no effects on blood pressure were found. Trials 
on vitamin C reported so far are too small to provide conclusive evidence of an 
effect of vitamin C on blood pressure. In addition, these trials used vitamin C 
supplementation in very high amounts (> 400 mg/d). 
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Conclusions 
This small randomized well-controlled dietary intervention trial of short duration 
with a considerable contrast in fruit and vegetable consumption shows no effect on 
the ratio LDL/HDL, although there was a non-significant tendency for both HDL 
and LDL cholesterol to decrease. Blood pressure and hemostatic variables were not 
influenced by fruit and vegetable consumption. We previously reported lower final 
plasma homocysteine concentrations in the 'high' group than in the 'low' group 
from the same study. The results presented now suggest that there is a lack on 
effect on other cardiovascular risk factors. 
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General discussion 
Chapter 9 
The main objective of the studies described in this thesis was to evaluate the 
potential health effects of carotenoids in normal physiological ranges in relation to 
eye, skin and cardiovascular health. In an observational study we evaluated the 
associations between serum carotenoid status in relation to biomarkers of eye, skin 
and cardiovascular health. The observational results were obtained from the 
baseline of an intervention study designed to evaluate the effects of decreased 
carotenoid concentrations, as caused by sucrose polyesters (SPE) on the same 
biomarkers. In a second intervention study, we evaluated the effects of a high but 
realistic intake of fruit and vegetable on serum carotenoid concentrations and 
biomarkers of cardiovascular health. 
As mentioned in the introduction, in the causal pathway between diet and 
disease, one may distinguish biomarkers of exposure/internal dose, biomarkers of 
target function/biological response and intermediate endpoints, the latter two 
designated as biomarkers of enhanced function and biomarkers of reduced risk 
(Diplock et ai, 1999). In the relation between diet and disease two aspects are 
important: (1) the potential of diet: which food components affect the biomarker 
and may thus reduce risk? (2) the validity of the biomarker: does a change in the 
biomarker reflects a change in risk? 
In this discussion we will discuss first the effects of intake of SPE and a high but 
realistic consumption of fruit and vegetables, that is related to carotenoid status in a 
normal range on biomarkers of enhanced function or reduced risk. Second we will 
discuss the predictive value of the biomarkers used in our studies and areas for 
future research are given. 
Main findings: effects of carotenoids in the normal physiological range on 
biomarkers 
In this discussion we will first look at eye health, then at skin health and finally at 
cardiovascular health. The main findings of the studies in this thesis are presented 
in Table 1. 
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Table 1 Studies described in this thesis and their main findings 
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Carotenoids and eye health 
Serum and adipose tissue concentrations of lutein were stronger associated with 
macular pigment (MP) density in men than in women in our observational study. 
MP density was not influenced by decreases in serum carotenoids after SPE 
consumption over 1 year (Table 1). A stronger relation between serum lutein and 
MP density in men, and a possible negative association between adipose tissue 
lutein and MP density in women have also been described by Johnson et al. (2000). 
They suggested that there could be more competition for the uptake of lutein 
between adipose tissue and the eye in women than in men (Johnson et al., 2000). 
Hammond et al. (2002) suggested that obese subjects have a lower MP density due 
to a lower intake of carotenoids or to competition between body fat and retina in 
the uptake of lutein and zeaxanthin. Differences in body composition between men 
and women could also explain our findings. 
The question however remains why significant associations have been found 
between serum lutein concentrations and MP density cross-sectionally whereas no 
significant effects on MP density have been observed after long-term lutein 
decrease. In the SPE study, serum lutein decreased by 20%, 11%, and 0.6% after 
consumption of 17, 10 and 7 g/d of SPE, respectively. According to the regression 
equation of the cross-sectional data, these decreases would be expected to be 
associated with changes in MP density of 4.8%, 2.5% and 0.7%, respectively. In all 
groups, including the control group MP density actually increased somewhat. 
Although the 17 g/d group did show a (non-significant) decrease of 4.8% relative 
to the control group, the 10 g/d and 7 g/d groups showed no tendency for a 
decrease comparable with the regression equations. The (non-significant) decreases 
relative to the control group were 1.4% and 2.7%, respectively. These results show 
that MP density is not simply a mathematical derivative of decreased 
concentrations of carotenoids in serum. 
Recently, a dietary supplementation study with lutein/zeaxanthin-rich vegetables 
(Johnson et al, 2000) showed a beneficial effect on MP density of ca. 18%. 
However, the increases in serum concentrations were 2-fold, much higher than the 
decreases of lutein we observed in the SPE study. The decreases in serum lutein in 
the SPE intervention study were probably too small to detect a significant effect on 
MP density. Whether a change of 1-5% is functionally relevant in relation to a 
change in disease risk remains unanswered. In this case, the difference between 
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significant effects and clinically relevant effects is important. The difference in MP 
density between eyes of AMD patients and eyes of control subjects is ca. 30% 
(Bone et ah, 2000). We speculate that an explanation for the difference between the 
cross-sectional and intervention findings could be that the eye has a sparing 
mechanism for the accumulation of carotenoids. As serum concentrations decrease, 
the capacity of the retina to accumulate carotenoids may increase. The mechanism 
of accumulation of carotenoids in the eye is not yet established. Recently, 
carotenoid-binding proteins have been discovered in the eye (Yemelyanov et ah, 
2001). Mechanistic studies in eyes of animals and extracts from human eyes in 
which isomers and oxidation products of carotenoids are measured could give more 
insight into the metabolism of lutein and zeaxanthin in the macula and carotenoid 
uptake and stabilization. 
In conclusion, in our study the associations of serum and adipose tissue with MP 
density are stronger in men than in women, probably because of a difference in 
body composition. Future research should focus on the role of body composition in 
the distribution of carotenoids in the body after an increased or decreased intake of 
carotenoids. Not only the bioavailability in serum, but also the functional 
bioavailability, i.e. the concentrations of lutein and zeaxanthin in these tissues has 
to be studied after carotenoid intake. In addition, the competition between adipose 
tissue and the eye in the uptake of lutein and zeaxanthin after intake of these 
carotenoids should be studied in subjects with different body fat distributions, 
subjects with high or low BMI or high or low body fat percentage. 
Supplementation studies have shown an accumulation of lutein and zeaxanthin in 
MP density when there is an increased supply of carotenoids. However, decreased 
concentrations as shown in our study did not have an influence on MP density, 
may-be due to a sparing mechanism in the eye. If there is a sparing mechanism, it 
is important to known how long this sparing mechanism will continue. Negative 
longer-term effects or minor changes of a decreased supply of lutein and 
zeaxanthin to MP density cannot be excluded by our study. 
Carotenoids and skin health 
Skin sensitivity to solar irradiation was not associated with serum carotenoid status 
in the cross-sectional study and was not influenced by a decrease in serum 
carotenoids (Table 1). Recently, a dietary supplementation study with lycopene-
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rich tomato paste (Stahl et al, 2001), showed a beneficial effect on the erythema 
reaction (-40%). However, the increases in serum concentrations were 2-fold, 
much higher than the decreases (24% for lycopene) we observed in the SPE study. 
The modifying effect of melanin on the association between serum carotenoids and 
minimal erythema dose (MED) suggests that the combination of high melanin 
concentrations and carotenoids is important, especially where maintenance of the 
carotenoid concentrations is vital to avoid deleterious effects of UV light, such as 
in the retina of the eye and the skin (Edge et al, 2000). 
In conclusion, supplementation studies show that carotenoids could influence the 
sensitivity to sunlight as measured by MED but our findings suggest that 
carotenoid decreases has no significant influence on MED. The mechanism behind 
a possible protective effect, probably by their antioxidant function, effect on gene 
regulation or interactions with melanin, could be studied by mechanistic studies in 
human skin cell-lines. 
Fruit and vegetables, carotenoids and cardiovascular health 
Although our fruit and vegetable study had limited statistical power, our findings 
do suggest that fruit and vegetables do not have a major impact on serum lipids and 
fibrinolysis/coagulation variables. Serum lipids were not influenced by a diet high 
in fruit and vegetables in another study (Obarzanek et al, 2001). Fruit and 
vegetable consumption could influence blood pressure regulation and 
homocysteine concentrations. Indeed, Appel et al. (1997) and Svetsky et al. (1999) 
showed that a diet high in fruit and vegetables could decrease systolic blood 
pressure and diastolic blood pressure. Our findings on blood pressure were within 
the range of the reported blood pressure-lowering effects of high fruit and 
vegetable consumption in that earlier study. In accordance with our findings, 
Brouwer et al. (1999) observed a decrease in homocysteine after 4 weeks of citrus 
fruit and vegetable consumption. In contrast, Appel et al. (2000) did not show a 
significant difference in homocysteine between the control group and the fruit and 
vegetable group. The mean baseline homocysteine concentrations differed between 
the studies, with the highest baseline levels in our study followed by the studies of 
Brouwer et al. (1999) and Appel et al. (2000), probably in part explaining the 
differences in observed decreases of homocysteine. 
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Atherosclerosis is currently seen as an inflammatory disease (Ross, 1999). In our 
cross-sectional studies it was shown that carotenoids are related to inflammation 
markers and markers of endothelial function, such as C-reactive protein (CRP), 
leucocytes and soluble intercellular adhesion molecule (sICAM-1). A possible 
mechanism could be that carotenoids have anti-inflammatory effects. However, in 
our SPE study decreases in carotenoids had no effect on the inflammation markers. 
This could indicate that a third factor could influence both carotenoids and 
inflammation markers, for example, obesity. In studying the relation between fruit 
and vegetables, carotenoids and cardiovascular disease, inflammatory processes 
have to be taken into account (Kritchevsky et al, 2000; Kritchevsky, 1999). 
Validity of biomarkers 
Macula pigment (MP) density as predictive marker for age-related macular 
degeneration 
Whether a change in MP density reflects a change in risk for age-related macular 
degeneration (AMD) is not yet established. It is biologically plausible that MP 
density plays a role in the development of AMD. MP density can absorb blue light, 
which is harmful to the eye, or it can act as antioxidant to prevent oxidative 
damage to photoreceptors of the eye (Landrum and Bone, 2001). Furthermore, low 
MP density is associated to risk factors of AMD, such as iris color, gender and 
smoking. Bone et al. (2000) showed that the retina of donors with AMD had 30% 
lower MP density than the retina of control donors without AMD. They showed 
that those in the highest quartile of macular pigment had 82% lower risk for AMD 
than those in the lowest quartile. In contrast, Berendschot et al. (in press) showed 
that there was no difference in MP density between healthy subjects and patients 
with different stages of AMD. Differences between these studies in study material 
(subjects and donor eyes), techniques (Bone used HLPC while Berendschot used 
reflectance), and different disease stages makes it difficult to compare these results. 
It has been suggested that AMD is multifactorial. In addition to the possible 
protective role of carotenoids in MP, other components with antioxidant capacity 
could prevent the oxidative stress in the eye, such as vitamins C and E, and 
cofactors of antioxidant enzymes, like minerals. Other nutrients could also have an 
influence on AMD, such as fatty acids as important components of photoreceptors. 
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Other hypotheses are related to vascular damage in the eye. If MP density is part of 
the mainstream causal pathway relevant to the majority of disease cases, it could be 
a valid marker, despite other processes involved in the development of AMD. 
Further research should be focused on the relation between MP density and AMD. 
Measurement of MP density in patients with AMD as compared to healthy controls 
could contribute to the biological plausibility of MP density as marker of AMD. In 
these studies a decrease of MP density in patients could be a cause or consequence 
of AMD. To study the predictive value of MP density on AMD, cohort studies or 
cohort-nested case-control studies could be used to evaluate the differences in MP 
density measured at the start of the cohort study and during follow-up in patients 
and controls. These studies are very expensive and time-consuming. 
To validate the notion that a change in MP density reflects a change in AMD as a 
result of, for example, dietary modulation requires intervention studies with high-
risk groups, for example patients with AMD in at least one eye. This could reduce 
the study period. By studying the effect of dietary modulation on MP density and 
the progression of AMD measured by photographs of the eye or visual acuity loss 
could elucidate the predictive value of MP density for the further development of 
AMD. Once the predictive value of MP density is established human intervention 
trials could be performed with MP density as endpoint. 
Lens density as a predictive marker for cataract 
Lens density increases with age, with a rapid acceleration after age 50. Lens 
density measured in vivo is associated with the accumulation of protein aggregates 
in the lens (Mota et al, 1992). However, lens density varies among younger 
subjects with no discernible lens opacities (Hammond et al, 1997). Observational 
studies show that lens density in subjects with cataract is higher than in age-
matched subjects without cataract (Sample et al, 1988). There are no longitudinal 
data available evaluating the predictive value of lens density early in life for 
cataract risk later in life. 
Following subjects over time in cohort studies or cohort-nested case-control studies 
could elucidate the predictive value of lens density early in life for cataract risk 
later in life. Such studies could detect other factors that may be responsible for the 
difference in a common pattern of lens aging in most individuals and the 
accelerated pattern of lens aging in subjects who develop cataract. 
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To validate that a change in lens density reflects a change in cataract by dietary 
modulation, intervention studies are required with high-risk groups, for example 
diabetes patients, patients with cataract in at least one eye or patients who had 
previously one lens with cataract removed. The effect of the dietary intervention 
could be studied on lens density and the progression of cataract measured by 
opacity grades, cataract surgery or vision acuity loss. 
Minimal erythema dose (MED) as a predictive marker for non-melanoma skin 
cancer 
MED is a direct effect marker of personal sensitivity to sunburn. Is it necessary to 
validate MED as marker of non-melanoma skin cancer? The marker is used as a 
sensitivity marker, indicating that subjects with low MED values have to be careful 
with high sun exposure. There is persuasive evidence that sun exposure is a causal 
factor in the development of skin cancer. Observational studies have shown that the 
incidence rate of skin cancer is higher in fair-skinned, sun-sensitive subjects than in 
dark-skinned, less sun-sensitive subjects (Armstrong and Kricker, 2001). In 
observational studies sensitivity to sunlight is based on the comparison between 
ethnic groups of different skin color, color of unexposed skin, ability to tan and 
different skin types. In subjects with a skin that tans poorly, exposure to 0.3-0.5 
standard MED (sMED; 1 sMED is the effective dose of UV irradiation capable of 
causing minimal erythema in an average skin type 2) may be sufficient to lead to 
erythema. In persons with a less sun-sensitive skin that has been adapted through 
regular exposure, 3-5 sMED leads to erythema, a difference by a factor of 10 
(Report Health Council of the Netherlands, 1994). 
Next to sun exposure, including the pattern as well as the amount of sun exposure, 
other factors are important in the development of skin cancer. Individual 
differences in repair mechanisms of DNA damage and immunosuppression and 
gene expression by UV-light could have an influence on the development of 
mutations and cancer cells. The question is whether the acute effect to UV 
(sensitivity to sunlight) is related to the chronic effect of UV (DNA damage, 
mutation induction and skin cancer). Young et al (1998) showed that DNA 
damage spectra are comparable with erythema spectra after different doses of UV 
in human volunteers and induced repair of DNA damage can prevent erythema 
formation (Stege et al, 2000). Heenen et al. (2001) showed a weak correlation 
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between erythema response and DNA damage after UV exposure because of the 
large intraindividual variation in DNA damage response after exposure to the same 
relative dose of MED. 
The development of skin cancer is a multifactorial process. Increasing fundamental 
understanding of the factors in mechanistic studies that are of influence on the 
development of skin cancer after UV exposure will reveal the precise relationship 
between sensitivity to sunlight and the development of skin cancer. 
However, the most important factor in the development of skin cancer is the sun 
exposure itself. When subjects with a low MED, reflect high sensitivity to UV-
light, are not exposed to UV-light, they will not develop skin cancer. But they have 
the chance to develop skin cancer if they are exposed to UV-light. 
A change in erythema as observed in dietary supplementation studies is not 
comparable with the use of a sunscreen with a high protection factor. Others 
suggest that dietary intake may provide basal skin protection against sunburn 
(Stahl, 2000). The question remains if this small change in sunburn sensitivity is 
related to a change in disease risk. 
FMD, ICAM and homocysteine as predictive biomarkers for cardiovascular 
disease 
Flow-mediated vasodilation is related to several risk factors of cardiovascular 
disease. Neunteufl et al (2000) showed that cardiovascular events occurred more 
frequently in chest-pain patients with a FMD lower than 10% in comparison with 
chest-pain patients with a FMD higher than 10%. In another study, FMD of the 
coronary arteries was predictive of future coronary events (Schachinger et al, 
2000). 
Concentrations of adhesion molecules, such as sICAM-1, are elevated in patients 
with ischemic heart disease (Morisaki et al, 1997) and coronary heart disease 
(Hwang et al., 1997) and could predict future death of cardiovascular disease in 
patients with coronary artery disease (Blankenberg et al, 2001). In a study of 
Ridker et al. (1998) healthy subjects at baseline in the highest quartile of sICAM-1 
(> 260 ng/mL) had 80% higher risk of myocardial infarction than subjects in the 
lowest quartile (< 193 ng/mL). However, Malik et al (2001) reported that sICAM 
was only moderately associated with vascular disease after correction for classical 
risk factors. 
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As to homocysteine, it is not yet established if higher homocysteine concentrations 
are a cause or a consequence of cardiovascular disease, because retrospective 
epidemiological studies find much stronger associations between homocysteine 
concentrations and cardiovascular disease than do prospective studies. A 3-4 
umol/L reduction in homocysteine should lower vascular disease risk by one third 
(Eikelboom et al, 1999). As shown in observational epidemiological studies folic 
acid is associated with risk of cardiovascular disease (Eichholzer et al, 2001). 
Recently, it was shown that folic acid reduced homocysteine concentrations and 
new blockage of the treated artery in patients who had undergone angioplasty 
(Schnyder et al, 2001). The question is if this is mediated via a homocysteine-
lowering effect. Human placebo-controlled intervention studies are required to 
study the homocysteine-lowering effects by components other than B-vitamins on 
cardiovascular disease risk. 
In conclusion, for all previously mentioned biomarkers of cardiovascular disease it 
is biologically plausible that they play a role in the development of cardiovascular 
disease. It is likely that changes in these biomarkers are related to changes in 
disease risk, but it is not yet established. For these variables, there is no clear cut-
off point for disease. Every decrease in each variable could contribute to the 
reduced risk of cardiovascular disease. The pattern of different variables is 
important in risk estimation. Additional epidemiological prospective studies are 
necessary to evaluate the predictive values of these markers. In addition, in 
intervention trials with high-risk groups, for example in subjects who suffered from 
cardiac events, the effect of manipulation of these markers on the disease outcome 
can be studied. Interventions may alter one factor, but other factors could be 
adversely affected. Thus, studies with hard endpoints remain critical. 
Conclusion 
This thesis reports on a number of studies on serum carotenoid concentrations in 
relation to several biomarkers of eye, skin and cardiovascular health. 
With regard to macular pigment as a marker of eye health, we did find cross-
sectional associations with serum carotenoids, but these were influenced by gender 
and possibly by body composition. We did not observe clear adverse effects of 
SPE-induced serum carotenoid decreases over one year, but we cannot exclude 
minor changes. This does not add support to the hypothesis that changes in serum 
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carotenoids are associated with age-related macular degeneration. However, the 
relation of especially lutein and zeaxanthin with macula degeneration remains 
plausible, information on the biological relevance of minor changes in macula 
pigment is lacking, and we cannot exclude effects over a period of more than one 
year. Moreover, interpretation is hampered by our limited knowledge of the 
kinetics and metabolism of carotenoids. Competition between tissues for 
carotenoid absorption and possible 'sparing' of carotenoids by the macular tissue 
are hypotheses that deserve further study. Finally, the predictive value of MP 
density for AMD should be studied in follow-up studies. 
With regard to cardiovascular disease, we did find several cross-sectional 
associations with serum carotenoids that confirm previously found inverse 
associations between carotenoids and chronic disease risk. However, our 
intervention studies with SPE or fruits and vegetables did not show effects of 
carotenoid changes in a normal physiological range on the biomarkers studied. This 
is in line with previous intervention studies with high doses of p-carotene that did 
not show a preventive effect. Our fruit and vegetable study did show an effect on 
plasma homocysteine and our results on blood pressure, with limited statistical 
power, are within the range of a previously reported blood pressure-lowering 
effects of high fruit and vegetable consumption. The latter two effects, however, 
are mechanistically unlikely to be mediated by serum carotenoids. 
For MED as a marker of skin sensitivity to sunburn, we found neither clear cross-
sectional associations with serum carotenoids nor effects in our 1-year SPE 
carotenoid reduction trial. Previous studies have shown effects of high dietary 
intake of carotenoids, but our studies indicate that associations between MED and 
serum carotenoids in the normal physiological range are non-significant. 
Overall, our studies used biomarkers that are indicative of biological processes 
currently thought to be important in disease etiology, but the predictive value has 
not been established. Therefore, our studies are not conclusive for disease risk, but 
they seem to add proof to the hypothesis that serum carotenoid decreases or 
increases within normal physiological ranges in periods up to one year, have no or 
limited impact on biomarkers related to eye, skin and cardiovascular health. Future 
studies, specifically on the metabolism of carotenoids and follow-up studies on 
disease incidence, should clarify this matter further. 
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Observational epidemiological studies have consistently shown that high 
consumption of carotenoid-rich fruit and vegetables is associated with a reduced 
risk of chronic diseases, such as cardiovascular, some types of cancer, cataract and 
macular degeneration. Although the preventive mechanisms are not fully 
understood, many authorities now recommend an intake of more than 400 g/d of 
fruit and vegetables and carotenoids have been frequently hypothesized to explain 
in part the beneficial effect of fruit and vegetables. Because of the potential 
beneficial effects of carotenoids, the introduction of products in which fat was 
replaced by non-digestible sucrose polyesters (SPE) was met with scientific 
concern, since SPE intake lowers plasma levels of carotenoids. Intervention trials 
showed that high dose P-carotene supplementation has no protective effect or even 
exerts an increased risk. Therefore, it seems advisable to study the effects of those 
carotenoids that are most abundant in the diet at nutritionally relevant levels on 
disease risk. Because intervention studies with hard end-points are time-consuming 
and costly, the use of biomarkers as predictors of the actual effect of diet on disease 
could be a promising approach. 
The objective of this thesis was to evaluate the relation between serum carotenoid 
status in a normal physiological range and biomarkers of eye, skin and 
cardiovascular health in man. In an observational study the quantitative relations 
between serum carotenoid concentrations and biomarkers of eye (macular pigment 
and lens density), skin (minimal erythema dose) and cardiovascular health 
(markers of endothelial function and inflammation) were studied. The 
observational results were obtained from the baseline of an intervention study 
designed to evaluate the effect of long-term carotenoid decreases, as caused by 
SPE on markers of oxidative damage and functional markers of eye (macular 
pigment), skin (minimal erythema dose) and cardiovascular health (flow-mediated 
vasodilation). In the second intervention study the effect of a high but realistic 
consumption of fruit and vegetables was studied on serum carotenoids, vitamin 
concentrations and biomarkers of cardiovascular health (homocysteine, serum 
lipids, blood pressure, coagulation and fibrinolysis variables). In the introduction of 
this thesis background information on the health effects of carotenoids in relation 
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to eye, skin and cardiovascular health is given. Furthermore, several biomarkers of 
eye, skin and cardiovascular health are described. 
Observational study 
The 380 subjects in our study were recruited from the pool of volunteers of TNO 
Nutrition and Food Research and through advertizing in local and regional 
newspapers and on television. We aimed to select Dutch volunteers with high and 
low fruit and vegetable consumption according to a brief questionnaire in order to 
reach a wide range in carotenoid exposure. Respondents in the highest quintile of 
fruit and vegetable consumption and those in the lowest tertile were selected. The 
final study group comprised 178 men aged 42 ± 15 years and 201 women aged 41 
± 13 years. Of these volunteers, 33% and 27% were smokers, respectively. 
Eye health 
Macular pigment (MP), concentrated in the central area of the retina in the eye, 
contains the carotenoids lutein and zeaxanthin. A low MP density could be a risk 
factor for age-related macular degeneration (AMD). In our study, the quantitative 
relations between serum and adipose tissue concentrations of lutein and MP density 
were stronger in men than in women (Chapter 2). In men, an increment of 1 
standard deviation (SD) in serum lutein was associated with 13% higher MP 
density. An increment of 1 SD in adipose tissue lutein was associated with 11% 
higher MP density in men. The weaker associations in women could be a 
consequence of more competition between uptake of lutein in the eye or adipose 
tissue. 
No associations were found of serum carotenoids and vitamins with lens density, 
measured as a marker of cataract risk (Chapter 3). Macular pigment, as a marker of 
lutein and zeaxanthin in the eye, the only carotenoids that have been found in the 
human lens, was inversely associated with lens density. An increment of 1 SD in 
MP density was associated with 2.7% lower lens density. This suggests that lutein 
and zeaxanthin in the eye may retard aging of the lens. However, the uptake of 
lutein and zeaxanthin in the eye is still not clear. 
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Skin health 
Sunburn is a well-known acute effect of excessive UV exposure. Low-dose or brief 
exposure to UV irradiation is tolerated by the skin without noticeable or clinically 
relevant changes. Only after reaching a certain threshold, an inflammatory response 
is induced, which is clinically visible as erythema, redness of the skin. A frequently 
used measure for the skin's sensitivity to UV light is the minimal erythema dose 
(MED). One MED is the minimum amount of energy required to induce visible 
erythema, which can be defined as a uniform, clearly demarcated or just 
perceptible redness at 16-24 h after UV exposure. Thus, a low MED indicates a 
high sensitivity to sunburn. Male subjects were found to be more sensitive to UV 
irradiation than female subjects (Chapter 4). Skin melanin content, the brown color 
of the skin, which was positively associated with iris color in both sexes and with 
hair color in men, was the main phenotypical determinant of sensitivity to UV-
irradiation. No associations were found between serum carotenoids and MED in 
the total study group. However, associations between carotenoids concentrations 
and MED showed a positive trend in subjects with melanin values above the 
median and a negative trend in subjects below the median. We do not have a clear 
biological explanation for this modifying effect of melanin on the association 
between carotenoids and MED. 
Cardiovascular health 
The vascular endothelium is the primary site of dysfunction in atherosclerosis. 
Endothelial cell dysfunction may be related to an increase in cellular oxidative 
stress, a dysbalance between anti-oxidative and pro-oxidative factors. Carotenoids 
and vitamins could have an antioxidant-mediated tempering influence on 
endothelial function and inflammation, thereby reducing the risk of atherosclerosis. 
High-sensitive C-reactive protein (CRP), fibrinogen (Fbg) and leucocytes were 
measured as markers of inflammation. Soluble intercellular adhesion molecule-1 
(sICAM-1) and flow-mediated vasodilation (FMD) were measured as markers of 
endothelial function. In the total study group, lutein and lycopene were inversely 
related to sICAM-1. p-Carotene was inversely related to leucocytes and CRP. 
Vitamin C was inversely related to CRP, whereas a-tocopherol was positively 
related to CRP. Zeaxanthin was inversely related to FMD. No significant 
associations were found between carotenoids, vitamins and fibrinogen. The inverse 
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relations between carotenoids, vitamin C and sICAM-1, CRP and leucocytes may 
help to explain the possibly protective effect of carotenoids and vitamin C on 
atherosclerosis through an influence on inflammatory processes and endothelial 
function (Chapter 5). 
Intervention studies 
SPE products lower concentrations of serum carotenoids in short-term studies. 
Experimental studies on the longer-term effects on health of decreased carotenoid 
concentrations are lacking. A 1-year randomized, double blind, placebo-controlled 
parallel trial was performed (Chapter 6). A total of 380 subjects were randomly 
assigned to the treatment with intakes of 0, 7, 10 or 17 g/d SPE. SPE was given in 
the form of spreads (daily consumption), chips (snackwise consumption), or both. 
Of the 380 subjects, 341 completed the study. After 1 year of intervention, serum 
lipid-adjusted carotenoids showed the largest decrease (13-33%) in the group 
consuming both SPE chips and SPE spread (17 g/d) compared with the control 
group. Consumption of SPE spread (10 g/d SPE) or SPE chips (7 g/d SPE) 
decreased carotenoid concentrations by 11-29% and 0.2-21%, respectively. In 
comparison with the control group, serum lipid-adjusted ot-tocopherol decreased 
significantly by 6-8% (all P < 0.001) in all SPE groups. No negative effects were 
observed on biomarkers of oxidative damage to DNA (comet assay), proteins 
(carbonyls), lipids (8-epi-prostaglanins F2a) and skin (minimal erythema dose), and 
functional biomarkers of eye health (macular pigment density), cardiovascular 
health (flow-mediated vasodilation), and immune status (antibodies against 
hepatitis B vaccination) despite the decreased concentrations of carotenoids. These 
results suggest that substantial decreases in serum carotenoid concentrations do not 
imply an increased risk for chronic diseases. However, the relation between the 
change in biomarkers and the change in disease risk has to be established. 
A 4-week single-blind placebo-controlled human intervention study with 48 
subjects was performed to study the effect of a high but realistic intake of fruit and 
vegetables on serum carotenoids, vitamins and biomarkers of cardiovascular health 
(Chapters 7 and 8). Of the 48 subjects, 47 completed the study. In this study serum 
carotenoid concentrations increased by 22-128% in the group consuming 500 g/d 
fruit and vegetables + 200 mL fruit juice ('high' group) as compared to the group 
consuming 100 g/d fruit and vegetables ('low' group). Plasma homocysteine 
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concentrations decreased by 11% and folic acid increased by 15% in the 'high' 
group relative to the 'low' group. No effects were observed on serum lipids, blood 
pressure and markers of coagulation and fibrinolysis. Although this study did not 
have sufficient statistical power, our findings suggest that fruit and vegetables do 
not have a major impact on serum lipids and fibrinolysis/coagulation variables. Our 
results on blood-pressure are within the range of a previously reported blood 
pressure lowering effects of high fruit and vegetable consumption. The effects on 
homocysteine and blood pressure however, are mechanistically unlikely to be 
mediated by serum carotenoids. 
In Chapter 9, results described in this thesis, studying the relation between serum 
carotenoids in a normal physiological range and biomarkers are summarized and 
discussed. Furthermore, the predictive value of these biomarkers is discussed. 
Overall, our studies used biomarkers that are indicative of biological processes 
currently thought to be important in disease etiology. But the predictive value has 
not been established. Therefore, our studies cannot be conclusive for disease risk, 
but they seem to add proof to the hypothesis that decreases or increases in serum 
carotenoid concentrations within normal physiological ranges in periods up to one 
year have no or limited impact on biomarkers related to eye, skin and 
cardiovascular health. Future studies, specifically on the metabolism of carotenoids 
and follow-up studies on disease incidence, should clarify this matter further. 
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Observationele epidemiologische studies hebben aangetoond dat een hoge 
consumptie van groente en fruit, welke rijk zijn aan carotenoi'den, geassocieerd is 
met een lager risico op chronische ziekten, zoals hart- en vaatziekten, verschillende 
vormen van kanker en de oogziekten staar en macula degeneratie. De preventieve 
mechanismen zijn nog niet helemaal bekend, maar de consumptie van meer dan 
400 gram groente en fruit per dag wordt aanbevolen. De hypothese is dat het 
preventieve effect van groente en fruit voor een gedeelte verklaard kan worden 
door de aanwezigheid van carotenoi'den in groente en fruit. Produkten met 
vetvervangers, zoals bijvoorbeeld sucrose polyesters (SPE) verlagen carotenoi'den 
in het bloed. De introductie van deze producten op de markt werd met bezorgheid 
ontvangen in de wetenschappelijke wereld vanwege de daling in carotenoi'den 
niveaus na consumptie van SPE. Interventie studies die het effect onderzochten van 
hoge doseringen P-caroteen laten geen preventieve effecten zien op ziekterisico. In 
enkele gevallen werd zelfs een verhoogd risico op ziekte aangetoond. Het is aan te 
raden om de effecten te bestuderen van een normale inname van carotenoi'den op 
het ziekterisico. Interventie studies met harde eindpunten, zoals bijvoorbeeld het 
ontstaan van kanker, zijn kostbaar en tijdrovend. Het gebruik van biomarkers kan 
hierin uitkomst bieden. Biomarkers kunnen dienen als voorspellers van het effect 
van de voeding op de gezondheid of het uiteindelijk ontstaan van ziekte. 
De doelstelling van dit proefschrift was om de relatie te bestuderen tussen normale 
fysiologische concentraties van carotenoi'den in het bloed en biomarkers 
gerelateerd aan de gezondheid van het oog, huid en hart en bloedvaten in de mens. 
In een observationele studie werden de kwantitatieve relaties bestudeerd tussen 
carotenoi'den in het serum en biomarkers van gezondheid van het oog (macula 
pigment dichtheid en lensdichtheid), huid (minimale erythema dosis), en hart en 
bloedvaten (markers van endotheel functie en ontsteking). Hiervoor werd gebruik 
gemaakt van de baseline gegevens van een interventie studie. In deze studie werd 
het effect bestudeerd van een langdurige daling van carotenoi'den in het serum, als 
gevolg van SPE consumptie, op biomarkers van oxidatieve schade en functionele 
markers van de gezondheid van het oog (macula pigment), huid (minimale 
erythema dose) en hart en vaten (flow-mediated vasodilation). In een tweede 
interventie studie werd het effect van een hoge maar realistische inname van 
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groente en fruit bestudeerd op concentraties van carotenoi'den en vitamines in het 
bloed en biomarkers gerelateerd aan de gezondheid van hart en bloedvaten 
(homocysteine, serum lipiden, bloeddruk, coagulatie en fibrinolyse variabelen). 
In de introductie van dit proefschrift wordt achtergrond informatie gegeven over de 
gezondheidseffecten van carotenoi'den in relatie tot het oog, huid en hart en 
bloedvaten. Verder worden er verschillende biomarkers die gerelateerd zijn aan de 
gezondheid van het oog, huid en hart en bloedvaten besproken. 
Observationele studie 
In onze studie werden 380 proefpersonen geworven via het proefpersonen bestand 
van TNO Voeding en via advertenties in lokale en regionale kranten en op 
televisie. We probeerden om proefpersonen met een hoge en lage dagelijkse 
groente en fruit inname te selecteren met behulp van een korte vragenlijst. 
Daardoor zou het bereik in de carotenoi'den concentraties in het bloed breder zijn. 
Van de proefpersonen die de vragenlijst retourneerden, selecteerden we de mensen 
in het hoogste kwintiel en het laagste tertiel van de dagelijkse groente en fruit 
inname. De uiteindelijke groep bestond uit 178 mannen en 201 vrouwen met een 
gemiddelde leeftijd van respectievelijk 42 ± 15 en 41 ± 13 jaar. Deze groepen 
bestonden voor 33% en 27% uit rokers. 
Gezondheid van het oog 
Macula pigment (MP) is geconcentreerd in het centrale gedeelte van het netvlies in 
het oog. Het bestaat uit de carotenoi'den luteine en zeaxanthine. Een lage MP 
dichtheid kan een risicofactor zijn voor het optreden van de ouderdoms oogziekte 
macula degeneratie. In onze studie waren de kwantitieve relaties tussen 
concentraties van luteine in het serum en vetweefsel en macula pigment in mannen 
sterker dan in vrouwen (hoofdstuk 2). Een stijging van 1 standaard deviatie (SD) in 
serum luteine was geassocieerd met een stijging van 13%) in MP dichtheid. Een 
stijging van 1 SD in luteine in vetweefsel was geassocieerd met een stijging van 
11%I in MP dichtheid. Het vinden van zwakkere associaties in vrouwen zou een 
gevolg kunnen zijn van een grotere competitie in de opname van luteine in het oog 
of in het vetweefsel. Geen associaties werden gevonden tussen carotenoi'den en 
vitamines in het bloed en lens dichtheid, een marker voor het optreden van staar 
(hoofdstuk 3). Macula pigment als marker voor luteine en zeaxanthine in het oog, 
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de enige carotenoi'den die ook in de ooglens aanwezig zijn, was negatief 
geassocieerd met lens dichtheid. Dit suggereert dat luteine en zeaxanthine in het 
oog de veroudering van de lens tegen kunnen gaan. Het opname mechanisme van 
luteine en zeaxanthine in het oog is echter nog niet bekend. 
Gezondheid van de huid 
Verbranding van de huid is een bekend acuut effect van blootstelling aan ultaviolet 
(UV) licht. Blootstelling aan een lage dosis UV of een korte blootstelling wordt 
getolereerd door de huid. Alleen bij het bereiken van een drempel wordt een 
ontstekings respons gei'nduceerd, waardoor de huid rood kleurt (erytheem). Een 
bekende maat voor het meten van de gevoeligheid van de huid voor UV licht is de 
minimale erythema dosis (MED). Een MED komt overeen met de minimale 
hoeveelheid energie, die nodig is voor het induceren van net visueel zichtbare 
roodheid van de huid, 16 tot 24 uur na blootstelling. Dus een lage MED komt 
overeen met een hoge gevoeligheid voor zonlicht. Mannen waren gevoeliger voor 
zonlicht dan vrouwen (hoofdstuk 4). De concentratie van melanine in de huid, 
waardoor de huid bruin kleurt, was geassocieerd met de iriskleur in mannen en 
vrouwen en haarkleur in mannen. De melanine concentratie was de belangrijkste 
fenotypische determinant voor de gevoeligheid voor zonlicht. We vonden geen 
associaties tussen carotenoi'den en MED in de totale studie groep. Echter, de 
associaties tussen carotenoi'den en MED laten een positieve trend zien in mensen 
met een donkere huid (hoog melanine) en een negatieve trend in mensen met een 
lichte huid (laag melanine). Voor dit verstorende effect van melanine op deze 
associaties hebben we geen duidelijke biologische verklaring. 
Gezondheid van hart en bloedvaten 
Bij atherosclerose (aderverkalking) is het evenwicht in het endotheel van de 
vaatwand verstoord. Deze verstoring zou gerelateerd kunnen zijn aan oxidatieve 
stress, een verstoorde balans tussen anti-oxidatieve en pro-oxidatieve factoren. 
Carotenoi'den en vitamines zouden vanwege de antioxidant capaciteit een invloed 
kunnen hebben op endotheelfunctie en ontstekingsprocessen, waardoor het risico 
op atherosclerose verlaagd kan worden. C-reactief eiwit (CRP), fibrinogeen (Fbg) 
en witte bloedcellen werden gemeten als markers van ontsteking. Intercellulair 
adhesie-eiwit (sICAM-1) en flow-mediated vasodilation (FMD; vaatverwijding 
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door toegenomen bloeddoorstroming) werden gemeten als markers van endotheel 
functie. In de totale studie groep, waren lutei'ne en lycopene negatief geassocieerd 
met sICAM-1. P-Carotene was negatief geassocieerd met CRP en leukocyten. 
Vitamine C was negatief geassocieerd met CRP en vitamine E was positief 
geassocieerd met CRP. Zeaxanthine was inverse geassocieerd met endotheel 
functie, gemeten met FMD. Er werden geen associaties gevonden tussen 
fibrinogeen en carotenoi'den en vitamines. Deze inverse associaties tussen 
carotenoi'den, vitamin C en sICAM-1, CRP en witte bloedcellen dragen bij aan de 
mogelijke verklaring dat carotenoi'den en vitamine C een beschermend effect 
hebben op het risico voor atherosclerose als gevolg van een invloed op 
ontstekingsprocessen en endotheelfunctie. 
Interventie studies 
Resultaten van korte termijn studies laten zien dat produkten met SPE de 
concentraties van carotenoi'den in het bloed verlagen. Studies waarin de lange 
termijn effecten van deze verlaagde carotenoi'den concentraties bestudeerd worden, 
zijn nog niet uitgevoerd. Daarom hebben wij een 1-jaar durende, gerandomiseerde, 
dubbel-blinde, placebo-gecontroleerde studie uitgevoerd. 380 mensen werden 
verdeeld over 4 behandelingen met een inname van 0, 7, 10 of 17 gram SPE per 
dag (hoofdstuk 6). Dit werd gegeven in de vorm van smeersel (dagelijkse 
consumptie), chips (snack consumptie) of beide. Van de 380 mensen hebben 341 
mensen de studie afgemaakt. Na een jaar waren de carotenoi'den concentraties 
(aangepast aan lipiden concentraties in het bloed; gestandaardiseerd) gedaald met 
13-33% in de groep die zowel chips als smeersel met SPE consumeerde (17 
gram/dag) in vergelijking met de controle groep (0 gram/dag SPE). In de groepen 
die alleen smeersel met SPE (10 gram/dag SPE) of chips met SPE (7 gram/dag 
SPE) consumeerden, daalden de gestandaardiseerde carotenoi'den concentraties 
respectievelijk met 11 tot 29% en 0,2 tot 21%. 
In vergelijking met de controle groep, daalden de gestandaardiseerde a-tocopherol 
concentraties met 6-8% (P < 0.001) in alle SPE groepen. Ondanks de sterke 
dalingen in carotenoi'den concentraties, werden er geen negatieve effecten 
gevonden op biomarkers voor oxidatieve schade aan DNA, het erfelijk materiaal 
van de mens (comet assay), vetten (8-epi-prostaglandines F2a), eiwitten (carbonyls) 
en de huid (minimal erythema dosis), en functionele biomarkers voor de 
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gezondheid van het oog (macula pigment dichtheid), hart en vaten (FMD) en 
immuun status (geproduceerde antilichamen na een hepatitis B vaccinatie). Deze 
studie suggereert dat een behoorlijke caroteno'iden daling niet geassocieerd is met 
een verhoogd risico op chronische ziekten. Echter, de relatie tussen een 
verandering in deze biomarkers en een verandering in het risico op ziekte moet nog 
worden vastgesteld. 
In een tweede interventiestudie (enkel-blind, placebo-gecontroleerd) van 4 weken 
met 48 mensen werd het effect bestudeerd van een hoge maar realistische inname 
van groente en fruit op caroteno'iden, vitamines in het bloed en biomarkers van 
hart- en vaatgezondheid (hoofdstuk 7 en 8). In deze studie stegen de caroteno'iden 
concentraties met 22-128% in de groep waarin de mensen 500 gram groente en 
fruit en 200 ml vruchtensap (hoge groep) per dag consumeerden in vergelijking 
met de groep waarin de mensen 100 gram groente en fruit (lage groep) per dag 
consumeerden. Homocysteine concentraties daalden met 11% en foliumzuur 
concentraties stegen met 15% in de hoge groep in vergelijking met de lage groep. 
Geen effecten werden gevonden op bloedlipiden, bloeddruk en markers van 
coagulatie en fibrinolyse. Onze resultaten voor bloeddruk vallen binnen het bereik 
van de resultaten van een ander onderzoek, waarin werd aangetoond dat na een 
hoge groente en fruitconsumptie de bloeddruk kan dalen. De effecten op 
homocysteine en bloeddruk na groente en fruit consumptie zijn waarschijnlijk niet 
gerelateerd aan de stijgende caroteno'iden concentraties. 
In hoofdstuk 9 worden de resultaten die beschreven zijn in dit proefschrift 
samengevat en bediscussieerd. Verder wordt de voorspellende waarde voor ziekte 
en gezondheid van de verschillende biomarkers bediscussieerd. In onze studies 
maakten we gebruik van biomarkers die indicatief zijn voor biologische processen, 
die mogelijk ten grondslag liggen aan de ontwikkeling van ziekten. Van deze 
biomarkers is de voorspellende waarde voor het ontstaan van ziekte alleen nog niet 
vastgesteld. Daarom kunnen we uit onze studies geen conclusies trekken wat 
betreft ziekterisico. Echter, deze resultaten dragen bij aan de hypothese dat 
stijgingen en dalingen van serum caroteno'iden binnen een normaal fysiologisch 
bereik, geen effect hebben op biomarkers gerelateerd aan de gezondheid van het 
oog, huid en hart en bloedvaten. Verdere studies die het metabolisme van 
caroteno'iden bestuderen en de incidentie van ziekte zouden kunnen bijdragen aan 
dit onderwerp. 
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opmerkingen nooit vergeten. Evelijn, Ellen en Lucy, we hebben heel wat 
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kilometers afgelegd op de fiets van Utrecht naar Zeist. Dat uurtje fietsen per dag 
met de lekker ontspannende gesprekken mis ik nu al. 
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met Romain, Jane, Martijn, Judith, Tiny, Margje, Mariska, Machteld, Alida, Siti, 
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goede zet om iedereen wat beter te leren kennen. Bedankt voor jullie gezelligheid. 
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stonden voor de proefpersonen, waardoor de studies goed zijn verlopen. Alle 
mensen op de labs bedankt voor de uitvoer van de vele analyses. Ook wil ik graag 
Tos Berendschot, Michiel Bots, Kees Kluft, Hans Princen, Jan Weststrate en Lilian 
Tijburg bedanken voor hun bijdrage aan het onderzoek en de prettige 
samenwerking. 
Vanessa en Judith, het contact dat we hadden in Maastricht is de afgelopen jaren 
alleen maar beter geworden. Ik vind het daarom ook heel erg leuk dat jullie straks 
als paranimfen naast me staan in de aula in Wageningen. V., jouw korte 
motiverende emailtjes kwamen altijd op het goede moment en bevestigden jouw 
medeleven. Ik vond het erg leuk en gezellig om de afgelopen jaren samen met jou 
in Zeist te werken. Trouwens, volgend jaar gaan we wel de tennisfinale winnen in 
Zevenaar. Judith, jij was mijn vaste punt in Wageningen. Bedankt voor je 
luisterend oor, gezelligheid en vele kopjes thee in Wageningen. Wanneer gaan we 
samen weer op cursus? Want die zijn zeker voor herhaling vatbaar. 
Sacha, Cindy, Nicole, Klaartje en Violet: ondanks onze verschillende studies, 
banen en woonplaatsen zijn we elkaar gelukkig nog steeds niet uit het oog verloren. 
Bedankt voor jullie interesse en de dagjes/weekendjes uit houden we er zeker in de 
komende jaren. Lieve pap, mam en Miriam, bedankt voor jullie interesse, dat jullie 
altijd voor mij klaarstaan en trots op me zijn. En natuurlijk niet te vergeten, lieve 
Marc, bedankt voor alles en voor jou een hele dikke zoen! Ik vind het echt 
geweldig dat we dit jaar nog een bijzondere dag voor ons tweetjes in het 
vooruitzicht hebben. 
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